| LncBook ID
|
Symbol
|
Synonyms
|
Functional Mechanism
|
Biological Process
|
Disease
|
Mesh Ontology
|
| HSALNT0289501
|
HPVC1
|
PE5L,HPV18E5L
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0289605
|
Alpha 250/ Alpha 280
|
NONHSAT104559,lnc-C9orf53-2:1
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0199632
|
N4BP2L2-IT2
|
CG030
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0171094
|
LINC01150
|
2G7,TCONS_00019134
|
NA
|
pathogenic process
|
Wilms' tumor
|
Neoplasms
|
| HSALNT0289115
|
LINC01587
|
C4orf6,aC1
|
NA
|
pathogenic process
|
neuroblastoma
|
Neoplasms
|
| HSALNT0290105
|
NTT
|
NONHSAT115106
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289234
|
RNF217-AS1
|
STL
|
NA
|
pathogenic process
|
acute lymphoblastic leukemia
|
Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases
|
| HSALNT0280481
|
INE2
|
NCRNA00011
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289485
|
INE1
|
NCRNA00010
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289511
|
LINC01565
|
C3orf27,GR6
|
NA
|
pathogenic process
|
leukemia
|
Neoplasms
|
| HSALNT0289068
|
LINC00869
|
KIAA0493
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289430
|
ERC2-IT1
|
C1orf1,C3orf51,Po42
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0290394
|
Y RNAs
|
lnc-PDIA4-1:1
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289195
|
NOP14-AS1
|
C4orf10,RES4-24
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0290309
|
TncRNA
|
NONHSAT022116,AF080092,TSU
|
NA
|
developmental process
|
NA
|
NA
|
| HSALNT0289243
|
SMAD5-AS1
|
SMAD5O,DAMS
|
NA
|
pathogenic process
|
malignant hematopoietic
|
Cell Physiological Phenomena
|
| HSALNT0289025
|
LINC00244
|
C7orf4,NCRNA00244
|
NA
|
pathogenic process
|
preaxial polydactyly
|
NA
|
| HSALNT0289017
|
KIF25-AS1
|
C6orf54,NCRNA00300,HGC6.1.1
|
NA
|
pathogenic process
|
ovarian cancer
|
Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0289332
|
LINC01558
|
C6orf123,LINC01557,HGC6.2,dJ431P23.4
|
NA
|
pathogenic process
|
ovarian cancer
|
Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0289438
|
AFDN-AS1
|
C6orf124,MLLT4-AS1,HGC6.4,dJ431P23.3
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0289232
|
RFPL3S
|
RFPL3-AS1,RFPL3-A, NCRNA00005
|
NA
|
pathogenic process
|
opitz syndrome
|
NA
|
| HSALNT0289393
|
RFPL1S
|
RFPL1-AS1,RFPL1-A, NCRNA00006
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0289500
|
HCG4B
|
HCG4P6,HCGIV-6,HCGIV.5,HCGIV-06,bCX67J3.3,Em:AB023056.16,bPG309N1.1,bQB90C11.3
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289894
|
LINC00294
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289345
|
LINC00893
|
NA
|
NA
|
pathogenic process
|
hunter syndrome
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
|
| HSALNT0290133
|
PCBP3-OT1
|
PCBP3-OT1,FLJ44028
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289488
|
BPESC1
|
NCRNA00187
|
NA
|
pathogenic process
|
blepharophimosis syndrome
|
Eye Diseases
|
| HSALNT0289712
|
COPG2IT1
|
CIT1,NCRNA00170,COPG2AS
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0265040
|
LINC00652
|
HSPC072
|
NA
|
developmental process
|
NA
|
NA
|
| HSALNT0289282
|
WASIR2
|
NCRNA00286A
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0246856
|
LINC00470
|
C18orf2
|
NA
|
pathogenic process
|
age-related macular degeneration
|
Eye Diseases
|
| HSALNT0289507
|
LINC00588
|
C8orf71,DKFZP434F122
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0276604
|
TTC28-AS1
|
TTC28AS,TTC28-AS,KIAA1648
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0237577
|
CDRT7
|
NCRNA00025,LINC00025
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0288912
|
CDRT8
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0275048
|
CECR3
|
NA
|
NA
|
pathogenic process
|
cat eye syndrome
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
|
| HSALNT0288915
|
CECR9
|
NA
|
NA
|
pathogenic process
|
cat eye syndrome
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
|
| HSALNT0288998
|
HDHD5-AS1
|
CECR4,CECR5-AS1,NCRNA00017
|
NA
|
pathogenic process
|
cat eye syndrome
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
|
| HSALNT0288914
|
CECR5-AS1
|
NCRNA00017
|
NA
|
pathogenic process
|
cat eye syndrome
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
|
| HSALNT0288919
|
CLRN1-AS1
|
CLRN1O,UCRP
|
NA
|
pathogenic process
|
usher syndrome type 3
|
NA
|
| HSALNT0289271
|
TMEM9B-AS1
|
C11orf18
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289324
|
LINC01547
|
C21orf69,C21orf67
|
NA
|
pathogenic process
|
Down syndrome
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
|
| HSALNT0270409
|
LINC00029
|
C20orf51,NCRNA00029,bA305P22.4
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289336
|
LINC00529
|
C8orf8
|
NA
|
pathogenic process
|
keratolytic winter erythema
|
NA
|
| HSALNT0288978
|
FLVCR1-AS1
|
FLVCR1-DT,LQK1
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0238050
|
SMCR2
|
NA
|
NA
|
pathogenic process
|
Smith-Magenis syndrome
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
|
| HSALNT0289401
|
SMCR5
|
NCRNA00034
|
NA
|
pathogenic process
|
Smith-Magenis syndrome
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
|
| HSALNT0290246
|
SMCR6
|
NA
|
NA
|
pathogenic process
|
Smith-Magenis syndrome
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
|
| HSALNT0274626
|
LINC00205
|
C21orf86,NCRNA00205,
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0271512
|
C21orf91-OT1
|
NCRNA00285,D21S2089E
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0272596
|
LINC00307
|
NCRNA00307,D21S2091E
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0274502
|
TSPEAR-AS2
|
C21orf90
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0274807
|
MCM3AP-AS1
|
C21orf85,MCM3APAS,MCM3AP-AS,FLJ10508,NCRNA00031
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0288888
|
B3GALT5-AS1
|
C21orf88
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0288898
|
BRWD1-AS2
|
C21orf87,NCRNA00257,BRWD1-IT2
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289031
|
LINC00315
|
C21orf93,NCRNA00315
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289033
|
LINC00334
|
C21orf89,NCRNA00334
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289322
|
LINC00314
|
C21orf94,NCRNA00314
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0271821
|
LINC00308
|
C21orf74,NCRNA00308,PRED16
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0289023
|
LINC00189
|
C21orf109,NCRNA00189
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0289375
|
NCRUPAR
|
ncR-uPAR,ncRuPAR,NCRNA00193
|
transcriptional regulation
|
developmental process
|
NA
|
NA
|
| HSALNT0273467
|
DSCR10
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289480
|
DSCR9
|
NCRNA00038
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0290051
|
MDS2
|
NA
|
NA
|
pathogenic process
|
myelodysplastic syndrome
|
Hemic and Lymphatic Diseases
|
| HSALNT0127810
|
ST7-AS2
|
ST7OT2,ST7AS2
|
NA
|
pathogenic process
|
autism
|
Mental Disorders
|
| HSALNT0127813
|
ST7-OT3
|
ST7OT3,NCRNA00026
|
NA
|
pathogenic process
|
autism
|
Mental Disorders
|
| HSALNT0290258
|
ST7-OT4
|
NA
|
NA
|
pathogenic process
|
autism
|
Mental Disorders
|
| HSALNT0290257
|
ST7OT
|
NONHSAT122926
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289372
|
MIR600HG
|
C9orf45,NCRNA00287,GL012,FLJ22161
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0013239
|
ATP1A1-AS1
|
C1orf203,ATP1A1OS,MGC16179
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0048563
|
SPATA3-AS1
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0050859
|
LINC00852
|
C3orf42,GHRLOS2,NAG73,GHRL-AS2
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0069395
|
LINC01096
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0072367
|
LINC02260
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0077259
|
LINC01091
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0096480
|
SAP30L-AS1
|
FLJ38109,GALNT10-AS1
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0098558
|
PRR7-AS1
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0099356
|
LINC01622
|
TCONS_00011202
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0113415
|
LINC01312
|
MGC34034
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0134652
|
EXTL3-AS1
|
C8orf50
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0138253
|
C8orf34-AS1
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0154876
|
PSMD5-AS1
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0163228
|
LINC01553
|
C10orf40,AC023904.2
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0175689
|
LINC00301
|
C11orf64,NCRNA00301,MGC39681
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0247235
|
DLGAP1-AS3
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0254200
|
CIRBP-AS1
|
C19orf23,MGC39338
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0257335
|
LINC01785
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0261582
|
LINC01869
|
MGC45922
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0269743
|
LINC01711
|
MGC4294
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0288468
|
FAM41AY1
|
FAM41AY
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0288899
|
C5orf66-AS2
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0288922
|
CSTF3-AS1
|
CSTF3-DT
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0288923
|
CYP1B1-AS1
|
C2orf58,MGC34824
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0288957
|
ENTPD3-AS1
|
FLJ36665
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0288970
|
FAM27E3
|
MGC42630
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0288972
|
FAM41C
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0288977
|
FLG-AS1
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0288983
|
GABPB1-IT1
|
FLJ10038
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289010
|
ILF3-AS1
|
ILF3-DT
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289034
|
LINC00347
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289039
|
LINC00466
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289040
|
LINC00471
|
C2orf52,MGC43122
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289044
|
LINC00526
|
C18orf18,MGC17515,HsT959
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289048
|
LINC00593
|
C15orf50,MGC42951
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289050
|
LINC00608
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289054
|
LINC00638
|
MGC23270
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289056
|
LINC00661
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289057
|
LINC00662
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289062
|
LINC00692
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289064
|
LINC00705
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289067
|
LINC00868
|
C17orf52
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0130693
|
LINC00996
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289101
|
LINC01252
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289131
|
LINC02135
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289193
|
NIFK-AS1
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289244
|
SMG7-AS1
|
DKFZP564C196
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0235326
|
SNAI3-AS1
|
MGC23284
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0215205
|
SNHG10
|
C14orf62,FLJ40557,NCRNA00063,LINC00063
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289290
|
ZNF205-AS1
|
MGC3771
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289294
|
LINC00260
|
C1orf217,NCRNA00260,MGC5457
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289295
|
LINC00337
|
C1orf211,NCRNA00337,MGC40168
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289298
|
WAC-AS1
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289299
|
LINC00839
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289303
|
LINC00612
|
C12orf33,MGC40170,FLJ41814
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289312
|
LINC00663
|
MGC39821
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289320
|
LINC00494
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289330
|
LINC01019
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289333
|
LINC00265
|
NCRNA00265,NCRNA00265-1
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289334
|
LINC00689
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289337
|
LINC01591
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289340
|
LINC01501
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289346
|
LINC01560
|
CXorf24
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289352
|
LINC01959
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289353
|
LINC02175
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289354
|
LINC02209
|
FAM183CP
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289359
|
LINGO1-AS1
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289362
|
MAFG-AS1
|
MAFG-DT
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289373
|
MORF4L2-AS1
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289381
|
NPHP3-AS1
|
NCRNA00119
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289385
|
PAXIP1-AS1
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289413
|
TOLLIP-AS1
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289416
|
LINC00311
|
TMEM148,NCRNA00311,MGC22001
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289422
|
ZNF252P-AS1
|
C8orf77
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289423
|
ZNF436-AS1
|
C1orf213,FLJ90508
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289429
|
BFSP2-AS1
|
MGC2848
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289432
|
CTBP1-AS1
|
C4orf42,CTBP1-DT,CTBP1-DT,MGC21675
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289436
|
EXOC3-AS1
|
C5orf55
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289441
|
HCG27
|
bPG299F13.9,bCX101P6.9,bQB115I13.2,FLJ40123
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289450
|
BAALC-AS2
|
C8orf56,BAALCOS,MGC39526
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289453
|
FAM87A
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289459
|
JMJD1C-AS1
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289465
|
ATP2B1-AS1
|
LINC00936
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289466
|
CEP83-AS1
|
CEP83-DT
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289470
|
HEXA-AS1
|
C15orf34,FLJ13315
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289487
|
BIN3-IT1
|
FLJ14107
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289490
|
CSNK1G2-AS1
|
C19orf34,MGC39696
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289508
|
LINC00634
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289510
|
LINC00685
|
CXYorf10,NCRNA00107,PPP2R3B-AS1,OTTHUMT00000055574
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289515
|
SHANK2-AS3
|
C11orf76
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0290073
|
NCBP2-AS2
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289502
|
KCNIP4-IT1
|
NCRNA00099,UM9-5
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289856
|
GTSCR1
|
NA
|
NA
|
pathogenic process
|
Gilles de la Tourette syndrome
|
Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
|
| HSALNT0289325
|
LINC00272
|
C1orf120,NCRNA00272,RP1-223H12.3
|
NA
|
pathogenic process
|
prostate cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0288512
|
TTTY9B
|
NCRNA00132
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0290155
|
Prion-associated RNAs
|
NA
|
NA
|
pathogenic process
|
prion disease
|
Nervous System Diseases
|
| HSALNT0289444
|
BLACE
|
NA
|
NA
|
pathogenic process
|
acute B lymphoblastic leukemias
|
Hemic and Lymphatic Diseases
|
| HSALNT0060411
|
H1FX-AS1
|
C3orf47,FLJ34151
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0186668
|
LINC00477
|
C12orf67,FLJ32894,FAM191B
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0275096
|
LINC00528
|
C22orf37,FLJ40542
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0287824
|
ASMTL-AS1
|
CXYorf2,NCRNA00105,ASMTLAS,ASMTL-AS,FLJ13330
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0288887
|
ANP32A-IT1
|
C15orf28,NCRNA00321,FLJ11722,HsT18971
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289370
|
MIR29B2CHG
|
C1orf132,FLJ35650
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289396
|
RUSC1-AS1
|
C1orf104,FLJ35976
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0084628
|
LINC01194
|
CT49,TAG
|
NA
|
pathogenic process
|
melanoma
|
Neoplasms
|
| HSALNT0289468
|
DIO3OS
|
C14orf134,NCRNA00041,DIO3-AS1,NONHSAT040032,NONHSAT040039,BC111049
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0121060
|
NPSR1-AS1
|
AAA1,IMAGE:4827585
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0074370
|
LINC00575
|
C4orf11
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0137345
|
LINC01602
|
T1560
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0289433
|
FAM13A-AS1
|
FAM13A1OS,FAM13AOS,NCRNA00039
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289186
|
MIRLET7DHG
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0155254
|
MIR181A2HG
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289283
|
WDFY3-AS2
|
C4orf12,NCRNA00247,FBI4
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0154555
|
PAPPA-AS1
|
PAPPAS,PAPPA-AS,DIPAS,TAF4B,TAF2C2,TAFII105,NCRNA00156
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0136307
|
LINC00293
|
BEYLA
|
NA
|
developmental process
|
NA
|
NA
|
| HSALNT0030983
|
SIX3-AS1
|
SIX3OS
|
NA
|
developmental process
|
NA
|
NA
|
| HSALNT0211503
|
OTX2-AS1
|
OTX2OS1
|
NA
|
developmental process
|
NA
|
NA
|
| HSALNT0063422
|
LINC01192
|
CT64
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0217123
|
LINC01193
|
CT60,LOC348120
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289664
|
C1QTNF9B-AS1
|
PCOTH
|
NA
|
pathogenic process
|
prostate cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0289623
|
ATP6V1G2-DDX39B
|
NA
|
NA
|
pathogenic process
|
dilated cardiomyopathy
|
Cardiovascular Diseases
|
| HSALNT0289498
|
FAM226B
|
CXorf50B,NCRNA00246B,LINC00246B
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289321
|
LINC00163
|
C21orf134,NCRNA00163,NLC1-A,NLC1A
|
NA
|
pathogenic process
|
narcolepsy
|
Mental Disorders;Nervous System Diseases
|
| HSALNT0289505
|
LINC00165
|
C21orf135,NCRNA00165,NLC1-B
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0290297
|
TEA-ncRNAs
|
ENSG00000251002
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0274212
|
LINC00322
|
C21orf136,NCRNA00322,FLJ16545
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289741
|
DHFR upstream transcripts
|
DHFR minor transcript 5'-UTR,ENSG00000228716,NONHSAT102417
|
transcriptional regulation
|
NA
|
NA
|
NA
|
| HSALNT0289527
|
21A
|
ncRNA 21A,NONHSAT128494
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289409
|
TLX1NB
|
TD1,TDI,APT-B7
|
NA
|
pathogenic process
|
leukemogenesis
|
Hemic and Lymphatic Diseases
|
| HSALNT0289662
|
C15orf2
|
NA
|
NA
|
pathogenic process
|
Angelman syndrome
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
|
| HSALNT0290097
|
NPAP1
|
NA
|
NA
|
pathogenic process
|
Angelman syndrome
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
|
| HSALNT0217406
|
PWRN2
|
NCRNA00199
|
NA
|
pathogenic process
|
Prader-Willi syndrome
|
Nutritional and Metabolic Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
|
| HSALNT0289227
|
PWRN1
|
NCRNA00198
|
NA
|
pathogenic process
|
Prader-Willi syndrome
|
Nutritional and Metabolic Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
|
| HSALNT0262816
|
MIMT1
|
MIM1,NCRNA00067,LINC00067
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289180
|
MIR34AHG
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289357
|
LINC02570
|
XXbac-BPG27H4.8
|
NA
|
pathogenic process
|
MHC-associated diseases
|
Immune System Diseases
|
| HSALNT0290177
|
RNY1
|
NA
|
NA
|
pathogenic process
|
cervix cancer;prostate cancer;colorectal cancer;bladder cancer;kidney cancer;lung cancer
|
Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases
|
| HSALNT0289378
|
NKX2-2-AS1
|
NKX2-2AS
|
transcriptional regulation
|
pathogenic process
|
NA
|
NA
|
| HSALNT0290151
|
PR antisense transcripts
|
FJ515872.1,NONHSAT023851
|
transcriptional regulation
|
NA
|
NA
|
NA
|
| HSALNT0180290
|
PGR-AS1,PR antisense transcripts
|
AT1,AT2,AT3
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289607
|
anti-NOS2A
|
NA
|
NA
|
pathogenic process
|
meningioma;glioblastoma
|
Neoplasms;Nervous System Diseases
|
| HSALNT0289687
|
CDKN1A-AS1
|
p21NAT
|
transcriptional regulation
|
NA
|
NA
|
NA
|
| HSALNT0289166
|
MEG9
|
LINC00584
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0116668
|
RPS6KA2-AS1
|
NA
|
NA
|
pathogenic process
|
breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0289384
|
PAPPA-AS2
|
AGU1
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0262802
|
ZIM2-AS1
|
ZIM2as
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289824
|
Evf2
|
Evf-2,Dlx6as1,Dlx6os1,ENSG00000231764, ENST00000430027.2,lnc-DLX5-3:1
|
transcriptional regulation
|
NA
|
NA
|
NA
|
| HSALNT0289481
|
ADORA2A-AS1
|
C22orf45,FLJ34651
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0290146
|
POU5F1P4
|
NA
|
NA
|
pathogenic process
|
prostate cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0290033
|
LSINCT1
|
NA
|
NA
|
pathogenic process
|
lung cancer;breast cancer
|
Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0290034
|
LSINCT10
|
NA
|
NA
|
pathogenic process
|
lung cancer;breast cancer
|
Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0290035
|
LSINCT11
|
NA
|
NA
|
pathogenic process
|
lung cancer;breast cancer
|
Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0290036
|
LSINCT12
|
NA
|
NA
|
pathogenic process
|
lung cancer;breast cancer
|
Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0290037
|
LSINCT2
|
NA
|
NA
|
pathogenic process
|
lung cancer;breast cancer
|
Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0290038
|
LSINCT3
|
NA
|
NA
|
pathogenic process
|
lung cancer;breast cancer
|
Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0290039
|
LSINCT4
|
NA
|
NA
|
pathogenic process
|
lung cancer;breast cancer
|
Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0290041
|
LSINCT6
|
NA
|
NA
|
pathogenic process
|
lung cancer;breast cancer
|
Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0290042
|
LSINCT7
|
NA
|
NA
|
pathogenic process
|
lung cancer;breast cancer
|
Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0290043
|
LSINCT8
|
NA
|
NA
|
pathogenic process
|
lung cancer;breast cancer
|
Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0290044
|
LSINCT9
|
NA
|
NA
|
pathogenic process
|
lung cancer;breast cancer
|
Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0289676
|
CAR Intergenic 10
|
FLJ31066,NONHSAT016928,lnc-FANK1-3:1
|
transcriptional regulation
|
NA
|
NA
|
NA
|
| HSALNT0290032
|
LRRC3DN
|
C21orf30,DKFZP434C128
|
transcriptional regulation
|
NA
|
NA
|
NA
|
| HSALNT0266984
|
SNHG11
|
C20orf198,LINC00101,NCRNA00101
|
NA
|
pathogenic process
|
obesity
|
Nutritional and Metabolic Diseases
|
| HSALNT0289880
|
KRASP1
|
NONHSAT113225,ENSG00000220635
|
ceRNA
|
NA
|
NA
|
NA
|
| HSALNT0006368
|
CYP4A22-AS1
|
ncRNA-a3
|
transcriptional regulation
|
NA
|
NA
|
NA
|
| HSALNT0027470
|
LINC00570
|
ncRNA-a5
|
transcriptional regulation
|
NA
|
NA
|
NA
|
| HSALNT0289066
|
LINC00853
|
PDZK1IP1-AS1,ncRNA-a4
|
transcriptional regulation
|
NA
|
NA
|
NA
|
| HSALNT0289936
|
lincRNA-ROR
|
ROR,lincRNA-ST8SIA3,ENSG00000258609,NONHSAT059436
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289705
|
CHL1-AS2
|
NA
|
NA
|
pathogenic process
|
adolescent idiopathic scoliosis
|
Musculoskeletal Diseases
|
| HSALNT0076084
|
SEC24B-AS1
|
1/2-SBSRNA4
|
siRNA
|
NA
|
NA
|
NA
|
| HSALNT0290137
|
PDZRN3-AS1
|
NA
|
NA
|
pathogenic process
|
type 2 diabetes
|
Nutritional and Metabolic Diseases;Endocrine System Diseases
|
| HSALNT0290237
|
SCAANT1
|
ATXN7-AS1
|
transcriptional regulation
|
pathogenic process
|
spinocerebellar ataxia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
|
| HSALNT0289594
|
AK123790
|
NA
|
NA
|
pathogenic process
|
hepatocelluar cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289911
|
LINC01451
|
NA
|
NA
|
pathogenic process
|
hepatocelluar cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290401
|
ZNF350-AS1
|
NA
|
NA
|
pathogenic process
|
hepatocelluar cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289845
|
GADD45G
|
NA
|
NA
|
pathogenic process
|
pituitary adenoma
|
Endocrine System Diseases;Neoplasms;Nervous System Diseases
|
| HSALNT0289410
|
TMEM161B-AS1
|
AK082072,linc-POLR3G-8,ENSG00000247828
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289736
|
DAPK1
|
NA
|
NA
|
pathogenic process
|
Pancreatic ductal adenocarcinoma
|
Neoplasms
|
| HSALNT0290048
|
MAP3K14
|
MAP3K14
|
NA
|
pathogenic process
|
Pancreatic ductal adenocarcinoma
|
Neoplasms
|
| HSALNT0290150
|
PPP3CB
|
NA
|
NA
|
pathogenic process
|
Pancreatic ductal adenocarcinoma
|
Neoplasms
|
| HSALNT0151531
|
DAPK1-IT1
|
NA
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0288990
|
GDNF-AS1
|
GDNFOS
|
transcriptional regulation
|
pathogenic process
|
Alzheimer's disease
|
Mental Disorders;Nervous System Diseases
|
| HSALNT0029702
|
BIRC6-AS2
|
megamind
|
NA
|
developmental process
|
NA
|
NA
|
| HSALNT0029692
|
BIRC6-AS1
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289310
|
LINC00854
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0290332
|
uc.73
|
NA
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289841
|
FR0257520
|
NA
|
NA
|
pathogenic process
|
prostate cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0290104
|
NRG1
|
NA
|
NA
|
pathogenic process
|
lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0289689
|
CDKN2B-AS11
|
NA
|
NA
|
pathogenic process;developmental process
|
stroke
|
Cardiovascular Diseases;Nervous System Diseases
|
| HSALNT0289690
|
CDKN2B-AS12
|
NA
|
NA
|
pathogenic process
|
glioma
|
Neoplasms
|
| HSALNT0289691
|
CDKN2B-AS13
|
NA
|
NA
|
pathogenic process
|
plexiform neurofibroma
|
Neoplasms;Nervous System Diseases
|
| HSALNT0289697
|
CDKN2B-AS7
|
NA
|
NA
|
pathogenic process
|
acute lymphoblastic leukemia
|
Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases
|
| HSALNT0289826
|
FADS1
|
NA
|
NA
|
pathogenic process
|
lipid metabolism disorder
|
Nutritional and Metabolic Diseases
|
| HSALNT0289698
|
CDKN2B-AS8
|
NA
|
NA
|
pathogenic process
|
melanoma
|
Neoplasms
|
| HSALNT0289696
|
CDKN2B-AS6
|
NA
|
NA
|
pathogenic process
|
neuroblastoma
|
Neoplasms
|
| HSALNT0289699
|
CDKN2B-AS9
|
NA
|
NA
|
pathogenic process
|
prostate cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0289688
|
CDKN2B-AS10
|
NA
|
NA
|
pathogenic process
|
stroke
|
Cardiovascular Diseases;Nervous System Diseases
|
| HSALNT0288950
|
ENST00000456816
|
NA
|
NA
|
pathogenic process
|
clear cell renal cell cancer
|
Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0290021
|
LOC389332
|
NA
|
NA
|
pathogenic process
|
clear cell renal cell cancer
|
Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0290306
|
TMEM72
|
NA
|
NA
|
pathogenic process
|
clear cell renal cell cancer
|
Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0289641
|
BC029135
|
NA
|
NA
|
pathogenic process
|
renal clear cell cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0290374
|
X91348
|
NA
|
NA
|
pathogenic process
|
renal clear cell cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0289694
|
CDKN2B-AS4
|
NA
|
NA
|
pathogenic process
|
cancer
|
Neoplasms
|
| HSALNT0289692
|
CDKN2B-AS2
|
NA
|
NA
|
pathogenic process
|
coronary heart disease
|
Cardiovascular Diseases
|
| HSALNT0289693
|
CDKN2B-AS3
|
NA
|
NA
|
pathogenic process
|
intracranial aneurysm
|
Cardiovascular Diseases;Nervous System Diseases
|
| HSALNT0289695
|
CDKN2B-AS5
|
NA
|
NA
|
pathogenic process
|
type 2 diabetes
|
Nutritional and Metabolic Diseases;Endocrine System Diseases
|
| HSALNT0290319
|
T-UCRs
|
NA
|
NA
|
pathogenic process
|
neuroblastoma
|
Neoplasms
|
| HSALNT0289530
|
51A
|
NA
|
splicing regulation
|
pathogenic process
|
Alzheimer's disease
|
Mental Disorders;Nervous System Diseases
|
| HSALNT0290163
|
RAB4B-EGLN2
|
NA
|
NA
|
pathogenic process
|
cancer
|
Neoplasms
|
| HSALNT0290167
|
RERT
|
NA
|
NA
|
pathogenic process
|
hepatocellular cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0265263
|
LINC00237
|
NCRNA00237
|
NA
|
pathogenic process
|
macrocephaly;obesity
|
Musculoskeletal Diseases;Pathological Conditions, Signs and Symptoms;Nutritional and Metabolic Diseases;Physiological Phenomena
|
| HSALNT0267186
|
LINC01370
|
HI-LNC25,HILNC25
|
NA
|
pathogenic process
|
type 2 diabetes
|
Nutritional and Metabolic Diseases;Endocrine System Diseases
|
| HSALNT0289114
|
LINC01574
|
HI-LNC12,TCONS_00009551
|
NA
|
pathogenic process
|
type 2 diabetes
|
Nutritional and Metabolic Diseases;Endocrine System Diseases
|
| HSALNT0290159
|
PTHLH
|
NA
|
NA
|
pathogenic process
|
brachydactyly
|
Musculoskeletal Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities
|
| HSALNT0189394
|
CISTR
|
CISTR-ACT,CISTRACT,re52431
|
transcriptional regulation
|
pathogenic process
|
brachydactyly
|
Musculoskeletal Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities
|
| HSALNT0289862
|
HELLPAR
|
LINC-HELLP
|
NA
|
pathogenic process
|
HELLP syndrome
|
Female Urogenital Diseases and Pregnancy Complications
|
| HSALNT0289904
|
LINC01125
|
NA
|
NA
|
pathogenic process
|
uremia
|
Male Urogenital Diseases
|
| HSALNT0289544
|
AC002511.1
|
LINC01531
|
NA
|
pathogenic process
|
enterovirus 71 infection
|
Virus Diseases
|
| HSALNT0289609
|
AP000688.29
|
AP000688.2
|
NA
|
pathogenic process
|
enterovirus 71 infection
|
Virus Diseases
|
| HSALNT0289832
|
FFAR2
|
NA
|
NA
|
pathogenic process
|
enterovirus 71 infection
|
Virus Diseases
|
| HSALNT0290222
|
RP4-620F22.3
|
AC099063.2
|
NA
|
pathogenic process
|
enterovirus 71 infection
|
Virus Diseases
|
| HSALNT0290227
|
RP5-843L14.1
|
LINC01716
|
NA
|
pathogenic process
|
enterovirus 71 infection
|
Virus Diseases
|
| HSALNT0287285
|
MAGEA8-AS1
|
RP5-869M20.2
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289019
|
LHX5-AS1
|
locus4010
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0288902
|
CAPN10-AS1
|
CAPN10-DT,locus959
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289404
|
STAM-AS1
|
locus3182
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0148276
|
PTENP1-AS
|
PTENpg1-asRNA
|
transcriptional regulation
|
NA
|
NA
|
NA
|
| HSALNT0289562
|
AF116616
|
NA
|
NA
|
pathogenic process
|
osteosarcoma
|
Neoplasms
|
| HSALNT0289589
|
AK094838
|
NA
|
NA
|
pathogenic process
|
osteosarcoma
|
Neoplasms
|
| HSALNT0289620
|
ASLNC00339
|
NA
|
NA
|
pathogenic process
|
osteosarcoma
|
Neoplasms
|
| HSALNT0289629
|
BC002350
|
NA
|
NA
|
pathogenic process
|
osteosarcoma
|
Neoplasms
|
| HSALNT0289651
|
BC091525
|
NA
|
NA
|
pathogenic process
|
osteosarcoma
|
Neoplasms
|
| HSALNT0289652
|
BE503655
|
NA
|
NA
|
pathogenic process
|
osteosarcoma
|
Neoplasms
|
| HSALNT0289753
|
ENO1
|
NA
|
NA
|
pathogenic process
|
osteosarcoma
|
Neoplasms
|
| HSALNT0289835
|
FKBP10
|
NA
|
NA
|
pathogenic process
|
osteosarcoma
|
Neoplasms
|
| HSALNT0290064
|
MYHAS
|
NA
|
NA
|
pathogenic process
|
osteosarcoma
|
Neoplasms
|
| HSALNT0289985
|
LncRNA-LALR1
|
NA
|
transcriptional regulation
|
pathogenic process
|
liver cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289934
|
lincRNA-LALR1
|
NA
|
transcriptional regulation
|
pathogenic process
|
NA
|
NA
|
| HSALNT0091577
|
NR2F1-AS1
|
FLJ42709
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289709
|
CK19
|
NA
|
NA
|
pathogenic process
|
breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0289943
|
Llme23
|
NA
|
NA
|
pathogenic process
|
melanoma
|
Neoplasms
|
| HSALNT0289553
|
AC096655.1
|
NA
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289178
|
MIR222HG
|
Lnc-Ang362
|
NA
|
pathogenic process
|
Ang II-associated cardiovascular disease
|
Cardiovascular Diseases
|
| HSALNT0289261
|
STX18-AS1
|
LOC100507266
|
NA
|
pathogenic process
|
atrial septal defect
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0289849
|
GHSR
|
NA
|
NA
|
pathogenic process
|
non-small cell lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0289850
|
GHSROS
|
NA
|
NA
|
pathogenic process
|
non-small cell lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0289210
|
PCAT7
|
PCAN-R2
|
NA
|
pathogenic process
|
prostate cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0289702
|
CES1P1
|
NA
|
NA
|
pathogenic process
|
non-small cell lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0289892
|
LINC00210
|
NA
|
NA
|
pathogenic process
|
non-small cell lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0290006
|
LOC100506974
|
NA
|
NA
|
pathogenic process
|
non-small cell lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0290219
|
RP3-508I15.14
|
NA
|
NA
|
pathogenic process
|
non-small cell lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0290243
|
SLC6A6
|
NA
|
NA
|
pathogenic process
|
non-small cell lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0290342
|
uc003bgl.1
|
NA
|
NA
|
pathogenic process
|
non-small cell lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0289075
|
LINC00970
|
NA
|
NA
|
pathogenic process
|
non-small cell lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0211868
|
SALRNA1
|
SAL-RNA1,XLOC_023166
|
NA
|
developmental process
|
NA
|
NA
|
| HSALNT0222267
|
SALRNA3
|
SAL-RNA3,XLOC_025918
|
NA
|
developmental process
|
NA
|
NA
|
| HSALNT0222274
|
SALRNA2
|
SAL-RNA2,XLOC_025931
|
NA
|
developmental process
|
NA
|
NA
|
| HSALNT0289428
|
GPR1-AS
|
GPR1-AS1,GPR1AS
|
transcriptional regulation
|
NA
|
NA
|
NA
|
| HSALNT0226207
|
LINC00235
|
NA
|
NA
|
pathogenic process
|
anorexia nervosa
|
Mental Disorders
|
| HSALNT0289526
|
1B FGF-antisense transcripts
|
NA
|
NA
|
pathogenic process
|
endometriosis
|
Female Urogenital Diseases and Pregnancy Complications
|
| HSALNT0290171
|
RNA polymerase III-dependent lncRNAs
|
NA
|
NA
|
pathogenic process
|
diffuse cerebral hypomyelination
|
NA
|
| HSALNT0290168
|
REST/CoREST-regulated lncRNAs
|
NA
|
NA
|
pathogenic process
|
Huntington disease
|
Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
|
| HSALNT0289606
|
Alu lncRNAs
|
NA
|
NA
|
pathogenic process
|
macular degeneration
|
Eye Diseases
|
| HSALNT0290358
|
UCH1LAS
|
NA
|
NA
|
pathogenic process
|
Parkinson's disease
|
Nervous System Diseases
|
| HSALNT0290244
|
SLC7A2-IT1A/B
|
NA
|
NA
|
pathogenic process
|
progressive encephalopathy with severe infantile anorexia
|
Nervous System Diseases
|
| HSALNT0289877
|
Kcna2-AS
|
NA
|
NA
|
pathogenic process
|
neuropathic pain
|
Nervous System Diseases
|
| HSALNT0289191
|
NCOA7-AS1
|
NA
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0290020
|
LOC389023
|
NA
|
transcriptional regulation
|
pathogenic process
|
psychiatric disease
|
Nervous System Diseases
|
| HSALNT0175124
|
PTPRJ-AS1
|
NA
|
transcriptional regulation
|
NA
|
NA
|
NA
|
| HSALNT0289654
|
BM742401
|
NA
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289331
|
LINC00951
|
lincRNA-uc003opf.1,FLJ41649
|
NA
|
pathogenic process
|
esophageal squamous cell cancer
|
Neoplasms
|
| HSALNT0290130
|
PAWR
|
NA
|
NA
|
pathogenic process
|
acute lymphoblastic leukemia
|
Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases
|
| HSALNT0290264
|
T-ALL-R-LncR1
|
NA
|
NA
|
pathogenic process
|
acute lymphoblastic leukemia
|
Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases
|
| HSALNT0289599
|
AK130977
|
NA
|
NA
|
pathogenic process
|
malignant pleural mesothelioma
|
Neoplasms
|
| HSALNT0289625
|
AX746718
|
NA
|
NA
|
pathogenic process
|
malignant pleural mesothelioma
|
Neoplasms
|
| HSALNT0289738
|
DDR2
|
NA
|
NA
|
pathogenic process
|
malignant pleural mesothelioma
|
Neoplasms
|
| HSALNT0290003
|
LOC100131831
|
NA
|
NA
|
pathogenic process
|
malignant pleural mesothelioma
|
Neoplasms
|
| HSALNT0290144
|
POT1-AS1
|
NA
|
NA
|
pathogenic process
|
malignant pleural mesothelioma
|
Neoplasms
|
| HSALNT0290253
|
SNORA17B
|
NA
|
NA
|
pathogenic process
|
malignant pleural mesothelioma
|
Neoplasms
|
| HSALNT0207421
|
GAS6-AS1
|
NA
|
NA
|
pathogenic process
|
non-small cell lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0289838
|
FMR5
|
NA
|
NA
|
pathogenic process
|
fragile X syndrome
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
|
| HSALNT0208907
|
FOXG1-AS1
|
FOXG1-AS
|
NA
|
pathogenic process
|
autism spectrum disorder
|
Mental Disorders
|
| HSALNT0290263
|
SYNGAP1-AS1
|
SYNGAP1-AS
|
NA
|
pathogenic process
|
autism spectrum disorder
|
Mental Disorders
|
| HSALNT0290176
|
RNase MRP
|
NA
|
NA
|
pathogenic process
|
cartilage hair hypoplaisia
|
Cardiovascular Diseases
|
| HSALNT0289469
|
GABPB1-AS1
|
NA
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0289009
|
IDI2-AS1
|
C10orf110,IDI2-A,HT009,Em:AC022536.4
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289093
|
LINC01184
|
FLJ33630
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0290108
|
OGT
|
NA
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290077
|
ncNRFR
|
NA
|
transcriptional regulation
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290337
|
uc001lsz
|
NA
|
NA
|
pathogenic process
|
gastric cancer;prostate cancer;liver cancer;lung cancer
|
Respiratory Tract Diseases;Male Urogenital Diseases;Neoplasms;Digestive System Diseases
|
| HSALNT0289087
|
LINC01090
|
NA
|
NA
|
pathogenic process
|
post-traumatic stress disorder
|
Mental Disorders
|
| HSALNT0289746
|
DQ786227
|
NA
|
NA
|
pathogenic process
|
lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0289981
|
lncRNA-DQ786227
|
NA
|
NA
|
pathogenic process
|
lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0289876
|
JADRR
|
LINC00915,lncRNA-JADE
|
transcriptional regulation
|
pathogenic process
|
breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0290254
|
SOX2OT-S1
|
NA
|
NA
|
pathogenic process
|
esophageal squamous cell cancer
|
Neoplasms
|
| HSALNT0290404
|
SOX2OT-S2
|
NA
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0289870
|
HOXA13
|
NA
|
NA
|
pathogenic process
|
hepatocelluar cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0078946
|
SMAD1-AS1
|
ENST00000513542
|
NA
|
pathogenic process
|
ventricular septal defects
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0087329
|
FGF10-AS1
|
RP11-473L15.2
|
transcriptional regulation
|
pathogenic process
|
ventricular septal defects
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0290318
|
TUC339
|
NA
|
NA
|
pathogenic process
|
hepatocellular cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289819
|
ERICD
|
LINC01130,TCONS_00014875,ERIC
|
transcriptional regulation
|
pathogenic process
|
retinoblastoma
|
Neoplasms
|
| HSALNT0289615
|
ARA
|
NA
|
NA
|
pathogenic process
|
cancer
|
Neoplasms
|
| HSALNT0289822
|
ESCCAL-5
|
NA
|
NA
|
pathogenic process
|
esophageal squamous cell cancer
|
Neoplasms
|
| HSALNT0290074
|
ncC11orf49
|
NA
|
NA
|
pathogenic process
|
renal cell cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0290076
|
ncHDAC5
|
NA
|
NA
|
pathogenic process
|
renal cell cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0290078
|
ncRAB31
|
NA
|
NA
|
pathogenic process
|
renal cell cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0290080
|
ncSRPK1
|
NA
|
NA
|
pathogenic process
|
renal cell cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0018253
|
OVAAL
|
LINC01131,OVAL
|
NA
|
pathogenic process
|
ovarian cancer
|
Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0289884
|
LALR
|
NA
|
transcriptional regulation
|
pathogenic process
|
hepatocelluar cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289701
|
CEACAMP8
|
CEACAMP8
|
NA
|
pathogenic process
|
pre-eclampsia
|
Female Urogenital Diseases and Pregnancy Complications
|
| HSALNT0290018
|
LOC284100
|
NA
|
NA
|
pathogenic process
|
pre-eclampsia
|
Female Urogenital Diseases and Pregnancy Complications
|
| HSALNT0290023
|
LOC391533
|
NA
|
NA
|
pathogenic process
|
pre-eclampsia
|
Female Urogenital Diseases and Pregnancy Complications
|
| HSALNT0189558
|
LINC01154
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0196616
|
THRIL
|
BRI3BP-AS1,BRI3BPAS1,Linc1992,TCONS_00020260
|
transcriptional regulation
|
pathogenic process
|
Kawasaki disease
|
Cardiovascular Diseases
|
| HSALNT0289235
|
RNF219-AS1
|
NA
|
NA
|
pathogenic process
|
blood pressure
|
Cardiovascular Diseases
|
| HSALNT0289561
|
AF086415
|
NA
|
NA
|
pathogenic process
|
nasopharyngeal cancer
|
Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
|
| HSALNT0289583
|
AK056098
|
NA
|
NA
|
pathogenic process
|
nasopharyngeal cancer
|
Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
|
| HSALNT0289590
|
AK095147
|
NA
|
NA
|
pathogenic process
|
nasopharyngeal cancer
|
Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
|
| HSALNT0289600
|
AK294004
|
NA
|
transcriptional regulation
|
pathogenic process
|
nasopharyngeal cancer
|
Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
|
| HSALNT0289612
|
AP5M1
|
NA
|
NA
|
pathogenic process
|
nasopharyngeal cancer
|
Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
|
| HSALNT0290110
|
ORAOV1
|
NA
|
NA
|
pathogenic process
|
nasopharyngeal cancer
|
Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
|
| HSALNT0290210
|
RP1-179N16.3
|
Z95152.1
|
NA
|
pathogenic process
|
nasopharyngeal cancer
|
Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
|
| HSALNT0037026
|
LINC01159
|
linc-Brn1b
|
NA
|
developmental process
|
NA
|
NA
|
| HSALNT0289014
|
KANTR
|
KDM5C adjacent non-coding transcript
|
NA
|
developmental process
|
NA
|
NA
|
| HSALNT0289905
|
LINC01157
|
TCONS_00010378,linc-Enc1
|
NA
|
developmental process
|
NA
|
NA
|
| HSALNT0289460
|
APOA1-AS
|
NA
|
transcriptional regulation
|
NA
|
NA
|
NA
|
| HSALNT0290400
|
ZNF300P1
|
ZNF300P1
|
NA
|
pathogenic process
|
ovarian cancer
|
Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0289750
|
EEF1A1P9
|
NA
|
NA
|
pathogenic process
|
gastric cardia adenocarcinoma
|
Neoplasms
|
| HSALNT0289796
|
ENST00000318333
|
NA
|
NA
|
pathogenic process
|
gastric cardia adenocarcinoma
|
Neoplasms
|
| HSALNT0289797
|
ENST00000374520
|
NA
|
NA
|
pathogenic process
|
gastric cardia adenocarcinoma
|
Neoplasms
|
| HSALNT0289800
|
ENST00000422362
|
NA
|
NA
|
pathogenic process
|
gastric cardia adenocarcinoma
|
Neoplasms
|
| HSALNT0289808
|
ENST00000455912
|
NA
|
NA
|
pathogenic process
|
gastric cardia adenocarcinoma
|
Neoplasms
|
| HSALNT0289809
|
ENST00000456007
|
NA
|
NA
|
pathogenic process
|
gastric cardia adenocarcinoma
|
Neoplasms
|
| HSALNT0289810
|
ENST00000456185
|
NA
|
NA
|
pathogenic process
|
gastric cardia adenocarcinoma
|
Neoplasms
|
| HSALNT0289817
|
EPOR
|
NA
|
NA
|
pathogenic process
|
gastric cardia adenocarcinoma
|
Neoplasms
|
| HSALNT0289913
|
LINC01550
|
NA
|
NA
|
pathogenic process
|
gastric cardia adenocarcinoma
|
Neoplasms
|
| HSALNT0290142
|
PMS2P5
|
NA
|
NA
|
pathogenic process
|
gastric cardia adenocarcinoma
|
Neoplasms
|
| HSALNT0290269
|
TCF7
|
NA
|
NA
|
pathogenic process
|
gastric cardia adenocarcinoma
|
Neoplasms
|
| HSALNT0290345
|
uc003jfz.2
|
NA
|
NA
|
pathogenic process
|
gastric cardia adenocarcinoma
|
Neoplasms
|
| HSALNT0289095
|
LINC01191
|
VIN,lnc-ACTR3
|
transcriptional regulation
|
pathogenic process
|
influenza A virus
|
Virus Diseases
|
| HSALNT0288976
|
FIRRE
|
LINC01200
|
transcriptional regulation
|
NA
|
NA
|
NA
|
| HSALNT0289097
|
LINC01202
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0290271
|
TCONS_00014512
|
NA
|
NA
|
pathogenic process
|
hepatoblastoma
|
Neoplasms
|
| HSALNT0290272
|
TCONS_00014978
|
NA
|
NA
|
pathogenic process
|
hepatoblastoma
|
Neoplasms
|
| HSALNT0290274
|
TCONS_00024647
|
NA
|
NA
|
pathogenic process
|
hepatoblastoma
|
Neoplasms
|
| HSALNT0290279
|
TCONS_00090092_MEG3
|
NA
|
NA
|
pathogenic process
|
hepatoblastoma
|
Neoplasms
|
| HSALNT0290280
|
TCONS_l2_00000179
|
NA
|
NA
|
pathogenic process
|
hepatoblastoma
|
Neoplasms
|
| HSALNT0290283
|
TCONS_l2_00004424
|
NA
|
NA
|
pathogenic process
|
hepatoblastoma
|
Neoplasms
|
| HSALNT0290284
|
TCONS_l2_00006843
|
NA
|
NA
|
pathogenic process
|
hepatoblastoma
|
Neoplasms
|
| HSALNT0290289
|
TCONS_l2_00014091
|
NA
|
NA
|
pathogenic process
|
hepatoblastoma
|
Neoplasms
|
| HSALNT0290291
|
TCONS_l2_00018070
|
NA
|
NA
|
pathogenic process
|
hepatoblastoma
|
Neoplasms
|
| HSALNT0290292
|
TCONS_l2_00020565
|
NA
|
NA
|
pathogenic process
|
hepatoblastoma
|
Neoplasms
|
| HSALNT0290293
|
TCONS_l2_00021262
|
NA
|
NA
|
pathogenic process
|
hepatoblastoma
|
Neoplasms
|
| HSALNT0290296
|
TCONS_l2_00030560
|
NA
|
NA
|
pathogenic process
|
hepatoblastoma
|
Neoplasms
|
| HSALNT0289927
|
lincRNA1611
|
NA
|
NA
|
pathogenic process
|
Pancreatic ductal adenocarcinoma
|
Neoplasms
|
| HSALNT0290149
|
Ppp3ca
|
NA
|
NA
|
pathogenic process
|
Pancreatic ductal adenocarcinoma
|
Neoplasms
|
| HSALNT0290265
|
TC0100223
|
NA
|
NA
|
pathogenic process
|
epithelial ovarian cancer
|
Neoplasms
|
| HSALNT0290267
|
TC0101686
|
NA
|
NA
|
pathogenic process
|
epithelial ovarian cancer
|
Neoplasms
|
| HSALNT0290268
|
TC1500845
|
NA
|
NA
|
pathogenic process
|
ovarian cancer
|
Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0289318
|
LAMP5-AS1
|
NA
|
NA
|
pathogenic process
|
acute lymphoblastic leukemia
|
Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases
|
| HSALNT0234022
|
LINC01228
|
lincRNA-DYNLRB2-2
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0162654
|
SGMS1-AS1
|
NA
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0289206
|
PCAT19
|
LOC100505495,LINC01190
|
NA
|
pathogenic process
|
prostate cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0289521
|
ABHD15-AS1
|
linc-TP53I13,lnc-TP53I13
|
NA
|
pathogenic process
|
cardiometabolic disease
|
Cardiovascular Diseases
|
| HSALNT0289100
|
LINC01230
|
linc-DMRT2,lnc-DRMT2,TCONS_00015639
|
NA
|
pathogenic process
|
cardiometabolic disease
|
Cardiovascular Diseases
|
| HSALNT0249183
|
PCAT18
|
LINC01092
|
NA
|
pathogenic process
|
prostate cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0290029
|
LOC728606
|
NA
|
NA
|
pathogenic process
|
prostate cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0288956
|
ENST00000547963.1
|
NA
|
NA
|
pathogenic process
|
esophageal squamous cell cancer
|
Neoplasms
|
| HSALNT0289802
|
ENST00000435885
|
NA
|
NA
|
pathogenic process
|
oesophageal squamous cell cancer
|
Neoplasms
|
| HSALNT0205898
|
LINC01232
|
FLJ41590,TCONS_00021520
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0257311
|
LINC01233
|
XLOC_013014
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0183247
|
SENCR
|
FLI1-AS1
|
NA
|
pathogenic process
|
vascular SMC phenotype
|
Cardiovascular Diseases
|
| HSALNT0289296
|
LINC00467
|
C1orf97,MGC14801
|
NA
|
pathogenic process
|
neuroblastoma
|
Neoplasms
|
| HSALNT0143586
|
CASC21
|
LINC01244,CARLo-2
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0288906
|
CASC19
|
LINC01245,CARLo-6
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0289754
|
ENSG00000135253.9
|
NA
|
NA
|
pathogenic process
|
hereditary haemorrhagic telangiectasia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0289755
|
ENSG00000147753.5
|
NA
|
NA
|
pathogenic process
|
hereditary haemorrhagic telangiectasia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0289756
|
ENSG00000196096
|
AC079610.1
|
NA
|
pathogenic process
|
hereditary haemorrhagic telangiectasia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0289757
|
ENSG00000197251.3
|
NA
|
NA
|
pathogenic process
|
hereditary haemorrhagic telangiectasia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0289758
|
ENSG00000203325
|
AL445248.1
|
NA
|
pathogenic process
|
hereditary haemorrhagic telangiectasia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0289759
|
ENSG00000206129
|
AC006305.1
|
NA
|
pathogenic process
|
hereditary haemorrhagic telangiectasia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0289760
|
ENSG00000215231.3
|
NA
|
NA
|
pathogenic process
|
hereditary haemorrhagic telangiectasia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0289761
|
ENSG00000215374.4
|
NA
|
NA
|
pathogenic process
|
hereditary haemorrhagic telangiectasia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0289762
|
ENSG00000215808.2
|
NA
|
NA
|
pathogenic process
|
hereditary haemorrhagic telangiectasia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0289763
|
ENSG00000226496.1
|
NA
|
NA
|
pathogenic process
|
hereditary haemorrhagic telangiectasia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0289764
|
ENSG00000229563.1
|
NA
|
NA
|
pathogenic process
|
hereditary haemorrhagic telangiectasia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0289765
|
ENSG00000230133.1
|
NA
|
NA
|
pathogenic process
|
hereditary haemorrhagic telangiectasia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0289766
|
ENSG00000230544.1
|
NA
|
NA
|
pathogenic process
|
hereditary haemorrhagic telangiectasia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0289767
|
ENSG00000231133.1
|
NA
|
NA
|
pathogenic process
|
hereditary haemorrhagic telangiectasia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0289768
|
ENSG00000231185
|
AC010317.1
|
NA
|
pathogenic process
|
hereditary haemorrhagic telangiectasia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0289769
|
ENSG00000232021.2
|
NA
|
NA
|
pathogenic process
|
hereditary haemorrhagic telangiectasia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0289770
|
ENSG00000232046.1
|
NA
|
NA
|
pathogenic process
|
hereditary haemorrhagic telangiectasia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0289771
|
ENSG00000232956.3
|
NA
|
NA
|
pathogenic process
|
hereditary haemorrhagic telangiectasia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0289772
|
ENSG00000233154.1
|
NA
|
NA
|
pathogenic process
|
hereditary haemorrhagic telangiectasia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0289773
|
ENSG00000233251
|
AC007743.1
|
NA
|
pathogenic process
|
hereditary haemorrhagic telangiectasia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0289774
|
ENSG00000235285.1
|
NA
|
NA
|
pathogenic process
|
hereditary haemorrhagic telangiectasia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0289775
|
ENSG00000237036.3
|
NA
|
NA
|
pathogenic process
|
hereditary haemorrhagic telangiectasia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0289776
|
ENSG00000237548.1
|
NA
|
NA
|
pathogenic process
|
hereditary haemorrhagic telangiectasia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0289777
|
ENSG00000240453.1
|
NA
|
NA
|
pathogenic process
|
hereditary haemorrhagic telangiectasia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0289778
|
ENSG00000241269.1
|
NA
|
NA
|
pathogenic process
|
hereditary haemorrhagic telangiectasia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0289779
|
ENSG00000245910.3
|
NA
|
NA
|
pathogenic process
|
hereditary haemorrhagic telangiectasia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0289780
|
ENSG00000248176
|
AC109349.1
|
NA
|
pathogenic process
|
hereditary haemorrhagic telangiectasia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0289781
|
ENSG00000249364
|
AC112206.2
|
NA
|
pathogenic process
|
hereditary haemorrhagic telangiectasia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0289782
|
ENSG00000249772
|
AC026427.1
|
NA
|
pathogenic process
|
hereditary haemorrhagic telangiectasia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0289783
|
ENSG00000250195
|
AC109927.1
|
NA
|
pathogenic process
|
hereditary haemorrhagic telangiectasia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0289784
|
ENSG00000250608
|
AC010210.1
|
NA
|
pathogenic process
|
hereditary haemorrhagic telangiectasia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0289785
|
ENSG00000254154
|
AL359075.2
|
NA
|
pathogenic process
|
hereditary haemorrhagic telangiectasia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0289786
|
ENSG00000255471
|
AP001528.2
|
NA
|
pathogenic process
|
hereditary haemorrhagic telangiectasia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0289787
|
ENSG00000256218
|
AC007848.2
|
NA
|
pathogenic process
|
hereditary haemorrhagic telangiectasia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0289788
|
ENSG00000259150.1
|
NA
|
NA
|
pathogenic process
|
hereditary haemorrhagic telangiectasia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0289789
|
ENSG00000259334.1
|
NA
|
NA
|
pathogenic process
|
hereditary haemorrhagic telangiectasia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0289790
|
ENSG00000259484.1
|
NA
|
NA
|
pathogenic process
|
hereditary haemorrhagic telangiectasia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0289791
|
ENSG00000259758.1
|
NA
|
NA
|
pathogenic process
|
hereditary haemorrhagic telangiectasia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0289793
|
ENSG00000263753.1
|
NA
|
NA
|
pathogenic process
|
hereditary haemorrhagic telangiectasia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0289794
|
ENSG00000264772
|
AC016876.2
|
NA
|
pathogenic process
|
hereditary haemorrhagic telangiectasia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0289795
|
ENSG00000266952.1
|
NA
|
NA
|
pathogenic process
|
hereditary haemorrhagic telangiectasia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0289828
|
FAM66B
|
FAM66E
|
NA
|
pathogenic process
|
hereditary haemorrhagic telangiectasia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0289895
|
LINC00336
|
C6orf227,NCRNA00336
|
NA
|
pathogenic process
|
hereditary haemorrhagic telangiectasia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0289899
|
LINC00929
|
NA
|
NA
|
pathogenic process
|
hereditary haemorrhagic telangiectasia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0289906
|
LINC01204
|
NA
|
NA
|
pathogenic process
|
hereditary haemorrhagic telangiectasia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0289912
|
LINC01538
|
NA
|
NA
|
pathogenic process
|
hereditary haemorrhagic telangiectasia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0289915
|
LINC01721
|
NA
|
NA
|
pathogenic process
|
hereditary haemorrhagic telangiectasia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0289916
|
LINC01762
|
NA
|
NA
|
pathogenic process
|
hereditary haemorrhagic telangiectasia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0289917
|
LINC01798
|
NA
|
NA
|
pathogenic process
|
hereditary haemorrhagic telangiectasia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0290247
|
SMIM2-IT1
|
C13orf44-IT1
|
NA
|
pathogenic process
|
hereditary haemorrhagic telangiectasia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0290316
|
TTTY7
|
CLONE795723,LINC00129,NCRNA00129A,TTTY7B,TTY7,TTTY7
|
NA
|
pathogenic process
|
hereditary haemorrhagic telangiectasia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0289872
|
HTTAS_v1
|
NA
|
transcriptional regulation
|
pathogenic process
|
Huntington disease
|
Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
|
| HSALNT0290175
|
RNA-a
|
NA
|
transcriptional regulation
|
pathogenic process
|
Opitz-Kaveggia syndrome
|
NA
|
| HSALNT0289525
|
116HG
|
NA
|
transcriptional regulation
|
pathogenic process
|
Prader-Willi syndrome
|
Nervous System Diseases
|
| HSALNT0290320
|
U1 spliceosomal lncRNA
|
NA
|
NA
|
pathogenic process
|
Parkinson's disease
|
Nervous System Diseases
|
| HSALNT0289102
|
LINC01262
|
TCONS_l2_00021807,RP11-462G22.1
|
ceRNA
|
pathogenic process
|
Parkinson's disease
|
Nervous System Diseases
|
| HSALNT0289681
|
CCAT1-L
|
NA
|
transcriptional regulation
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290062
|
MT-LIPCAR
|
uc022bqs.1,LIPCAR
|
NA
|
pathogenic process
|
heart disease
|
Cardiovascular Diseases
|
| HSALNT0289941
|
LIPCAR
|
NA
|
NA
|
pathogenic process
|
heart failure
|
Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases
|
| HSALNT0200965
|
TUSC8
|
LINC01071,XLOC_010588
|
NA
|
pathogenic process
|
cervical cancer
|
Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0161787
|
LINC01264
|
RP11-124O11.2
|
NA
|
pathogenic process
|
breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0289733
|
D4Z4
|
NA
|
NA
|
pathogenic process;developmental process
|
facioscapulohumeral muscular dystrophy
|
Musculoskeletal Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
|
| HSALNT0289678
|
CARL
|
NA
|
ceRNA
|
pathogenic process
|
myocardial infarction
|
Cardiovascular Diseases
|
| HSALNT0289923
|
linc-CBR1-2
|
NA
|
NA
|
pathogenic process
|
lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0243354
|
WFDC21P
|
WAP four-disulfide core domain 21,pseudogene
|
transcriptional regulation
|
pathogenic process
|
DC dysfunction
|
NA
|
| HSALNT0290232
|
RUNX1
|
NA
|
NA
|
pathogenic process
|
acute myeloid leukemia
|
Neoplasms
|
| HSALNT0290234
|
RUNXOR
|
NA
|
NA
|
pathogenic process
|
hematopoietic malignancies
|
Neoplasms;Hemic and Lymphatic Diseases
|
| HSALNT0289979
|
lncRNA-CIR
|
NA
|
NA
|
pathogenic process
|
osteoarthritis
|
Musculoskeletal Diseases
|
| HSALNT0290368
|
VIM2P
|
NA
|
NA
|
pathogenic process
|
osteoarthritis
|
Musculoskeletal Diseases
|
| HSALNT0289879
|
KRAS1P
|
NA
|
NA
|
pathogenic process
|
cancer
|
Neoplasms
|
| HSALNT0290054
|
MINA
|
NA
|
NA
|
pathogenic process
|
esophageal squamous cell cancer;gastric cancer;lung cancer;hepatocelluar cancer
|
Respiratory Tract Diseases;Neoplasms;Digestive System Diseases
|
| HSALNT0289270
|
TMEM92-AS1
|
RP11-893F2.9,lncRNA-508851,TCONS_00025237
|
NA
|
pathogenic process
|
hepatocellular cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0288900
|
CAHM
|
LINC00468
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289593
|
AK123657
|
NA
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289659
|
BX648207
|
NA
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289660
|
BX649059
|
NA
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289846
|
GAS2L3
|
NA
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289633
|
BC011663
|
NA
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289867
|
HIV1230
|
NA
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290045
|
M14574
|
NA
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290245
|
SLCO5A1
|
NA
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290326
|
uc.341
|
NA
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290344
|
uc003iqu
|
NA
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290346
|
uc003tfx
|
NA
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289950
|
lnc-AL355149.1-1
|
NA
|
NA
|
pathogenic process
|
nasopharyngeal cancer
|
Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
|
| HSALNT0290001
|
lnc-ZNF674-1
|
NA
|
NA
|
pathogenic process
|
nasopharyngeal cancer
|
Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
|
| HSALNT0286909
|
LINC00632
|
NA
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289105
|
LINC01317
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0234804
|
LINC01081
|
TCONS_00024764
|
transcriptional regulation
|
pathogenic process
|
alveolar capillary dysplasia
|
Respiratory Tract Diseases
|
| HSALNT0289840
|
FOSB
|
NA
|
NA
|
pathogenic process
|
hepatocelluar cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289587
|
AK093543
|
NA
|
NA
|
pathogenic process
|
hepatocellular cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289732
|
D16366
|
NA
|
NA
|
pathogenic process
|
hepatocellular cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289814
|
ENST00000501583
|
NA
|
NA
|
pathogenic process
|
hepatocellular cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290273
|
TCONS_00018278
|
NA
|
NA
|
pathogenic process
|
hepatocellular cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289907
|
LINC01374
|
TCONS_00018278
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0231106
|
CASC22
|
LINC01373,TCONS_00024290,LincRNA-ENST00000515084
|
NA
|
pathogenic process
|
breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0058246
|
LINC00882
|
NA
|
ceRNA
|
pathogenic process
|
airway diseases
|
Respiratory Tract Diseases
|
| HSALNT0018288
|
KIAA1614-AS1
|
RP11-46A10.4
|
ceRNA
|
pathogenic process
|
airway smooth muscle (ASM) disease
|
Respiratory Tract Diseases
|
| HSALNT0142310
|
LINC00536
|
NA
|
NA
|
pathogenic process
|
trichorhinophalangeal syndrome
|
NA
|
| HSALNT0034200
|
LBX2-AS1
|
NA
|
NA
|
pathogenic process
|
renal cell cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0149799
|
ENST00000414223
|
NA
|
NA
|
pathogenic process
|
renal cell cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0290012
|
LOC105374631
|
NA
|
NA
|
pathogenic process
|
renal cell cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0290305
|
TMEM179
|
NA
|
NA
|
pathogenic process
|
renal cell cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0290315
|
TSPAN8
|
NA
|
NA
|
pathogenic process
|
renal cell cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0290334
|
uc001aka.2
|
NA
|
NA
|
pathogenic process
|
renal cell cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0290339
|
uc001vjj.1
|
NA
|
NA
|
pathogenic process
|
renal cell cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0290343
|
uc003erl.1
|
NA
|
NA
|
pathogenic process
|
renal cell cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0290354
|
uc009wkz.1
|
NA
|
NA
|
pathogenic process
|
renal cell cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0027893
|
MYCNUT
|
MYCNUN,lncUSMycN
|
NA
|
pathogenic process
|
neuroblastoma
|
Neoplasms
|
| HSALNT0273205
|
LINC01436
|
AP000688.8
|
NA
|
pathogenic process
|
Down syndrome
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
|
| HSALNT0266116
|
MIR663AHG
|
RP3-410C9.1
|
NA
|
pathogenic process
|
turner syndrome
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Endocrine System Diseases
|
| HSALNT0289108
|
LINC01435
|
RP11-215N21.1,TCONS_00018040
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0289674
|
CADM3-AS1
|
NA
|
NA
|
pathogenic process
|
bladder cancer
|
Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0289882
|
KRT19P3
|
NA
|
NA
|
pathogenic process
|
bladder cancer
|
Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0290310
|
TNXA
|
NA
|
NA
|
pathogenic process
|
bladder cancer
|
Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0008750
|
ZRANB2-AS2
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289745
|
DMTF1
|
NA
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290059
|
MRUL
|
NA
|
transcriptional regulation
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0185163
|
FAM66C
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289476
|
CYYR1-AS1
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289535
|
AA174084
|
NA
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0266298
|
ABALON
|
INXS
|
splicing regulation
|
pathogenic process
|
renal cell cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0290370
|
VTRNA2-1
|
CBL-3,CBL3,MIR886,MIRN886,VTRNA2,hsa-mir-886,hvg-5,nc886,svtRNA2-1a
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289619
|
ASK00420
|
NA
|
NA
|
pathogenic process
|
cervical cancer
|
Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0289749
|
EBIC
|
NA
|
transcriptional regulation
|
pathogenic process
|
cervical cancer
|
Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0290299
|
TI09485
|
NA
|
NA
|
pathogenic process
|
cervical cancer
|
Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0290300
|
TI10124
|
NA
|
NA
|
pathogenic process
|
cervical cancer
|
Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0290301
|
TI13831
|
NA
|
NA
|
pathogenic process
|
cervical cancer
|
Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0290302
|
TI18318
|
NA
|
NA
|
pathogenic process
|
cervical cancer
|
Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0290303
|
TI21327
|
NA
|
NA
|
pathogenic process
|
cervical cancer
|
Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0290304
|
TI22687
|
NA
|
NA
|
pathogenic process
|
cervical cancer
|
Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0290307
|
TMPOP2
|
NA
|
transcriptional regulation
|
pathogenic process
|
cervical cancer
|
Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0289570
|
AK021444
|
NA
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289601
|
AK307796
|
NA
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289801
|
ENST00000425785
|
SEC63P1
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289871
|
HOXB-AS3
|
NA
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290367
|
URHC
|
NA
|
NA
|
pathogenic process
|
hepatocellular cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289085
|
LINC01080
|
TCONS_00021856
|
NA
|
pathogenic process
|
Alzheimer's disease
|
Mental Disorders;Nervous System Diseases
|
| HSALNT0289751
|
EFNA3
|
NA
|
NA
|
pathogenic process
|
breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0289798
|
ENST00000395084
|
NA
|
NA
|
pathogenic process
|
hepatocelluar cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289829
|
FAM83A-AS1
|
NA
|
NA
|
pathogenic process
|
hepatocelluar cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290164
|
RAD1
|
NA
|
NA
|
pathogenic process
|
hepatocelluar cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289585
|
AK056988
|
NA
|
NA
|
pathogenic process
|
hepatocellular cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289638
|
BC017743
|
NA
|
NA
|
pathogenic process
|
hepatocellular cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290156
|
PRR26
|
C10orf108
|
NA
|
pathogenic process
|
hepatocellular cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290349
|
uc003yqb.1
|
NA
|
NA
|
pathogenic process
|
hepatocellular cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289675
|
CAI2
|
NA
|
NA
|
pathogenic process
|
neuroblastoma
|
Neoplasms
|
| HSALNT0289673
|
CADM1-AS1
|
NA
|
transcriptional regulation
|
pathogenic process
|
renal clear cell cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0290313
|
TSLC1-AS1
|
NA
|
NA
|
pathogenic process
|
glioma
|
Neoplasms
|
| HSALNT0013359
|
LINC01525
|
lnc-MAN1A2-1
|
NA
|
pathogenic process
|
squamous cell cancer
|
Neoplasms
|
| HSALNT0109106
|
LINC01526
|
Lnc-FAM46A-1
|
NA
|
pathogenic process
|
squamous cell cancer
|
Neoplasms
|
| HSALNT0162774
|
LINC01468
|
lnc-MBL2-4
|
NA
|
pathogenic process
|
squamous cell cancer
|
Neoplasms
|
| HSALNT0289110
|
LINC01503
|
lnc-PPP2R4-5
|
NA
|
pathogenic process
|
tongue squamous cell cancer
|
Neoplasms
|
| HSALNT0289968
|
lnc-MBL2-4:3
|
NA
|
NA
|
pathogenic process
|
tongue squamous cell cancer
|
Neoplasms
|
| HSALNT0289993
|
lnc-STXBP5-1
|
NA
|
NA
|
pathogenic process
|
tongue squamous cell cancer
|
Neoplasms
|
| HSALNT0289563
|
AF118081
|
NA
|
NA
|
pathogenic process
|
lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0289597
|
AK124939
|
NA
|
NA
|
pathogenic process
|
pulmonary adenocarcinoma
|
Neoplasms
|
| HSALNT0290153
|
PRAS
|
NA
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290249
|
SNAR-A1
|
NA
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289929
|
lincRNA-BC2
|
NA
|
NA
|
pathogenic process
|
breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0289930
|
lincRNA-BC4
|
NA
|
NA
|
pathogenic process
|
breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0289931
|
lincRNA-BC5
|
NA
|
NA
|
pathogenic process
|
breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0289932
|
lincRNA-BC8
|
NA
|
NA
|
pathogenic process
|
breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0083190
|
LINC01511
|
RP11-325I22.2
|
NA
|
pathogenic process
|
lung adenocarcinoma
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0290026
|
LOC440905
|
NA
|
NA
|
pathogenic process
|
lung adenocarcinoma
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0083190
|
LINC01511
|
RP11-325I22.2
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289552
|
AC079776.2
|
NA
|
NA
|
pathogenic process
|
lung adenocarcinoma
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0289720
|
CTA-363E6.2
|
NA
|
NA
|
pathogenic process
|
lung adenocarcinoma
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0289901
|
LINC00987
|
NA
|
NA
|
pathogenic process
|
lung adenocarcinoma
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0290185
|
RP11-1C1.7
|
NA
|
NA
|
pathogenic process
|
lung adenocarcinoma
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0290197
|
RP11-445K13.2
|
NA
|
NA
|
pathogenic process
|
lung adenocarcinoma
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0290199
|
RP11-473M20.11
|
NA
|
NA
|
pathogenic process
|
lung adenocarcinoma
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0290213
|
RP11-893F2.6
|
NA
|
NA
|
pathogenic process
|
lung adenocarcinoma
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0290217
|
RP13-514E23.1
|
NA
|
NA
|
pathogenic process
|
lung adenocarcinoma
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0290218
|
RP1-90D4.3
|
NA
|
NA
|
pathogenic process
|
lung adenocarcinoma
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0290220
|
RP4-575N6.5
|
NA
|
NA
|
pathogenic process
|
lung adenocarcinoma
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0290226
|
RP5-826L7.1
|
NA
|
NA
|
pathogenic process
|
lung adenocarcinoma
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0290378
|
XLOC_003286
|
NA
|
NA
|
pathogenic process
|
lung adenocarcinoma
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0290379
|
XLOC_003405
|
NA
|
NA
|
pathogenic process
|
lung adenocarcinoma
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0290389
|
XLOC_012255
|
NA
|
NA
|
pathogenic process
|
lung adenocarcinoma
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0290056
|
MIR21
|
NA
|
NA
|
pathogenic process
|
laryngeal squamous cell cancer
|
Neoplasms
|
| HSALNT0289621
|
ASncmtRNAs
|
NA
|
transcriptional regulation
|
pathogenic process
|
cancer
|
Neoplasms
|
| HSALNT0289316
|
LINC01614
|
LCAL4,TCONS_00003105
|
NA
|
pathogenic process
|
lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0289982
|
lncRNA-FER1L4
|
NA
|
ceRNA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290016
|
LOC283177
|
NA
|
NA
|
pathogenic process
|
diffuse large B-cell lymphoma
|
Hemic and Lymphatic Diseases
|
| HSALNT0289003
|
HORMAD2-AS1
|
MTMR3-AS1,NONHSAG033653
|
NA
|
pathogenic process
|
type 1 diabetes;bowel disease
|
Nutritional and Metabolic Diseases;Endocrine System Diseases;Digestive System Diseases
|
| HSALNT0290372
|
WNT4
|
NA
|
NA
|
pathogenic process
|
endometriosis
|
Female Urogenital Diseases and Pregnancy Complications
|
| HSALNT0289540
|
AB074278
|
NA
|
NA
|
pathogenic process
|
bladder cancer
|
Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0290166
|
RCCRT1
|
NA
|
NA
|
pathogenic process
|
renal cell cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0289043
|
LINC00491
|
BC008363
|
NA
|
pathogenic process
|
pancreatic ductal adenocarcinoma
|
Neoplasms
|
| HSALNT0289632
|
BC008363
|
NA
|
NA
|
pathogenic process
|
Pancreatic ductal adenocarcinoma
|
Neoplasms
|
| HSALNT0289858
|
H1.3
|
NA
|
NA
|
pathogenic process
|
ovarian cancer
|
Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0289896
|
LINC00582
|
NA
|
NA
|
pathogenic process
|
endometrial cancer
|
Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0289301
|
LINC01537
|
RP11-169D4.1-001
|
NA
|
pathogenic process
|
laryngeal squamous cell cancer
|
Neoplasms
|
| HSALNT0289551
|
AC026166.2
|
MTCO1P5
|
NA
|
pathogenic process
|
laryngeal squamous cell cancer
|
Neoplasms
|
| HSALNT0290184
|
RP11-169D4.1-001
|
NA
|
NA
|
pathogenic process
|
laryngeal squamous cell cancer
|
Neoplasms
|
| HSALNT0289545
|
AC006050.3
|
NA
|
NA
|
pathogenic process
|
lung squamous cell cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0289556
|
AC138128.1
|
NA
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289818
|
ERCC1
|
NA
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290061
|
MT1DP
|
MT1DP
|
NA
|
pathogenic process
|
liver cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289578
|
AK023096
|
NA
|
NA
|
pathogenic process
|
Wilmsâ tumor;uterine leiomyomas
|
Neoplasms
|
| HSALNT0289112
|
LINC01562
|
RP11-296A18.3
|
transcriptional regulation
|
pathogenic process
|
intervertebral disc degeneration
|
Musculoskeletal Diseases
|
| HSALNT0289567
|
AK000974
|
NA
|
NA
|
pathogenic process
|
breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0289579
|
AK024118
|
NA
|
NA
|
pathogenic process
|
breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0289645
|
BC040204
|
NA
|
NA
|
pathogenic process
|
breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0290321
|
U79277
|
NA
|
NA
|
pathogenic process
|
breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0289869
|
HOST2
|
NA
|
ceRNA
|
pathogenic process
|
epithelial ovarian cancer
|
Neoplasms
|
| HSALNT0289368
|
MGAT3-AS1
|
TapSAKI
|
NA
|
pathogenic process
|
acute kidney injury
|
Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications
|
| HSALNT0289624
|
ATXN7L3B
|
NA
|
NA
|
pathogenic process
|
spinocerebellar ataxia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
|
| HSALNT0289990
|
lnc-SCA7
|
NA
|
ceRNA
|
pathogenic process
|
spinocerebellar ataxia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
|
| HSALNT0290004
|
LOC100287482
|
NA
|
NA
|
pathogenic process
|
prostate cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0290383
|
XLOC_007697
|
NA
|
NA
|
pathogenic process
|
prostate cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0290384
|
XLOC_008559
|
NA
|
NA
|
pathogenic process
|
prostate cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0290385
|
XLOC_009911
|
NA
|
NA
|
pathogenic process
|
prostate cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0289813
|
ENST00000480739
|
RPL13AP23
|
NA
|
pathogenic process
|
Pancreatic ductal adenocarcinoma
|
Neoplasms
|
| HSALNT0290111
|
OS9
|
NA
|
NA
|
pathogenic process
|
Pancreatic ductal adenocarcinoma
|
Neoplasms
|
| HSALNT0290324
|
uc.283-plus
|
NA
|
NA
|
pathogenic process
|
glioma
|
Neoplasms
|
| HSALNT0289117
|
LINC01611
|
RP1-90L14.1,TCONS_l2_00025430
|
NA
|
pathogenic process
|
diabetic retinopathy
|
Endocrine System Diseases;Male Urogenital Diseases;Cardiovascular Diseases
|
| HSALNT0289529
|
2900055J20Rik
|
2900055J20Rik
|
NA
|
pathogenic process
|
left ventricular hypertrophy
|
Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases
|
| HSALNT0289792
|
ENSG00000261777
|
AC012184.3
|
NA
|
pathogenic process
|
prostate cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0289618
|
Asb3
|
NA
|
NA
|
pathogenic process
|
cardiovascular and renal disease
|
Cardiovascular Diseases
|
| HSALNT0289703
|
Chac2
|
NA
|
NA
|
pathogenic process
|
cardiovascular and renal disease
|
Cardiovascular Diseases
|
| HSALNT0290139
|
Pex11b
|
NA
|
NA
|
pathogenic process
|
cardiovascular and renal disease
|
Cardiovascular Diseases
|
| HSALNT0290255
|
Sp5
|
NA
|
NA
|
pathogenic process
|
cardiovascular and renal disease
|
Cardiovascular Diseases
|
| HSALNT0211639
|
PSMA3-AS1
|
FLJ31306
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0289319
|
LINC00493
|
LOC388789
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0288903
|
CARD8-AS1
|
LOC100505812
|
transcriptional regulation
|
pathogenic process
|
leukemia and neuroblastoma
|
Neoplasms
|
| HSALNT0064729
|
KCNMB2-AS1
|
RP11-385J1.2
|
NA
|
pathogenic process
|
non-small cell lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0289548
|
AC013264.2
|
NA
|
NA
|
pathogenic process
|
non-small cell lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0289857
|
GUCY1B2
|
NA
|
NA
|
pathogenic process
|
non-small cell lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0290190
|
RP11-385J1.2
|
NA
|
NA
|
pathogenic process
|
non-small cell lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0290216
|
RP1-317E23.3
|
NA
|
NA
|
pathogenic process
|
non-small cell lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0290317
|
TUBA4B
|
NA
|
NA
|
pathogenic process
|
non-small cell lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0290375
|
XLOC_000371
|
NA
|
NA
|
pathogenic process
|
non-small cell lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0290397
|
Z82214.3
|
NA
|
NA
|
pathogenic process
|
non-small cell lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0289735
|
DALIR
|
DALI
|
transcriptional regulation
|
NA
|
NA
|
NA
|
| HSALNT0290376
|
XLOC_000620
|
NA
|
NA
|
pathogenic process
|
H. pylori-related diseases
|
Bacterial Infections and Mycoses
|
| HSALNT0290380
|
XLOC_004122
|
NA
|
NA
|
pathogenic process
|
H. pylori-related diseases
|
Bacterial Infections and Mycoses
|
| HSALNT0290381
|
XLOC_004562
|
NA
|
NA
|
pathogenic process
|
H. pylori-related diseases
|
Bacterial Infections and Mycoses
|
| HSALNT0290382
|
XLOC_005912
|
NA
|
NA
|
pathogenic process
|
H. pylori-related diseases
|
Bacterial Infections and Mycoses
|
| HSALNT0290391
|
XLOC_014388
|
NA
|
NA
|
pathogenic process
|
H. pylori-related diseases
|
Bacterial Infections and Mycoses
|
| HSALNT0290028
|
LOC652276
|
NA
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290162
|
R05532
|
NA
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0098175
|
LINC01411
|
RP11-267A15.1
|
NA
|
pathogenic process
|
prostate cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0290025
|
LOC401317
|
NA
|
NA
|
pathogenic process
|
nasopharyngeal cancer
|
Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
|
| HSALNT0289726
|
CTD-2574D22.4
|
AC120114.2
|
NA
|
pathogenic process
|
osteoarthritis
|
Musculoskeletal Diseases
|
| HSALNT0290141
|
PMS2L2
|
NA
|
NA
|
pathogenic process
|
osteoarthritis
|
Musculoskeletal Diseases
|
| HSALNT0289974
|
lncRNA-422
|
NA
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289520
|
AATBC
|
NA
|
NA
|
pathogenic process
|
bladder cancer
|
Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0289311
|
LINC00974
|
NA
|
ceRNA
|
pathogenic process
|
hepatocellular cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0089943
|
ZBED3-AS1
|
NA
|
NA
|
developmental process
|
NA
|
NA
|
| HSALNT0289116
|
LINC01589
|
CTA-941F9.9,TCONS_00029353
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0289910
|
LINC01426
|
NA
|
NA
|
pathogenic process
|
esophageal squamous cell cancer
|
Neoplasms
|
| HSALNT0290341
|
uc002yug.2
|
NA
|
splicing regulation
|
pathogenic process
|
esophageal squamous cell cancer
|
Neoplasms
|
| HSALNT0290250
|
SNCG
|
NA
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289949
|
lnc-AF085935
|
NA
|
NA
|
pathogenic process
|
hepatocelluar cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289996
|
lnc-uc003wbd
|
NA
|
NA
|
pathogenic process
|
hepatocelluar cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289559
|
AF085935
|
NA
|
NA
|
pathogenic process
|
hepatocellular cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290347
|
uc003wbd
|
NA
|
NA
|
pathogenic process
|
hepatocellular cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290098
|
NR_001284
|
TNXA
|
NA
|
pathogenic process
|
chronic thromboembolic pulmonary hypertension
|
Cardiovascular Diseases
|
| HSALNT0290327
|
uc.343
|
NA
|
NA
|
pathogenic process
|
osteoarthritis
|
Musculoskeletal Diseases
|
| HSALNT0289196
|
NRAV
|
DYNLL1-AS1
|
transcriptional regulation
|
pathogenic process
|
influenza A virus
|
Virus Diseases
|
| HSALNT0290140
|
PLEC
|
NA
|
NA
|
pathogenic process
|
chronic obstructive pulmonary disease
|
Respiratory Tract Diseases
|
| HSALNT0290172
|
UCSC-2000-3182
|
NA
|
NA
|
pathogenic process
|
chronic obstructive pulmonary disease
|
Respiratory Tract Diseases
|
| HSALNT0290173
|
UCSC-9199-1005
|
NA
|
NA
|
pathogenic process
|
chronic obstructive pulmonary disease
|
Respiratory Tract Diseases
|
| HSALNT0290174
|
CombinedLit_316_550
|
NA
|
NA
|
pathogenic process
|
chronic obstructive pulmonary disease
|
Respiratory Tract Diseases
|
| HSALNT0289714
|
CR613944
|
NA
|
NA
|
pathogenic process
|
hepatocelluar cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289933
|
lincRNA-CALCA
|
NA
|
NA
|
pathogenic process
|
hepatocelluar cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290200
|
RP11-501G6.1
|
NA
|
NA
|
pathogenic process
|
hepatocelluar cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290208
|
RP11-672F9.1
|
NA
|
NA
|
pathogenic process
|
hepatocelluar cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290405
|
C14orf132
|
NA
|
NA
|
pathogenic process
|
hepatocelluar cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289937
|
lincRNA-TSPAN8
|
NA
|
NA
|
pathogenic process
|
hepatocellular cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290225
|
RP5-1014O16.1
|
AC244098.1
|
NA
|
pathogenic process
|
hepatocellular cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290275
|
TCONS_00026102
|
NA
|
NA
|
pathogenic process
|
atrial fibrillation
|
Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases
|
| HSALNT0290277
|
TCONS_00032546
|
NA
|
NA
|
pathogenic process
|
atrial fibrillation
|
Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases
|
| HSALNT0289037
|
LINC00441
|
RB1-DT,ncRNA-RB1
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0289661
|
C1401f132
|
NA
|
NA
|
pathogenic process
|
non-small cell lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0289141
|
LINC02365
|
LVCAT8
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0288885
|
ADGRD1-AS1
|
LACAT8
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289142
|
LINC02475
|
LVCAT1
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289542
|
Abhd11os
|
NA
|
NA
|
pathogenic process
|
neurodegenerative diseases
|
Nervous System Diseases
|
| HSALNT0288895
|
BISPR
|
NA
|
NA
|
pathogenic process
|
virus infection
|
Virus Diseases
|
| HSALNT0233975
|
MAFTRR
|
linc-MAF-4
|
transcriptional regulation
|
NA
|
NA
|
NA
|
| HSALNT0290058
|
MRAK052686
|
NA
|
NA
|
pathogenic process
|
nonalcoholic fatty liver disease
|
Digestive System Diseases
|
| HSALNT0290221
|
RP4-583P15.10
|
AL121845.1
|
NA
|
pathogenic process
|
breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0211341
|
KTN1-AS1
|
C14orf33,MYCLo-3
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0266752
|
DLGAP4-AS1
|
CCAT7
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289682
|
CCAT3
|
NA
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289684
|
CCAT8
|
NA
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289898
|
LINC00659
|
NA
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289683
|
CCAT7
|
NA
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0289627
|
BALR-2
|
NA
|
NA
|
pathogenic process
|
B cell acute lymphoblastic leukemia
|
Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases
|
| HSALNT0289948
|
lnc-ACACA-1
|
NA
|
NA
|
pathogenic process
|
clear cell renal cell cancer
|
Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0289953
|
lnc-BMP2-2
|
NA
|
NA
|
pathogenic process
|
clear cell renal cell cancer
|
Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0289955
|
lnc-CPN2-1
|
NA
|
NA
|
pathogenic process
|
clear cell renal cell cancer
|
Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0289958
|
lnc-FOXG1-2
|
NA
|
NA
|
pathogenic process
|
clear cell renal cell cancer
|
Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0289960
|
lnc-FZD1-2
|
NA
|
NA
|
pathogenic process
|
clear cell renal cell cancer
|
Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0289962
|
lnc-ITPR2-3
|
NA
|
NA
|
pathogenic process
|
clear cell renal cell cancer
|
Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0289965
|
lnc-LCP2-2
|
NA
|
NA
|
pathogenic process
|
clear cell renal cell cancer
|
Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0289988
|
lnc-RP3-368B9
|
NA
|
NA
|
pathogenic process
|
clear cell renal cell cancer
|
Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0289991
|
lnc-SLC30A4-1
|
NA
|
NA
|
pathogenic process
|
clear cell renal cell cancer
|
Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0289992
|
lnc-SPAM1-6
|
NA
|
NA
|
pathogenic process
|
clear cell renal cell cancer
|
Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0289995
|
lnc-TTC34-3
|
NA
|
NA
|
pathogenic process
|
clear cell renal cell cancer
|
Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0222064
|
DRAIC
|
NA
|
NA
|
pathogenic process
|
prostate cancer;glioma;cancer;bladder cancer;renal clear cell cancer;skin melanoma;hepatocellular cancer;lung adenocarcinoma;stomach adenocarcinoma
|
Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases
|
| HSALNT0005037
|
LINC01137
|
LOC728431
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0290390
|
XLOC_014172
|
NA
|
NA
|
pathogenic process
|
hepatocelluar cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290014
|
LOC149086
|
NA
|
NA
|
pathogenic process
|
hepatocellular cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290183
|
RP11-160H22.5
|
AL121983.2
|
NA
|
pathogenic process
|
hepatocellular cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289945
|
LNC00964-3
|
NA
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289616
|
Arid2-IR
|
NA
|
NA
|
pathogenic process
|
renal inflammation
|
NA
|
| HSALNT0289716
|
CR619813
|
NA
|
NA
|
pathogenic process
|
pancreatic cancer
|
Endocrine System Diseases;Neoplasms;Digestive System Diseases
|
| HSALNT0289739
|
DDX6P1
|
NA
|
NA
|
pathogenic process
|
pancreatic cancer
|
Endocrine System Diseases;Neoplasms;Digestive System Diseases
|
| HSALNT0289938
|
lincRNA-ZNF532
|
NA
|
NA
|
pathogenic process
|
pancreatic cancer
|
Endocrine System Diseases;Neoplasms;Digestive System Diseases
|
| HSALNT0290011
|
LOC105372753
|
NA
|
NA
|
pathogenic process
|
pancreatic cancer
|
Endocrine System Diseases;Neoplasms;Digestive System Diseases
|
| HSALNT0290013
|
LOC105377769
|
NA
|
NA
|
pathogenic process
|
pancreatic cancer
|
Endocrine System Diseases;Neoplasms;Digestive System Diseases
|
| HSALNT0290205
|
RP11-58D2.1
|
NA
|
NA
|
pathogenic process
|
pancreatic cancer
|
Endocrine System Diseases;Neoplasms;Digestive System Diseases
|
| HSALNT0288946
|
ENST00000434223
|
NA
|
NA
|
pathogenic process
|
lung adenocarcinoma
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0288947
|
ENST00000442037
|
NA
|
NA
|
pathogenic process
|
lung adenocarcinoma
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0288953
|
ENST00000540136
|
NA
|
NA
|
pathogenic process
|
lung adenocarcinoma
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0290103
|
NR_038125
|
NA
|
NA
|
pathogenic process
|
lung adenocarcinoma
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0290136
|
PDLIM3
|
NA
|
NA
|
pathogenic process
|
lung adenocarcinoma
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0290335
|
uc001gch.1
|
NA
|
NA
|
pathogenic process
|
lung adenocarcinoma
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0290336
|
uc001gzl.3
|
NA
|
NA
|
pathogenic process
|
lung adenocarcinoma
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0290351
|
uc004bbl.1
|
NA
|
NA
|
pathogenic process
|
lung adenocarcinoma
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0290369
|
VNN2
|
NA
|
NA
|
pathogenic process
|
lung adenocarcinoma
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0289577
|
AK022798
|
NA
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289663
|
C1orf74
|
NA
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289602
|
AKR7L
|
NA
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289711
|
COL3A1
|
NA
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289878
|
KCNE2
|
NA
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289636
|
BC015134
|
NA
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289713
|
CR594506
|
NA
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289928
|
lincRNA-BBOX1-2
|
NA
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0271719
|
LINC00320
|
PRED14,FLJ37539
|
NA
|
pathogenic process;developmental process
|
cortical white matter
|
Nervous System Diseases
|
| HSALNT0289823
|
EVADR
|
NA
|
NA
|
pathogenic process
|
pancreatic cancer;lung cancer;colorectal cancer;rectal cancer
|
Respiratory Tract Diseases;Endocrine System Diseases;Neoplasms;Digestive System Diseases
|
| HSALNT0289944
|
Lnc_bc060912
|
NA
|
NA
|
pathogenic process
|
lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0289952
|
lnc-bc060912
|
NA
|
NA
|
pathogenic process
|
lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0289613
|
APF
|
NA
|
ceRNA
|
pathogenic process
|
myocardial infarction
|
Cardiovascular Diseases
|
| HSALNT0289617
|
AS Uchl1
|
NA
|
NA
|
pathogenic process
|
Parkinson's disease
|
Nervous System Diseases
|
| HSALNT0289104
|
LINC01296
|
FLJ39632
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290403
|
ZXF2
|
NA
|
NA
|
pathogenic process
|
lung adenocarcinoma
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0290113
|
P14695
|
NA
|
NA
|
pathogenic process
|
hepatocelluar cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290114
|
P16984
|
NA
|
NA
|
pathogenic process
|
hepatocelluar cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290115
|
P19780
|
NA
|
NA
|
pathogenic process
|
hepatocelluar cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290116
|
P23099
|
NA
|
NA
|
pathogenic process
|
hepatocelluar cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290117
|
P24363
|
NA
|
NA
|
pathogenic process
|
hepatocelluar cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290118
|
P28210
|
NA
|
NA
|
pathogenic process
|
hepatocelluar cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290120
|
P33863
|
NA
|
NA
|
pathogenic process
|
hepatocelluar cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290121
|
P4091
|
NA
|
NA
|
pathogenic process
|
hepatocelluar cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290122
|
P6391
|
NA
|
NA
|
pathogenic process
|
hepatocelluar cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290123
|
P6488
|
NA
|
NA
|
pathogenic process
|
hepatocelluar cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290124
|
P700
|
NA
|
NA
|
pathogenic process
|
hepatocelluar cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290125
|
P8611
|
NA
|
NA
|
pathogenic process
|
hepatocelluar cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290126
|
P8725
|
NA
|
NA
|
pathogenic process
|
hepatocelluar cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290127
|
P8860
|
NA
|
NA
|
pathogenic process
|
hepatocelluar cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290128
|
P9745
|
NA
|
NA
|
pathogenic process
|
hepatocelluar cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289269
|
TH2LCRR
|
TH2-LCR
|
transcriptional regulation
|
pathogenic process
|
allergic asthma
|
Respiratory Tract Diseases;Immune System Diseases
|
| HSALNT0289964
|
lnc-LCE5A-1
|
NA
|
NA
|
pathogenic process
|
laryngeal cancer;head and neck squamous cell cancer
|
Respiratory Tract Diseases;Otorhinolaryngologic Diseases;Neoplasms
|
| HSALNT0055198
|
FAM3D-AS1
|
lnc-KCTD6-3
|
NA
|
pathogenic process
|
tongue cancer;pharyngeal cancer;head and neck squamous cell cancer;laryngeal cancer
|
Respiratory Tract Diseases;Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
|
| HSALNT0289843
|
FRLnc1
|
NA
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0242005
|
ENST00000575202
|
NA
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0288952
|
ENST00000539009
|
NA
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0288954
|
ENST00000544591
|
NA
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289752
|
EHHADH-AS1
|
NA
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289812
|
ENST00000468960
|
NA
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290276
|
TCONS_00026506
|
NA
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0189952
|
LRP1-AS
|
NA
|
transcriptional regulation
|
pathogenic process
|
Alzheimer's disease
|
Mental Disorders;Nervous System Diseases
|
| HSALNT0032045
|
LINC01122
|
FLJ30838,AC007092.1
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289565
|
AI364715
|
NA
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289921
|
LINC0949
|
NA
|
NA
|
pathogenic process
|
systemic lupus erythematosus
|
Immune System Diseases;Skin and Connective Tissue Diseases
|
| HSALNT0289680
|
CCAL
|
NA
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289079
|
LINC00993
|
NA
|
NA
|
pathogenic process
|
breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0289811
|
ENST00000460164
|
NA
|
NA
|
pathogenic process
|
triple-negative breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0290282
|
TCONS_l2_00003938
|
NA
|
NA
|
pathogenic process
|
triple-negative breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0289888
|
LGALS3
|
NA
|
NA
|
pathogenic process
|
papillary thyroid cancer
|
Endocrine System Diseases;Neoplasms
|
| HSALNT0289963
|
lnc-KCMF1-2:1
|
NA
|
NA
|
pathogenic process
|
papillary thyroid cancer
|
Endocrine System Diseases;Neoplasms
|
| HSALNT0289967
|
lnc-LLPH-2:1
|
NA
|
NA
|
pathogenic process
|
papillary thyroid cancer
|
Endocrine System Diseases;Neoplasms
|
| HSALNT0289971
|
lnc-PLA2R1-1:1
|
NA
|
NA
|
pathogenic process
|
papillary thyroid cancer
|
Endocrine System Diseases;Neoplasms
|
| HSALNT0289972
|
lnc-PSD4-1:14
|
NA
|
NA
|
pathogenic process
|
papillary thyroid cancer
|
Endocrine System Diseases;Neoplasms
|
| HSALNT0290066
|
n335550
|
NA
|
NA
|
pathogenic process
|
papillary thyroid cancer
|
Endocrine System Diseases;Neoplasms
|
| HSALNT0290070
|
n340790
|
NA
|
NA
|
pathogenic process
|
papillary thyroid cancer
|
Endocrine System Diseases;Neoplasms
|
| HSALNT0290072
|
n386477
|
NA
|
NA
|
pathogenic process
|
papillary thyroid cancer
|
Endocrine System Diseases;Neoplasms
|
| HSALNT0290286
|
TCONS_l2_00010365
|
NA
|
NA
|
pathogenic process
|
papillary thyroid cancer
|
Endocrine System Diseases;Neoplasms
|
| HSALNT0288944
|
ENST00000422494
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289118
|
LINC01612
|
RP11-789C1.1,TCONS_00008319
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289610
|
AP001439.2
|
NA
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289671
|
CACNAICAS3
|
NA
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289853
|
GS1-5L10.1
|
NA
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289875
|
INTS7
|
NA
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290065
|
MYLK-AS1
|
NA
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290157
|
PRSS21
|
NA
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290202
|
RP11-528G1.2
|
NA
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290207
|
RP11-643M14.1
|
NA
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290209
|
RP11-789C1.1
|
LINC01612
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290314
|
TSNAX-DISC1
|
NA
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290386
|
XLOC_010235
|
NA
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289558
|
AF075041
|
NA
|
NA
|
pathogenic process
|
pancreatic cancer
|
Endocrine System Diseases;Neoplasms;Digestive System Diseases
|
| HSALNT0289564
|
AF339813
|
NA
|
NA
|
pathogenic process
|
pancreatic cancer
|
Endocrine System Diseases;Neoplasms;Digestive System Diseases
|
| HSALNT0289575
|
AK022029
|
NA
|
NA
|
pathogenic process
|
pancreatic cancer
|
Endocrine System Diseases;Neoplasms;Digestive System Diseases
|
| HSALNT0289576
|
AK022159
|
NA
|
NA
|
pathogenic process
|
pancreatic cancer
|
Endocrine System Diseases;Neoplasms;Digestive System Diseases
|
| HSALNT0289604
|
AL389956
|
NA
|
NA
|
pathogenic process
|
pancreatic cancer
|
Endocrine System Diseases;Neoplasms;Digestive System Diseases
|
| HSALNT0289640
|
BC023629
|
NA
|
NA
|
pathogenic process
|
pancreatic cancer
|
Endocrine System Diseases;Neoplasms;Digestive System Diseases
|
| HSALNT0290096
|
NONHSAT125629
|
NA
|
NA
|
pathogenic process
|
breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0290393
|
XR_250621.1
|
NA
|
NA
|
pathogenic process
|
breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0288951
|
ENST00000503938
|
NA
|
NA
|
pathogenic process
|
triple-negative breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0290085
|
NONHSAT012762
|
NA
|
NA
|
pathogenic process
|
triple-negative breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0289151
|
LMCD1-AS1
|
NA
|
NA
|
pathogenic process
|
acute kidney injury
|
Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications
|
| HSALNT0289926
|
linc-PXN-1
|
NA
|
NA
|
pathogenic process
|
prostate cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0290281
|
TCONS_l2_00001418
|
NA
|
NA
|
pathogenic process
|
prostate cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0290285
|
TCONS_l2_00008237
|
NA
|
NA
|
pathogenic process
|
prostate cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0290287
|
TCONS_l2_00011130
|
NA
|
NA
|
pathogenic process
|
prostate cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0290288
|
TCONS_l2_00013175
|
NA
|
NA
|
pathogenic process
|
prostate cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0290294
|
TCONS_l2_00022611
|
NA
|
NA
|
pathogenic process
|
prostate cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0290295
|
TCONS_l2_00022670
|
NA
|
NA
|
pathogenic process
|
prostate cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0290352
|
uc004bdv.3
|
NA
|
NA
|
pathogenic process
|
hepatocelluar cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290363
|
ULK4P2
|
NA
|
NA
|
pathogenic process
|
hepatocelluar cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289942
|
LK4P2
|
NA
|
NA
|
pathogenic process
|
hepatocellular cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289538
|
AB019562
|
NA
|
NA
|
pathogenic process
|
hypopharyngeal squamous cell cancer
|
Neoplasms
|
| HSALNT0091661
|
ENST00000503710
|
NA
|
NA
|
pathogenic process
|
endometrial cancer
|
Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0289806
|
ENST00000445734
|
NA
|
NA
|
pathogenic process
|
endometrial cancer
|
Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0289807
|
ENST00000448093
|
NA
|
NA
|
pathogenic process
|
endometrial cancer
|
Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0289815
|
ENST00000502941
|
NA
|
NA
|
pathogenic process
|
endometrial cancer
|
Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0290340
|
uc002nbr.3
|
NA
|
NA
|
pathogenic process
|
endometrial cancer
|
Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0290348
|
uc003xut.
|
NA
|
NA
|
pathogenic process
|
endometrial cancer
|
Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0290356
|
uc021re1.1
|
NA
|
NA
|
pathogenic process
|
endometrial cancer
|
Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0289549
|
AC016745.3
|
AC016745.1
|
NA
|
pathogenic process
|
glioma
|
Neoplasms
|
| HSALNT0290180
|
RP11-128A17.1
|
AC078909.1
|
NA
|
pathogenic process
|
glioma
|
Neoplasms
|
| HSALNT0290377
|
XLOC_001711
|
NA
|
NA
|
pathogenic process
|
glioma
|
Neoplasms
|
| HSALNT0289975
|
lncRNA-AK058003
|
NA
|
NA
|
pathogenic process
|
breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0289061
|
LINC00682
|
NA
|
NA
|
pathogenic process
|
hepatocellular cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289305
|
LINC01559
|
FLJ33810
|
NA
|
pathogenic process
|
Huntington disease
|
Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
|
| HSALNT0289854
|
GSTT1-AS1
|
NA
|
transcriptional regulation
|
pathogenic process
|
mycobacterium tuberculosis infection
|
Bacterial Infections and Mycoses
|
| HSALNT0289978
|
lncRNA-CD244
|
NA
|
transcriptional regulation
|
pathogenic process
|
tuberculosis infection
|
Bacterial Infections and Mycoses
|
| HSALNT0289237
|
SAMD12-AS1
|
NA
|
NA
|
pathogenic process
|
neuroblastoma
|
Neoplasms
|
| HSALNT0290179
|
RP11-119F7.4
|
NA
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290278
|
TCONS_00068220
|
NA
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0285573
|
DANT1
|
NA
|
transcriptional regulation
|
NA
|
NA
|
NA
|
| HSALNT0288926
|
DANT2
|
NA
|
transcriptional regulation
|
NA
|
NA
|
NA
|
| HSALNT0290399
|
ZMAT1
|
NA
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289554
|
AC100865.1
|
NA
|
NA
|
pathogenic process
|
coronary artery disease
|
Cardiovascular Diseases
|
| HSALNT0289228
|
RAD51-AS1
|
TODRA
|
transcriptional regulation
|
pathogenic process
|
breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0289743
|
DKFZP434K028
|
NA
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289630
|
BC002811
|
NA
|
NA
|
pathogenic process
|
astrocytoma
|
Neoplasms
|
| HSALNT0290387
|
XLOC_010967
|
NA
|
NA
|
pathogenic process
|
astrocytoma
|
Neoplasms
|
| HSALNT0288955
|
ENST00000545440
|
NA
|
NA
|
pathogenic process
|
pediatric acute myeloid leukemia
|
Hemic and Lymphatic Diseases
|
| HSALNT0288981
|
FRGCA
|
LncRNA-AP001631.9
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289611
|
AP001631.9
|
NA
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289976
|
LncRNA-AP001631.9
|
NA
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289686
|
CD99P1
|
NA
|
ceRNA
|
pathogenic process
|
idiopathic pulmonary fibrosis
|
Respiratory Tract Diseases
|
| HSALNT0289119
|
LINC01613
|
n341773
|
NA
|
pathogenic process
|
idiopathic pulmonary fibrosis
|
Respiratory Tract Diseases
|
| HSALNT0289844
|
FTH1P3
|
FTH1P3
|
NA
|
pathogenic process
|
oral squamous cell cancer
|
Neoplasms
|
| HSALNT0289855
|
GTF2IRD2P1
|
GTF2IRD2P1
|
NA
|
pathogenic process
|
oral squamous cell cancer
|
Neoplasms
|
| HSALNT0290135
|
PDIA3F
|
NA
|
NA
|
pathogenic process
|
oral squamous cell cancer
|
Neoplasms
|
| HSALNT0289329
|
LINC00994
|
NA
|
NA
|
pathogenic process
|
inflammatory bowel disease
|
Digestive System Diseases
|
| HSALNT0289208
|
PCAT5
|
LINC01452,TPCAT-10-36067
|
NA
|
pathogenic process
|
prostate cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0114870
|
LUADT1
|
NA
|
transcriptional regulation
|
pathogenic process
|
lung adenocarcinoma
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0289154
|
LOXL1-AS1
|
NA
|
NA
|
pathogenic process
|
exfoliation syndrome
|
Eye Diseases
|
| HSALNT0289734
|
DACOR1
|
TCONS_00023265
|
transcriptional regulation
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289060
|
LINC00675
|
NA
|
NA
|
pathogenic process
|
Pancreatic ductal adenocarcinoma
|
Neoplasms
|
| HSALNT0288889
|
B4GALT1-AS1
|
NA
|
transcriptional regulation
|
pathogenic process
|
NA
|
NA
|
| HSALNT0289348
|
LINC01616
|
n341006
|
NA
|
pathogenic process
|
Alzheimer's disease
|
Mental Disorders;Nervous System Diseases
|
| HSALNT0290068
|
n336934
|
NA
|
NA
|
pathogenic process
|
Alzheimer's disease
|
Mental Disorders;Nervous System Diseases
|
| HSALNT0290240
|
SIRT1-AS
|
NA
|
NA
|
pathogenic process
|
hepatocellular cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290198
|
RP11-457M11.2
|
NA
|
ceRNA
|
pathogenic process
|
lung adenocarcinoma
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0150768
|
LINC01507
|
XLOC_000303
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289903
|
LINC01057
|
NA
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289914
|
LINC01617
|
C8orf23,NCRNA00249,XLOC_006844
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290015
|
LOC152578
|
NA
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0072252
|
LINC01618
|
LOC152578
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0156870
|
NALT1
|
MIR4674HG,LINC01573,TCONS_l2_00029132
|
transcriptional regulation
|
pathogenic process
|
acute lymphoblastic leukemia
|
Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases
|
| HSALNT0289083
|
MALINC1
|
LINC01024,MA-linc1
|
NA
|
pathogenic process
|
human breast and lung cancer
|
Neoplasms
|
| HSALNT0289902
|
LINC01024
|
MA-linc1
|
NA
|
pathogenic process
|
osteosarcoma;lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0289120
|
LINC01627
|
RP11-397D12.4
|
NA
|
pathogenic process
|
non-small cell lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0289121
|
LINC01628
|
AC007403.1
|
NA
|
pathogenic process
|
non-small cell lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0289820
|
ERICH1-AS1
|
NA
|
NA
|
pathogenic process
|
non-small cell lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0290193
|
RP11-397D12.4
|
LINC01627
|
NA
|
pathogenic process
|
non-small cell lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0289122
|
LINC01629
|
linc-KIAA1737-2
|
transcriptional regulation
|
pathogenic process
|
hypoxic and inflammatory renal epithelial injury
|
NA
|
| HSALNT0290161
|
PTPRG-AS1
|
NA
|
NA
|
pathogenic process
|
breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0289980
|
lncRNA-DLEU1
|
NA
|
ceRNA
|
pathogenic process
|
breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0289983
|
lncRNA-Hh
|
NA
|
NA
|
pathogenic process
|
breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0288986
|
GAS1RR
|
LncRNA-Hh
|
NA
|
pathogenic process
|
breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0288908
|
CCDC18-AS1
|
ENST00000440778.1
|
NA
|
pathogenic process
|
adolescent idiopathic scoliosis
|
Musculoskeletal Diseases
|
| HSALNT0289055
|
LINC00649
|
TCONS_00028768
|
NA
|
pathogenic process
|
adolescent idiopathic scoliosis
|
Musculoskeletal Diseases
|
| HSALNT0289219
|
PRKCQ-AS1
|
ENST00000414894.1
|
NA
|
pathogenic process
|
adolescent idiopathic scoliosis
|
Musculoskeletal Diseases
|
| HSALNT0290203
|
RP11-567G11.1
|
LINC02041
|
NA
|
pathogenic process
|
pancreatic cancer
|
Endocrine System Diseases;Neoplasms;Digestive System Diseases
|
| HSALNT0289805
|
ENST00000438550
|
RPS24P1
|
NA
|
pathogenic process
|
nasopharyngeal cancer
|
Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
|
| HSALNT0290083
|
NONHSAG011351
|
NA
|
NA
|
pathogenic process
|
type 1 diabetes
|
Nutritional and Metabolic Diseases;Endocrine System Diseases
|
| HSALNT0290049
|
MCHR2-AS1
|
NA
|
NA
|
pathogenic process
|
psychiatric disease
|
Nervous System Diseases
|
| HSALNT0289799
|
ENST00000414355
|
NA
|
NA
|
pathogenic process
|
cadmium toxicology
|
Disorders of Environmental Origin
|
| HSALNT0290241
|
SKP2
|
NA
|
NA
|
pathogenic process
|
non-small cell lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0289837
|
FLJ90757
|
NA
|
ceRNA
|
pathogenic process
|
hepatocellular cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290017
|
LOC283663
|
NA
|
ceRNA
|
pathogenic process
|
hepatocellular cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290019
|
LOC338651
|
NA
|
ceRNA
|
pathogenic process
|
hepatocellular cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290132
|
PCATs
|
NA
|
NA
|
pathogenic process
|
prostate cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0086786
|
EGFLAM-AS1
|
lncRNA-LOWEG
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290031
|
LOWEG
|
NA
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289635
|
BC014579
|
NA
|
NA
|
pathogenic process
|
hepatocelluar cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289721
|
CTB-167B5.2
|
NA
|
NA
|
pathogenic process
|
hepatocelluar cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289863
|
HELLS
|
NA
|
NA
|
pathogenic process
|
leukemia
|
Neoplasms
|
| HSALNT0290195
|
RP11-401P9.4
|
NA
|
NA
|
pathogenic process
|
hepatocelluar cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290252
|
SNHG19
|
NA
|
NA
|
pathogenic process
|
hepatocelluar cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289557
|
AF070632
|
NA
|
NA
|
pathogenic process
|
hepatocellular cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289569
|
AK021443
|
NA
|
NA
|
pathogenic process
|
hepatocellular cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289728
|
CTD-3080P12.3
|
NA
|
ceRNA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289987
|
lncRNA-n336928
|
NA
|
NA
|
pathogenic process
|
bladder cancer
|
Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0289723
|
CTC-523E23.5
|
AC008555.2
|
NA
|
pathogenic process
|
intervertebral disc degeneration
|
Musculoskeletal Diseases
|
| HSALNT0289724
|
CTD-2246P4.1
|
NA
|
NA
|
pathogenic process
|
intervertebral disc degeneration
|
Musculoskeletal Diseases
|
| HSALNT0290055
|
MIR132
|
MIRN132,miRNA132,mir-132
|
NA
|
pathogenic process
|
intervertebral disc degeneration
|
Musculoskeletal Diseases
|
| HSALNT0290189
|
RP11-363G2.4
|
NA
|
NA
|
pathogenic process
|
intervertebral disc degeneration
|
Musculoskeletal Diseases
|
| HSALNT0290191
|
RP11-38F22.1
|
LINC02424
|
NA
|
pathogenic process
|
intervertebral disc degeneration
|
Musculoskeletal Diseases
|
| HSALNT0290223
|
RP4-639J15.1
|
AC006967.2
|
NA
|
pathogenic process
|
intervertebral disc degeneration
|
Musculoskeletal Diseases
|
| HSALNT0290233
|
RUNX1-IT1
|
C21orf96
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0288943
|
ENST00000415964
|
NA
|
NA
|
pathogenic process
|
pediatric acute myeloid leukemia
|
Hemic and Lymphatic Diseases
|
| HSALNT0290009
|
LOC101927497
|
NA
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289956
|
lnc-CYP4A22-2/3
|
NA
|
NA
|
pathogenic process
|
clear cell renal cell cancer
|
Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0289999
|
lnc-ZNF180-2
|
NA
|
NA
|
pathogenic process
|
renal clear cell cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0290086
|
NONHSAT037832
|
NA
|
NA
|
pathogenic process
|
papillary thyroid cancer
|
Endocrine System Diseases;Neoplasms
|
| HSALNT0289658
|
BX647187
|
NA
|
NA
|
pathogenic process
|
prostate cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0288920
|
CNNM3-DT
|
LOC100506036
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289584
|
AK056155
|
NA
|
NA
|
pathogenic process
|
Loeys-Dietz syndrome
|
Musculoskeletal Diseases
|
| HSALNT0290057
|
MR1
|
NA
|
NA
|
pathogenic process
|
Loeys-Dietz syndrome
|
Musculoskeletal Diseases
|
| HSALNT0289543
|
AC002454.1
|
AC002454.1
|
NA
|
pathogenic process
|
endometriosis
|
Female Urogenital Diseases and Pregnancy Complications
|
| HSALNT0289909
|
LINC01420
|
NA
|
NA
|
pathogenic process
|
systemic lupus erythematosus
|
Immune System Diseases;Skin and Connective Tissue Diseases
|
| HSALNT0289531
|
53BP1
|
NA
|
NA
|
pathogenic process
|
breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0290101
|
NR_024118
|
NA
|
NA
|
pathogenic process
|
rheumatoid arthritis
|
Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases
|
| HSALNT0290239
|
SGO1-AS1
|
SGOL1-AS1
|
NA
|
pathogenic process
|
lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0289293
|
ZNF667-AS1
|
MORT
|
NA
|
pathogenic process
|
breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0289984
|
lncRNA-HIF2PUT
|
NA
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0288945
|
ENST00000433673
|
AC068282.1
|
NA
|
pathogenic process
|
polycystic ovary syndrome
|
Female Urogenital Diseases and Pregnancy Complications
|
| HSALNT0288948
|
ENST00000454271
|
AL021940.1
|
NA
|
pathogenic process
|
polycystic ovary syndrome
|
Female Urogenital Diseases and Pregnancy Complications
|
| HSALNT0289495
|
ENST00000432431
|
AC023128.1
|
NA
|
pathogenic process
|
polycystic ovary syndrome
|
Female Urogenital Diseases and Pregnancy Complications
|
| HSALNT0289918
|
LINC01828
|
NA
|
NA
|
pathogenic process
|
polycystic ovary syndrome
|
Female Urogenital Diseases and Pregnancy Complications
|
| HSALNT0290388
|
XLOC_011402
|
NA
|
NA
|
pathogenic process
|
polycystic ovary syndrome
|
Female Urogenital Diseases and Pregnancy Complications
|
| HSALNT0289873
|
ICAM-1
|
NA
|
NA
|
pathogenic process
|
hepatocellular cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289668
|
C5T1lncRNA
|
NA
|
transcriptional regulation
|
pathogenic process
|
rheumatoid arthritis
|
Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases
|
| HSALNT0289667
|
C5T1
|
NA
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0289666
|
C5-OT1
|
C5T1lncRNA
|
NA
|
pathogenic process
|
rheumatoid arthritis
|
Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases
|
| HSALNT0289626
|
AX800134
|
NA
|
NA
|
pathogenic process
|
hepatocellular cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290338
|
uc001ncr
|
NA
|
NA
|
pathogenic process
|
hepatocellular cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290330
|
uc.48+
|
NA
|
NA
|
pathogenic process
|
diabetic neuropathic pain
|
Male Urogenital Diseases
|
| HSALNT0289098
|
LINC01207
|
NA
|
transcriptional regulation
|
pathogenic process
|
lung adenocarcinoma
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0289628
|
BALR-6
|
NA
|
transcriptional regulation
|
pathogenic process
|
B-lymphoblastic leukemia
|
Hemic and Lymphatic Diseases
|
| HSALNT0290022
|
LOC389641
|
NA
|
NA
|
pathogenic process
|
Pancreatic ductal adenocarcinoma
|
Neoplasms
|
| HSALNT0289725
|
CTD-2541M15
|
NA
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289940
|
LINK-A
|
NA
|
NA
|
pathogenic process
|
triple-negative breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0290107
|
NUTF2P3
|
NUTF2P3
|
NA
|
pathogenic process
|
pancreatic cancer
|
Endocrine System Diseases;Neoplasms;Digestive System Diseases
|
| HSALNT0290095
|
NONHSAT123350
|
NA
|
NA
|
pathogenic process
|
renal clear cell cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0290362
|
UHRF1
|
NA
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290366
|
UPAT
|
NA
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289307
|
LINC00324
|
FLJ34790,MGC104931
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0289969
|
lnc-MX1-1
|
NA
|
NA
|
pathogenic process
|
prostate cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0290024
|
LOC400891
|
NA
|
NA
|
pathogenic process
|
prostate cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0289883
|
LA16c-313D11.11
|
NA
|
ceRNA
|
pathogenic process
|
endometrial cancer
|
Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0290192
|
RP11-395G23.3
|
AC027031.2
|
NA
|
pathogenic process
|
endometrial cancer
|
Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0289742
|
DILC
|
NA
|
transcriptional regulation
|
pathogenic process
|
liver cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289957
|
lnc-DILC
|
NA
|
transcriptional regulation
|
pathogenic process
|
liver cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289581
|
AK027294
|
NA
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290371
|
WISP1
|
NA
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0206117
|
FGF14-AS2
|
NA
|
NA
|
pathogenic process
|
breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0290131
|
PCAT2
|
CARLo-4,PCA2,TCONS_00015167
|
NA
|
pathogenic process
|
prostate cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0289528
|
2700086A05Rik
|
2700086A05Rik
|
NA
|
pathogenic process
|
idiopathic pulmonary fibrosis
|
Respiratory Tract Diseases
|
| HSALNT0290251
|
SNED1
|
NA
|
NA
|
pathogenic process
|
Idiopathic pulmonary fibrosis
|
Respiratory Tract Diseases
|
| HSALNT0290333
|
uc.77
|
NA
|
NA
|
pathogenic process
|
idiopathic pulmonary fibrosis
|
Respiratory Tract Diseases
|
| HSALNT0289816
|
ENST00000537266
|
NA
|
NA
|
pathogenic process
|
papillary thyroid cancer
|
Endocrine System Diseases;Neoplasms
|
| HSALNT0289860
|
HAGLROS
|
NA
|
NA
|
pathogenic process
|
papillary thyroid cancer
|
Endocrine System Diseases;Neoplasms
|
| HSALNT0289881
|
KRT18P55
|
KRT18P55
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0229266
|
IL21R-AS1
|
NA
|
NA
|
pathogenic process
|
coronary artery disease
|
Cardiovascular Diseases
|
| HSALNT0290112
|
OTTHUMT00000387022
|
NA
|
NA
|
pathogenic process
|
coronary artery disease
|
Cardiovascular Diseases
|
| HSALNT0000551
|
PRKCZ-AS1
|
RP11-181G12.2
|
NA
|
pathogenic process
|
lung adenocarcinoma
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0030981
|
LINC01833
|
RP11-89,K21.1
|
NA
|
pathogenic process
|
lung adenocarcinoma
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0290214
|
RP11-89K21
|
NA
|
NA
|
pathogenic process
|
lung adenocarcinoma
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0165271
|
LINC00857
|
NA
|
NA
|
pathogenic process
|
lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0290109
|
OR3A4
|
NA
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290046
|
MAGI1-IT1
|
NA
|
ceRNA
|
pathogenic process
|
cardiac hypertrophy
|
Cardiovascular Diseases
|
| HSALNT0290242
|
SLC26A4-AS1
|
NA
|
ceRNA
|
pathogenic process
|
cardiac hypertrophy
|
Cardiovascular Diseases
|
| HSALNT0289302
|
KRT7-AS
|
NA
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0218672
|
LINC01852
|
ENST00000434223
|
NA
|
pathogenic process
|
non-small cell lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0290178
|
RP11-1008C21.2
|
NA
|
NA
|
pathogenic process
|
non-small cell lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0289592
|
AK123072
|
NA
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289573
|
AK021954
|
NA
|
NA
|
pathogenic process
|
atherosclerosis
|
Cardiovascular Diseases
|
| HSALNT0288916
|
CERNA1
|
LOC100129973
|
ceRNA
|
pathogenic process
|
cardiovascular disease
|
Cardiovascular Diseases
|
| HSALNT0018525
|
LAMC1-AS1
|
lnc-LAMC2-1:1
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290087
|
NONHSAT040387
|
NA
|
NA
|
pathogenic process
|
atrial fibrillation
|
Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases
|
| HSALNT0290092
|
NONHSAT098586
|
NA
|
NA
|
pathogenic process
|
atrial fibrillation
|
Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases
|
| HSALNT0289213
|
PCSK6-AS1
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289637
|
BC016831
|
NA
|
NA
|
pathogenic process
|
breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0289874
|
IGKV
|
NA
|
NA
|
pathogenic process
|
breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0290196
|
RP11-434D9.1
|
AC112206.2
|
NA
|
pathogenic process
|
breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0289885
|
LCAL6
|
NA
|
NA
|
pathogenic process
|
lung adenocarcinoma
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0289650
|
BC088254
|
NA
|
NA
|
pathogenic process
|
myocardial hypertrophy
|
Cardiovascular Diseases
|
| HSALNT0289596
|
AK124454
|
NA
|
NA
|
pathogenic process
|
breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0289731
|
CYP4B1-PS1
|
NA
|
NA
|
pathogenic process
|
diabetic nephropathy
|
Endocrine System Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications
|
| HSALNT0289106
|
LINC01405
|
NA
|
NA
|
pathogenic process
|
breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0290259
|
ST8SIA6-AS1
|
NA
|
NA
|
pathogenic process
|
breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0289278
|
TRIM52-AS1
|
NA
|
NA
|
pathogenic process
|
renal cell cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0289634
|
BC012900
|
NA
|
NA
|
pathogenic process
|
ulcerative colitis
|
Digestive System Diseases
|
| HSALNT0274011
|
UMODL1-AS1
|
FLJ33471
|
NA
|
pathogenic process
|
breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0289454
|
ARRDC1-AS1
|
NA
|
NA
|
pathogenic process
|
breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0289456
|
FAM74A3
|
OTTHUMG00000067149
|
NA
|
pathogenic process
|
breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0289834
|
FH
|
NA
|
NA
|
pathogenic process
|
Fumarase deficiency
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0289961
|
lnc-HOXC4-3:1
|
NA
|
NA
|
pathogenic process
|
breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0289994
|
lnc-TEAD4-1:1
|
NA
|
NA
|
pathogenic process
|
breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0290270
|
TCONS_00003876
|
NA
|
NA
|
pathogenic process
|
breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0289825
|
EVI1
|
NA
|
transcriptional regulation
|
pathogenic process
|
hepatocellular cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290235
|
SARCC
|
NA
|
NA
|
pathogenic process
|
renal cell cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0290360
|
ucoo2kmd.1
|
NA
|
ceRNA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289015
|
KAZN-AS1
|
NA
|
NA
|
pathogenic process
|
breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0289722
|
CTB-89H12.4
|
AC021078.1
|
ceRNA
|
pathogenic process
|
prostate cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0289496
|
EPB41L4A-AS2
|
FLJ11235
|
NA
|
pathogenic process
|
lung cancer;breast cancer;kidney cancer
|
Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications
|
| HSALNT0289146
|
LINC02567
|
ENST00000427806
|
NA
|
pathogenic process
|
attention deficit hyperactivity disorder
|
Mental Disorders
|
| HSALNT0289833
|
FGFR3-AS1
|
NA
|
NA
|
pathogenic process
|
osteosarcoma
|
Neoplasms
|
| HSALNT0289707
|
CILinc01
|
NA
|
NA
|
pathogenic process
|
osteoarthritis
|
Musculoskeletal Diseases
|
| HSALNT0289708
|
CILinc02
|
NA
|
NA
|
pathogenic process
|
osteoarthritis
|
Musculoskeletal Diseases
|
| HSALNT0286597
|
LINC00629
|
LINC00629AB,LINC00629C,LINC00629D,LINC00629
|
NA
|
pathogenic process
|
choriocarcinoma
|
Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0289665
|
C2dat1
|
NA
|
NA
|
pathogenic process
|
ischemic brain injury
|
Cardiovascular Diseases
|
| HSALNT0289217
|
POU6F2-AS2
|
FLJ12971
|
protein localization
|
pathogenic process
|
oesophageal squamous cell cancer
|
Neoplasms
|
| HSALNT0289946
|
lnc13
|
NA
|
NA
|
pathogenic process
|
celiac disease
|
Nutritional and Metabolic Diseases;Digestive System Diseases
|
| HSALNT0289729
|
CTD903
|
NA
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290093
|
NONHSAT104436
|
NA
|
NA
|
pathogenic process
|
esophageal squamous cell cancer
|
Neoplasms
|
| HSALNT0289550
|
AC024560.2
|
AC024560.1
|
NA
|
pathogenic process
|
cervical cancer
|
Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0289483
|
ENST00000436681
|
AP000552.1
|
NA
|
pathogenic process
|
congenital heart defect
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0289536
|
AA584040
|
NA
|
NA
|
pathogenic process
|
congenital heart defect
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0289537
|
AA709223
|
NA
|
NA
|
pathogenic process
|
congenital heart defect
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0289657
|
BX478947
|
NA
|
NA
|
pathogenic process
|
congenital heart defect
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0247515
|
LINC00668
|
NA
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289719
|
CRNDE-h
|
NA
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0142879
|
SMILR
|
NA
|
NA
|
pathogenic process
|
vascular pathologies
|
Cardiovascular Diseases
|
| HSALNT0290396
|
Z38
|
NA
|
NA
|
pathogenic process
|
breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0197213
|
LINC00507
|
NA
|
NA
|
developmental process
|
NA
|
NA
|
| HSALNT0289086
|
LINC01082
|
TCONSNA00024492
|
NA
|
pathogenic process
|
alveolar capillary dysplasia with misalignment of pulmonary veins
|
Cardiovascular Diseases
|
| HSALNT0289094
|
LINC01185
|
FLJ16341
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0290160
|
PTPRD-AS1
|
NA
|
NA
|
pathogenic process
|
ovarian cancer
|
Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0290186
|
RP11-254I22.1
|
MIR583HG
|
NA
|
pathogenic process
|
ovarian cancer
|
Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0290204
|
RP11-57P19.1
|
AC009432.1
|
NA
|
pathogenic process
|
ovarian cancer
|
Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0290211
|
RP11-80H5.7
|
AL157400.4
|
NA
|
pathogenic process
|
ovarian cancer
|
Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0290215
|
RP1-223E5.4
|
AL441883.1
|
NA
|
pathogenic process
|
ovarian cancer
|
Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0290224
|
RP4-799P18.3
|
AL122008.4
|
NA
|
pathogenic process
|
ovarian cancer
|
Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0289126
|
LINC01844
|
LOC101926975
|
NA
|
pathogenic process
|
hirschsprung disease
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases
|
| HSALNT0289947
|
Lnc34a
|
NA
|
transcriptional regulation
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289150
|
LINP1
|
NA
|
NA
|
pathogenic process
|
breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0289951
|
lncARSR
|
NA
|
ceRNA
|
pathogenic process
|
renal cell cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0289392
|
RBM15-AS1
|
AS-RBM15
|
translational control
|
pathogenic process
|
acute megakaryocytic leukemia
|
Neoplasms
|
| HSALNT0290089
|
NONHSAT073641
|
NA
|
NA
|
pathogenic process
|
vascular diseases
|
Cardiovascular Diseases
|
| HSALNT0290027
|
LOC572558
|
NA
|
NA
|
pathogenic process
|
bladder cancer
|
Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0289582
|
AK033210
|
NA
|
NA
|
pathogenic process;developmental process
|
bronchopulmonary dysplasia
|
Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities
|
| HSALNT0289848
|
GClnc1
|
NA
|
transcriptional regulation
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289572
|
AK021630
|
NA
|
NA
|
pathogenic process
|
Parkinson's disease
|
Nervous System Diseases
|
| HSALNT0289603
|
AL049437
|
NA
|
NA
|
pathogenic process
|
Parkinson's disease
|
Nervous System Diseases
|
| HSALNT0290007
|
LOC100507661
|
NA
|
NA
|
pathogenic process
|
thyroid cancer
|
Endocrine System Diseases;Neoplasms
|
| HSALNT0289084
|
LINC01029
|
NA
|
NA
|
pathogenic process
|
cognitive functions and neuronal plasticity
|
Nervous System Diseases
|
| HSALNT0290169
|
RMEL3
|
NA
|
NA
|
pathogenic process
|
melanoma
|
Neoplasms
|
| HSALNT0289959
|
lnc-FRG2C-3
|
NA
|
NA
|
pathogenic process
|
ankylosing spondylitis
|
Musculoskeletal Diseases
|
| HSALNT0289966
|
lnc-LIN54-1
|
NA
|
NA
|
pathogenic process
|
ankylosing spondylitis
|
Musculoskeletal Diseases
|
| HSALNT0289997
|
lnc-USP50-2
|
NA
|
NA
|
pathogenic process
|
ankylosing spondylitis
|
Musculoskeletal Diseases
|
| HSALNT0290000
|
lnc-ZNF354A-1
|
NA
|
NA
|
pathogenic process
|
ankylosing spondylitis
|
Musculoskeletal Diseases
|
| HSALNT0288949
|
ENST00000455309
|
NA
|
NA
|
pathogenic process
|
primary Sjögren's syndrome
|
Immune System Diseases
|
| HSALNT0289920
|
LINC02384
|
NA
|
NA
|
pathogenic process
|
primary Sjögren's syndrome
|
Immune System Diseases
|
| HSALNT0289998
|
Lnc-UTS2D-1:1
|
NA
|
NA
|
pathogenic process
|
primary Sjögren's syndrome
|
Immune System Diseases
|
| HSALNT0290067
|
n336161
|
NA
|
NA
|
pathogenic process
|
primary Sjögren's syndrome
|
Immune System Diseases
|
| HSALNT0290069
|
n340599
|
NA
|
NA
|
pathogenic process
|
primary Sjögren's syndrome
|
Immune System Diseases
|
| HSALNT0290099
|
NR_002712
|
NA
|
NA
|
pathogenic process
|
primary Sjögren's syndrome
|
Immune System Diseases
|
| HSALNT0290290
|
TCONS_l2_00014794
|
NA
|
NA
|
pathogenic process
|
primary Sjögren's syndrome
|
Immune System Diseases
|
| HSALNT0290170
|
RMRP
|
CHH,NME1R,RRP2,RMRP
|
ceRNA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289900
|
LINC00961
|
NA
|
NA
|
pathogenic process
|
ovarian cancer
|
Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0289077
|
LINC00977
|
NA
|
NA
|
pathogenic process
|
primary spontaneous pneumothorax
|
Respiratory Tract Diseases
|
| HSALNT0289560
|
AF085995
|
NA
|
NA
|
pathogenic process
|
lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0289566
|
AK000053
|
NA
|
NA
|
pathogenic process
|
lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0289571
|
AK021595
|
NA
|
NA
|
pathogenic process
|
lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0289574
|
AK022024
|
NA
|
NA
|
pathogenic process
|
lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0289595
|
AK124307
|
NA
|
NA
|
pathogenic process
|
lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0289639
|
BC020384
|
NA
|
NA
|
pathogenic process
|
lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0289642
|
BC030759
|
NA
|
NA
|
pathogenic process
|
lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0289715
|
CR615992
|
NA
|
NA
|
pathogenic process
|
lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0289954
|
lnc-CC3
|
NA
|
NA
|
pathogenic process
|
cervical cancer
|
Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0289614
|
APOC1P1-3
|
NA
|
transcriptional regulation
|
pathogenic process
|
breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0290365
|
UNMIBC
|
NA
|
transcriptional regulation
|
pathogenic process
|
bladder cancer
|
Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0290323
|
uc.167
|
NA
|
NA
|
pathogenic process
|
ventricular septal defects
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0290212
|
RP11-838N2.4
|
GAPLINC
|
ceRNA
|
pathogenic process
|
glioblastoma
|
Neoplasms
|
| HSALNT0289109
|
LINC01478
|
NA
|
NA
|
pathogenic process
|
blood pressure
|
Cardiovascular Diseases
|
| HSALNT0289313
|
LINC00342
|
NA
|
NA
|
pathogenic process
|
non-small cell lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0289677
|
CAR10
|
NA
|
NA
|
pathogenic process
|
lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0289365
|
MAPT-AS1
|
NA
|
transcriptional regulation
|
pathogenic process
|
Parkinson's disease
|
Nervous System Diseases
|
| HSALNT0289679
|
CAT104
|
NA
|
ceRNA
|
pathogenic process
|
breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0290260
|
STXBP5-AS1
|
NA
|
ceRNA
|
pathogenic process
|
breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0289861
|
HAR1
|
NA
|
NA
|
pathogenic process
|
Huntington disease
|
Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
|
| HSALNT0290359
|
UCHL1-AS1
|
NA
|
translational control
|
pathogenic process
|
Parkinson's disease
|
Nervous System Diseases
|
| HSALNT0290238
|
SCAANT1-AS
|
NA
|
NA
|
pathogenic process
|
spinocerebellar ataxia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
|
| HSALNT0289648
|
BC041488
|
NA
|
transcriptional regulation
|
pathogenic process
|
bladder cancer
|
Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0290188
|
RP11-359E19.2
|
AC022733.1
|
transcriptional regulation
|
pathogenic process
|
bladder cancer
|
Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0289669
|
C6orf176-TV1
|
NA
|
NA
|
pathogenic process
|
non-small cell lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0289670
|
C6orf176-TV2
|
NA
|
NA
|
pathogenic process
|
non-small cell lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0289851
|
GIHCG
|
NA
|
transcriptional regulation
|
pathogenic process
|
hepatocellular cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289649
|
BC087858
|
NA
|
NA
|
pathogenic process
|
non-small cell lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0290353
|
uc004cov.4
|
NA
|
NA
|
pathogenic process
|
hypertrophic cardiomyopathy
|
Cardiovascular Diseases
|
| HSALNT0290357
|
uc022bqu.1
|
NA
|
NA
|
pathogenic process
|
hypertrophic cardiomyopathy
|
Cardiovascular Diseases
|
| HSALNT0127837
|
CFTR-AS1
|
BGas
|
transcriptional regulation
|
pathogenic process
|
cystic fibrosis
|
Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases
|
| HSALNT0046367
|
MYOSLID
|
NA
|
NA
|
pathogenic process
|
vascular smooth muscle cell (VSMC) contractile phenotype
|
Cardiovascular Diseases
|
| HSALNT0290331
|
uc.63
|
NA
|
NA
|
pathogenic process
|
breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0290106
|
numb
|
NA
|
NA
|
pathogenic process
|
uveal melanoma
|
Neoplasms
|
| HSALNT0289847
|
GCASPC
|
TCONS_00011605,RP1-56L9.7-001,lnc-SOD2-1
|
NA
|
pathogenic process
|
gallbladder cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289568
|
AK001094
|
NA
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289588
|
AK093735
|
NA
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289631
|
BC003519
|
NA
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290100
|
NR_003573
|
ANXA2P2
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290119
|
P2RX7-V3
|
NA
|
NA
|
pathogenic process
|
uveal melanoma
|
Neoplasms
|
| HSALNT0290308
|
TMSB4
|
NA
|
ceRNA
|
pathogenic process
|
osteoarthritis
|
Musculoskeletal Diseases
|
| HSALNT0288928
|
DDX11-AS1
|
CONCR
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0290052
|
MELOE
|
NA
|
NA
|
pathogenic process
|
melanoma
|
Neoplasms
|
| HSALNT0290231
|
RSU1P2
|
RSU1P2
|
ceRNA
|
pathogenic process
|
cervical cancer
|
Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0290165
|
RBMY2FP
|
RBMY2FP
|
NA
|
NA
|
hepatocellular cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290071
|
n375709
|
NA
|
NA
|
pathogenic process
|
nasopharyngeal cancer
|
Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
|
| HSALNT0289748
|
DUXAP8
|
DUXAP8
|
NA
|
NA
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290030
|
LOC729966
|
NA
|
NA
|
pathogenic process
|
papillary thyroid cancer
|
Endocrine System Diseases;Neoplasms
|
| HSALNT0290143
|
POIR
|
NA
|
ceRNA
|
pathogenic process
|
periodontitis
|
Stomatognathic Diseases
|
| HSALNT0067481
|
MELTF-AS1
|
MFI2-AS1,AC068302.3
|
NA
|
pathogenic process
|
osteosarcoma
|
Neoplasms
|
| HSALNT0290053
|
MFI2
|
NA
|
NA
|
pathogenic process
|
osteosarcoma
|
Neoplasms
|
| HSALNT0289922
|
linc-223
|
NA
|
ceRNA
|
pathogenic process
|
acute myeloid leukemia
|
Neoplasms
|
| HSALNT0014603
|
LINC01138
|
LINC00875,FLJ39739
|
NA
|
pathogenic process
|
prostate cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0290262
|
SUZ12P1
|
SUZ12P1
|
NA
|
pathogenic process
|
prostate cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0290005
|
LOC100505976
|
NA
|
NA
|
pathogenic process
|
laryngeal squamous cell cancer
|
Neoplasms
|
| HSALNT0290392
|
XLOC_l2_010636
|
NA
|
NA
|
pathogenic process
|
laryngeal squamous cell cancer
|
Neoplasms
|
| HSALNT0090295
|
RASGRF2-AS1
|
CTC-459I6.1
|
NA
|
pathogenic process
|
sepsis-induced endothelial dysfunction
|
Bacterial Infections and Mycoses
|
| HSALNT0289852
|
GPC3-AS1
|
NA
|
transcriptional regulation
|
pathogenic process
|
hepatocellular cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0189472
|
HOXC-AS1
|
NA
|
transcriptional regulation
|
pathogenic process
|
atherosclerosis
|
Cardiovascular Diseases
|
| HSALNT0289157
|
LUARIS
|
lncRNA#32
|
transcriptional regulation
|
NA
|
NA
|
NA
|
| HSALNT0289371
|
MIR3936HG
|
LOC553103,SLC22A5-AS1
|
NA
|
pathogenic process
|
gastric cancer;nasopharyngeal cancer
|
Otorhinolaryngologic Diseases;Stomatognathic Diseases;Neoplasms;Digestive System Diseases
|
| HSALNT0290148
|
Ppp1r1b
|
NA
|
transcriptional regulation
|
pathogenic process
|
congenital heart defect
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0289038
|
LINC00460
|
NA
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290194
|
RP1-13P20.6
|
NA
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290364
|
Unigene56159
|
NA
|
ceRNA
|
pathogenic process
|
hepatocellular cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290355
|
uc009yby.1
|
NA
|
NA
|
pathogenic process
|
renal cell cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0289406
|
TFAP2A-AS2
|
HIPSTR
|
NA
|
developmental process
|
NA
|
NA
|
| HSALNT0289704
|
Chaer
|
NA
|
transcriptional regulation
|
pathogenic process
|
cardiac hypertrophy
|
Cardiovascular Diseases
|
| HSALNT0289865
|
HIF-2α
|
NA
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0211378
|
LINC00520
|
C14orf34
|
NA
|
pathogenic process
|
breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0087374
|
MRPS30-DT
|
BRCAT54
|
NA
|
pathogenic process
|
breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0289388
|
PPP1R12A-AS1
|
R12A-AS1
|
translational control
|
NA
|
NA
|
NA
|
| HSALNT0289013
|
ITFG2-AS1
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0290088
|
NONHSAT041499
|
NA
|
NA
|
pathogenic process
|
schizophrenia
|
Mental Disorders
|
| HSALNT0290091
|
NONHSAT089447
|
NA
|
NA
|
pathogenic process
|
schizophrenia
|
Mental Disorders
|
| HSALNT0289970
|
lnc-NKX2-3-1
|
NA
|
transcriptional regulation
|
pathogenic process
|
acute lymphoblastic leukemia
|
Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases
|
| HSALNT0289989
|
lnc-RTN4R-1
|
NA
|
transcriptional regulation
|
pathogenic process
|
acute lymphoblastic leukemia
|
Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases
|
| HSALNT0289821
|
ERL
|
NA
|
NA
|
pathogenic process
|
Marek's disease
|
Immune System Diseases;Hemic and Lymphatic Diseases;Virus Diseases
|
| HSALNT0192459
|
LINC02258
|
RP11-248E9.5
|
NA
|
pathogenic process
|
pneumonia
|
Respiratory Tract Diseases
|
| HSALNT0241871
|
SKAP1-AS1
|
RP11-456D7.1
|
NA
|
pathogenic process
|
pneumonia
|
Respiratory Tract Diseases
|
| HSALNT0289439
|
DINOL
|
DINO
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0288901
|
CAMTA1-DT
|
lncCAMTA1
|
transcriptional regulation
|
pathogenic process
|
liver cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290328
|
uc.345
|
NA
|
transcriptional regulation
|
pathogenic process
|
pancreatic cancer
|
Endocrine System Diseases;Neoplasms;Digestive System Diseases
|
| HSALNT0290060
|
MSNP1AS
|
NA
|
translational control
|
pathogenic process
|
autism spectrum disorder
|
Mental Disorders
|
| HSALNT0289376
|
NEXN-AS1
|
C1orf118,FLJ90637
|
NA
|
pathogenic process
|
lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0183194
|
LINC02098
|
RP11-702B10.1
|
NA
|
pathogenic process
|
esophageal cancer
|
Neoplasms
|
| HSALNT0198055
|
PSPC1-AS2
|
RP11-523H24.3
|
NA
|
pathogenic process
|
esophageal cancer
|
Neoplasms
|
| HSALNT0289155
|
LRRC75A-AS1
|
C17orf45,NCRNA00188,C17orf76-AS1,FAM211A-AS1,MGC40157
|
NA
|
pathogenic process
|
rheumatoid arthritis
|
Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases
|
| HSALNT0289220
|
PRKG1-AS1
|
RP11-573I11.2
|
NA
|
pathogenic process
|
rheumatoid arthritis
|
Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases
|
| HSALNT0289262
|
SVIL-AS1
|
RP11-534G20.3
|
NA
|
pathogenic process
|
rheumatoid arthritis
|
Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases
|
| HSALNT0289281
|
VPS33B-DT
|
NA
|
NA
|
pathogenic process
|
rheumatoid arthritis
|
Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases
|
| HSALNT0289804
|
ENST00000438399
|
NA
|
NA
|
pathogenic process
|
rheumatoid arthritis
|
Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases
|
| HSALNT0290228
|
RPKG1-AS1
|
NA
|
NA
|
pathogenic process
|
rheumatoid arthritis
|
Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases
|
| HSALNT0290350
|
uc004afb.1
|
NA
|
NA
|
pathogenic process
|
rheumatoid arthritis
|
Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases
|
| HSALNT0289398
|
SLC5A4-AS1
|
RP1-90G24.10
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289411
|
TNFRSF10A-AS1
|
RP11-1149O23.2
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289727
|
CTD-2616J11.14
|
AC008750.7
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290182
|
RP11-150O12.3
|
AC124067.4
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289730
|
CXCL1P1
|
CXCL1P1
|
NA
|
pathogenic process
|
hepatocellular cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289803
|
ENST00000438347
|
CCND3P1
|
NA
|
pathogenic process
|
hepatocellular cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289897
|
LINC00601
|
NA
|
NA
|
pathogenic process
|
hepatocellular cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289503
|
KIAA0087
|
NA
|
NA
|
pathogenic process
|
endometrial cancer
|
Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0289827
|
FAM212B-AS1
|
NA
|
NA
|
pathogenic process
|
endometrial cancer
|
Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0290010
|
LOC102723552
|
NA
|
NA
|
pathogenic process
|
endometrial cancer
|
Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0290181
|
RP11-140I24
|
LINC01568
|
NA
|
pathogenic process
|
endometrial cancer
|
Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0290201
|
RP11-501O2
|
LINC02046
|
NA
|
pathogenic process
|
endometrial cancer
|
Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0290206
|
RP11-600K151
|
NA
|
NA
|
pathogenic process
|
endometrial cancer
|
Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0290084
|
NONHSAG051968
|
NA
|
NA
|
pathogenic process
|
papillary thyroid cancer
|
Endocrine System Diseases;Neoplasms
|
| HSALNT0290090
|
NONHSAT076747
|
NA
|
NA
|
pathogenic process
|
papillary thyroid cancer
|
Endocrine System Diseases;Neoplasms
|
| HSALNT0290094
|
NONHSAT122730
|
NA
|
NA
|
pathogenic process
|
papillary thyroid cancer
|
Endocrine System Diseases;Neoplasms
|
| HSALNT0138768
|
MIR2052HG
|
NA
|
transcriptional regulation
|
pathogenic process
|
breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0289096
|
LINC01198
|
NA
|
NA
|
pathogenic process
|
glioma
|
Neoplasms
|
| HSALNT0289274
|
TPT1-AS1
|
NA
|
NA
|
pathogenic process
|
glioma
|
Neoplasms
|
| HSALNT0289924
|
linc-cdh4-2
|
NA
|
NA
|
pathogenic process
|
hepatocellular cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0144641
|
LINC02055
|
RP1130-1
|
NA
|
pathogenic process
|
hepatocellular cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289737
|
DBCCR1
|
NA
|
transcriptional regulation
|
pathogenic process
|
bladder cancer
|
Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0289547
|
AC012065.7
|
NA
|
NA
|
pathogenic process
|
chronic lymphocytic leukemia
|
Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases
|
| HSALNT0289229
|
RAMP2-AS1
|
NA
|
NA
|
pathogenic process
|
glioblastoma
|
Neoplasms
|
| HSALNT0289591
|
AK098081
|
NA
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289644
|
BC037331
|
NA
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289646
|
BC040303
|
NA
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289717
|
CR749831
|
NA
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289250
|
SNHG18
|
NA
|
NA
|
pathogenic process
|
glioma
|
Neoplasms
|
| HSALNT0106140
|
FOXP4-AS1
|
NA
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0026202
|
RNASEH1-AS1
|
LOC100506054
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0288993
|
GSEC
|
ST3GAL4-AS1,DCPS-AS1,FLJ39051
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0060264
|
DNAJB8-AS1
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0248137
|
CHMP1B-AS1
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0021970
|
TGFB2-AS1
|
NR_046268
|
NA
|
pathogenic process
|
early-onset preeclampsia
|
Female Urogenital Diseases and Pregnancy Complications
|
| HSALNT0078323
|
SLC7A11-AS1
|
NA
|
NA
|
pathogenic process
|
early-onset preeclampsia
|
Female Urogenital Diseases and Pregnancy Complications
|
| HSALNT0134663
|
INTS9-AS1
|
ENST00000520055
|
NA
|
pathogenic process
|
early-onset preeclampsia
|
Female Urogenital Diseases and Pregnancy Complications
|
| HSALNT0231572
|
MMP2-AS1
|
NA
|
NA
|
pathogenic process
|
early-onset preeclampsia
|
Female Urogenital Diseases and Pregnancy Complications
|
| HSALNT0267869
|
SLC12A5-AS1
|
RP11-465L10.10
|
NA
|
pathogenic process
|
early-onset preeclampsia
|
Female Urogenital Diseases and Pregnancy Complications
|
| HSALNT0288921
|
CSMD2-AS1
|
ENST00000434181
|
NA
|
pathogenic process
|
early-onset preeclampsia
|
Female Urogenital Diseases and Pregnancy Complications
|
| HSALNT0288997
|
HDAC2-AS2
|
ENST00000421891
|
NA
|
pathogenic process
|
early-onset preeclampsia
|
Female Urogenital Diseases and Pregnancy Complications
|
| HSALNT0289012
|
INO80-AS1
|
NA
|
NA
|
pathogenic process
|
early-onset preeclampsia
|
Female Urogenital Diseases and Pregnancy Complications
|
| HSALNT0289140
|
LINC02247
|
NA
|
NA
|
pathogenic process
|
early-onset preeclampsia
|
Female Urogenital Diseases and Pregnancy Complications
|
| HSALNT0289161
|
MAGI2-AS3
|
NA
|
NA
|
pathogenic process
|
early-onset preeclampsia
|
Female Urogenital Diseases and Pregnancy Complications
|
| HSALNT0289188
|
MNX1-AS2
|
NA
|
NA
|
pathogenic process
|
early-onset preeclampsia
|
Female Urogenital Diseases and Pregnancy Complications
|
| HSALNT0289245
|
SMIM10L2B-AS1
|
NA
|
NA
|
pathogenic process
|
early-onset preeclampsia
|
Female Urogenital Diseases and Pregnancy Complications
|
| HSALNT0289407
|
TGFB3-AS1
|
NA
|
NA
|
pathogenic process
|
early-onset preeclampsia
|
Female Urogenital Diseases and Pregnancy Complications
|
| HSALNT0289457
|
HSD17B3-AS1
|
NA
|
NA
|
pathogenic process
|
early-onset preeclampsia
|
Female Urogenital Diseases and Pregnancy Complications
|
| HSALNT0289919
|
LINC02246
|
NA
|
NA
|
pathogenic process
|
early-onset preeclampsia
|
Female Urogenital Diseases and Pregnancy Complications
|
| HSALNT0289288
|
ZNF710-AS1
|
ENST00000558334
|
NA
|
pathogenic process
|
early-onset preeclampsia
|
Female Urogenital Diseases and Pregnancy Complications
|
| HSALNT0289266
|
TDRKH-AS1
|
RP11-98D18.9
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0289128
|
LINC01952
|
AC004854.4
|
NA
|
pathogenic process
|
recurrent miscarriage
|
Female Urogenital Diseases and Pregnancy Complications
|
| HSALNT0290075
|
NCF4-AS1
|
CTA-833B7.2
|
NA
|
pathogenic process
|
recurrent miscarriage
|
Female Urogenital Diseases and Pregnancy Complications
|
| HSALNT0289360
|
LNCSRLR
|
lncRNA-SRLR
|
transcriptional regulation
|
pathogenic process
|
renal cell cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0288918
|
CFLAR-AS1
|
ALS2CR10
|
NA
|
pathogenic process
|
esophageal squamous cell cancer
|
Neoplasms
|
| HSALNT0289710
|
COL1A2-AS1
|
TCONS_00013888,lncRNA8975-1
|
transcriptional regulation
|
pathogenic process
|
hypertrophic scar
|
Skin and Connective Tissue Diseases
|
| HSALNT0075075
|
LNCPRESS2
|
lncPRESS2
|
transcriptional regulation
|
NA
|
NA
|
NA
|
| HSALNT0011289
|
LINC01930
|
EU358092
|
NA
|
pathogenic process
|
schizophrenia
|
Mental Disorders
|
| HSALNT0097120
|
HMMR-AS1
|
NA
|
NA
|
pathogenic process
|
basal-like breast cancer
|
Neoplasms
|
| HSALNT0184498
|
CCND2-AS1
|
CCND2-AS2
|
NA
|
pathogenic process
|
glioma
|
Neoplasms
|
| HSALNT0289045
|
LINC00578
|
NA
|
NA
|
pathogenic process
|
major depression disorder
|
Behavior and Behavior Mechanisms
|
| HSALNT0288884
|
ADAMTS9-AS1
|
NA
|
NA
|
pathogenic process
|
epithelial ovarian cancer
|
Neoplasms
|
| HSALNT0080041
|
FAM198B-AS1
|
NA
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0103007
|
LINC00240
|
C6orf41,NCRNA00240,bA373D17.1
|
ceRNA
|
pathogenic process
|
esophageal squamous cell cancer
|
Neoplasms
|
| HSALNT0289071
|
LINC00909
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289509
|
LINC00680
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0129070
|
LINC00513
|
AC016831.7
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289129
|
LINC02001
|
RP11-1094M14.11
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289215
|
POC1B-AS1
|
RP11-734K2.4
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289241
|
SLC12A9-AS1
|
RP11-126L15.4
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289275
|
TRAM2-AS1
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0002243
|
LINC01772
|
ENSG00000226029
|
ceRNA
|
pathogenic process
|
oesophageal cancer
|
Neoplasms
|
| HSALNT0288941
|
ELF3-AS1
|
ENST00000415582
|
NA
|
pathogenic process
|
papillary thyroid cancer
|
Endocrine System Diseases;Neoplasms
|
| HSALNT0289134
|
LINC02158
|
NA
|
NA
|
pathogenic process
|
breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0289350
|
LINC01671
|
BC041455
|
NA
|
pathogenic process
|
breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0289124
|
LINC01684
|
lnc-JAM2-6
|
NA
|
pathogenic process
|
nonalcoholic fatty liver disease
|
Digestive System Diseases
|
| HSALNT0289036
|
LINC00365
|
NA
|
NA
|
pathogenic process
|
esophageal cancer
|
Neoplasms
|
| HSALNT0289111
|
LINC01554
|
C5orf27,FLJ38821,FIS
|
NA
|
pathogenic process
|
esophageal cancer
|
Neoplasms
|
| HSALNT0289132
|
LINC02154
|
GS1-600G8.5
|
NA
|
pathogenic process
|
esophageal cancer
|
Neoplasms
|
| HSALNT0137721
|
LINC02155
|
RP11-705O24.1
|
NA
|
pathogenic process
|
esophageal cancer
|
Neoplasms
|
| HSALNT0225363
|
LINC02157
|
RP11-327J17.1
|
NA
|
pathogenic process
|
esophageal cancer
|
Neoplasms
|
| HSALNT0289133
|
LINC02156
|
RP1-90J4.1
|
NA
|
pathogenic process
|
esophageal cancer
|
Neoplasms
|
| HSALNT0133924
|
LINC02153
|
NA
|
NA
|
pathogenic process
|
major depression disorder
|
Behavior and Behavior Mechanisms
|
| HSALNT0181656
|
LINC02151
|
TCONS_00019174
|
NA
|
pathogenic process
|
major depression disorder
|
Behavior and Behavior Mechanisms
|
| HSALNT0227367
|
LINC02152
|
NA
|
NA
|
pathogenic process
|
major depression disorder
|
Behavior and Behavior Mechanisms
|
| HSALNT0029246
|
BRE-AS1
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289251
|
SNHG26
|
AC005682.5
|
NA
|
pathogenic process
|
bladder urothelial cancer
|
Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0252719
|
LIVAR
|
lnc18q22.2
|
NA
|
pathogenic process
|
nonalcoholic steatohepatiti
|
Digestive System Diseases
|
| HSALNT0289074
|
LINC00969
|
ENST00000453324
|
NA
|
pathogenic process
|
lung squamous cell cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0289138
|
LINC02243
|
ENST00000441841
|
NA
|
pathogenic process
|
lung squamous cell cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0289399
|
SLC9A3-AS1
|
UC011CLY.2
|
NA
|
pathogenic process
|
lung squamous cell cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0288934
|
DM1-AS
|
NA
|
NA
|
pathogenic process
|
myotonic dystrophy type 1
|
Musculoskeletal Diseases;Nervous System Diseases
|
| HSALNT0009014
|
LINC02238
|
RP4-788P17.1
|
NA
|
pathogenic process
|
B cell lymphoma
|
Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases
|
| HSALNT0289163
|
MEF2C-AS2
|
CTC-467M3.1
|
NA
|
pathogenic process
|
diffuse large B-cell lymphoma
|
Hemic and Lymphatic Diseases
|
| HSALNT0289181
|
MIR4422HG
|
RP11-101C11.1
|
NA
|
pathogenic process
|
diffuse large B-cell lymphoma
|
Hemic and Lymphatic Diseases
|
| HSALNT0289403
|
SPON1-AS1
|
RP11-21,L19.1
|
NA
|
pathogenic process
|
diffuse large B-cell lymphoma
|
Hemic and Lymphatic Diseases
|
| HSALNT0289461
|
CD44-AS1
|
RP1-68D18.4
|
NA
|
pathogenic process
|
diffuse large B-cell lymphoma
|
Hemic and Lymphatic Diseases
|
| HSALNT0262277
|
LILRB1-AS1
|
AC009892.10
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0289546
|
AC009892.10
|
LILRB1-AS1
|
NA
|
NA
|
B cell lymphoma
|
Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases
|
| HSALNT0282241
|
LINC01186
|
NA
|
NA
|
pathogenic process
|
lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0289168
|
MHENCR
|
NA
|
ceRNA
|
pathogenic process
|
melanoma
|
Neoplasms
|
| HSALNT0072994
|
LINC02232
|
RP11-707A18.1
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0080161
|
LINC02233
|
RP11-6C14.1
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0084027
|
LINC02236
|
RP11-332J15.1
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0091870
|
LINC02234
|
RP11-455B3.1
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0139521
|
LINC02235
|
RP11-354A14.1
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0142040
|
LINC02237
|
RP11-1101K5.1
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0289135
|
LINC02179
|
RP11-189E14.4
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0289351
|
LINC01689
|
AP000469.2
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0289137
|
LINC02231
|
RP11-766N7.4
|
NA
|
pathogenic process
|
Esophageal squamous cell cancer
|
Neoplasms
|
| HSALNT0220239
|
MIR4713HG
|
RP11-108K3.1
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0288967
|
FAM160A1-DT
|
RP11-610P16.1
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289239
|
SATB2-AS1
|
NA
|
translational control
|
pathogenic process
|
osteosarcoma
|
Neoplasms
|
| HSALNT0289512
|
LINC01826
|
lnc-MKI67IP-3
|
ceRNA
|
pathogenic process
|
atherosclerosis
|
Cardiovascular Diseases
|
| HSALNT0289024
|
LINC00226
|
C14orf97,NCRNA00226
|
NA
|
pathogenic process
|
pancreatic ductaladenocarcinoma
|
Neoplasms
|
| HSALNT0082192
|
F11-AS1
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0219108
|
SPINT1-AS1
|
RP11-532F12.5
|
NA
|
pathogenic process
|
melanoma
|
Neoplasms
|
| HSALNT0289177
|
MIR200CHG
|
U47924.27
|
NA
|
pathogenic process
|
melanoma
|
Neoplasms
|
| HSALNT0289328
|
LINC00888
|
NA
|
NA
|
pathogenic process
|
melanoma
|
Neoplasms
|
| HSALNT0289309
|
LINC00672
|
NA
|
transcriptional regulation
|
pathogenic process
|
endometrial cancer
|
Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0289198
|
P4HA3-AS1
|
NA
|
NA
|
pathogenic process
|
parkinson's disease
|
Nervous System Diseases
|
| HSALNT0197312
|
TMEM132D-AS1
|
LOC283352
|
NA
|
pathogenic process
|
human dermal fibroblasts
|
Cell Physiological Phenomena
|
| HSALNT0289472
|
ATP2C2-AS1
|
RP11-517C16.2-001
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0233849
|
WWOX-AS1
|
RP11-190D6.2
|
NA
|
pathogenic process
|
epithelial ovarian cancer
|
Neoplasms
|
| HSALNT0128829
|
FLNC-AS1
|
NA
|
NA
|
pathogenic process
|
cervical squamous cancer
|
Neoplasms
|
| HSALNT0289889
|
LIF-AS1
|
Lnc-LIF-AS
|
NA
|
pathogenic process
|
cervical squamous cancer
|
Neoplasms
|
| HSALNT0011283
|
DPYD-AS2
|
NA
|
NA
|
pathogenic process
|
cervical squamous cancer
|
Neoplasms
|
| HSALNT0289836
|
FLICR
|
NA
|
transcriptional regulation
|
pathogenic process
|
autoimmune diabete
|
Immune System Diseases
|
| HSALNT0289356
|
LINC02402
|
ENST00000550337.1
|
NA
|
pathogenic process
|
diabetes
|
Endocrine System Diseases
|
| HSALNT0137118
|
CERNA3
|
CTA
|
ceRNA
|
pathogenic process
|
osteosarcoma
|
Neoplasms
|
| HSALNT0090838
|
LINC02488
|
CTD-2316B1
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0174947
|
LINC02489
|
CTD-2589M5
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0220441
|
LINC02490
|
RP11-209E8
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0289260
|
STK32A-AS1
|
CTC-255N20
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0289143
|
LINC02487
|
NA
|
NA
|
pathogenic process
|
squamous cell cancer
|
Neoplasms
|
| HSALNT0095585
|
SPRY4-AS1
|
THCAT68
|
NA
|
pathogenic process
|
bladder cancer
|
Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0288927
|
DDN-AS1
|
CAT1507
|
NA
|
pathogenic process
|
bladder cancer
|
Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0012862
|
SLC16A1-AS1
|
NA
|
NA
|
pathogenic process
|
acute myocardial infarction
|
Cardiovascular Diseases
|
| HSALNT0289412
|
TNFRSF14-AS1
|
ENST00000416860.2
|
NA
|
pathogenic process
|
acute myocardial infarction
|
Cardiovascular Diseases
|
| HSALNT0259139
|
LINC00665
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0040268
|
DARS-AS1
|
NA
|
NA
|
pathogenic process
|
renal disease
|
NA
|
| HSALNT0288913
|
CEBPA-AS1
|
CEBPA-DT
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289011
|
INHBA-AS1
|
NA
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0288988
|
GASAL1
|
GASL1
|
NA
|
pathogenic process
|
liver cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289127
|
LINC01857
|
AC079767.4
|
NA
|
pathogenic process
|
tuberculosis
|
Bacterial Infections and Mycoses
|
| HSALNT0289091
|
LINC01140
|
FLJ41676
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0281957
|
PINCR
|
NA
|
transcriptional regulation
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289344
|
LINC00890
|
NA
|
NA
|
pathogenic process
|
leiomyoma
|
Neoplasms
|
| HSALNT0019828
|
LINC00862
|
C1orf98,SMIM16
|
NA
|
pathogenic process
|
cystic fibrosis
|
Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases
|
| HSALNT0073790
|
LINC02562
|
RP11-44F21.5
|
NA
|
pathogenic process
|
cystic fibrosis
|
Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases
|
| HSALNT0263101
|
LINC02560
|
CTD-2619J13.13
|
NA
|
pathogenic process
|
cystic fibrosis
|
Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases
|
| HSALNT0289144
|
LINC02551
|
RP11-890B15.2
|
NA
|
pathogenic process
|
cystic fibrosis
|
Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases
|
| HSALNT0289458
|
DDIT4-AS1
|
RP11-442H21.2
|
NA
|
pathogenic process
|
cystic Fibrosis
|
Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases
|
| HSALNT0288992
|
GPRC5D-AS1
|
RP11-392P7.6
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289386
|
PCBP1-AS1
|
NA
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0289405
|
STARD4-AS1
|
NA
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0201547
|
LINC00462
|
NA
|
NA
|
pathogenic process
|
hepatocellular cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0207103
|
SOX1-OT
|
LINC00403
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0002131
|
SLC25A34-AS1
|
RP11-169K16.4
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289218
|
PPP1R26-AS1
|
NA
|
NA
|
pathogenic process
|
breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0289047
|
LINC00589
|
C8orf75,TSLNC8
|
NA
|
pathogenic process
|
hepatocellular cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289516
|
TPM1-AS
|
TPM1-AS1
|
splicing regulation
|
pathogenic process
|
esophageal cancer
|
Neoplasms
|
| HSALNT0289314
|
LINC01101
|
FLJ14816
|
NA
|
pathogenic process
|
HPV-induced cervical neoplasia
|
Neoplasms
|
| HSALNT0289147
|
LINC02572
|
AC079776.2
|
NA
|
pathogenic process
|
epithelial ovarian cancer
|
Neoplasms
|
| HSALNT0096804
|
LINC02202
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289076
|
LINC00973
|
CTD-2021J15.2
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0288625
|
TTTY10
|
NCRNA00133
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289323
|
LINC00319
|
C21orf125,NCRNA00319,PRED49,FLJ38036
|
ceRNA
|
pathogenic process
|
lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0015533
|
IL6R-AS1
|
RP11-350G8.5
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0090330
|
CKMT2-AS1
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0012995
|
HIPK1-AS1
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289216
|
POLH-AS1
|
RP3-337H4.8
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289276
|
TRDN-AS1
|
HRAT13
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289159
|
LY6E-DT
|
LOC100133669
|
NA
|
pathogenic process
|
ovarian cancer
|
Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0289434
|
BASP1-AS1
|
LOC285696
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0288991
|
GLIS3-AS1
|
C9orf70,MGC16153
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0288896
|
BNC2-AS1
|
RP11-62F24.2
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289292
|
ZNF503-AS1
|
NA
|
NA
|
pathogenic process
|
age-related macular degeneration
|
Eye Diseases
|
| HSALNT0159506
|
VIM-AS1
|
NA
|
NA
|
pathogenic process
|
endometrial cancer
|
Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0288882
|
ACBD3-AS1
|
RP11-275I14.4
|
NA
|
pathogenic process
|
endometrial cancer
|
Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0289156
|
LRRC8C-DT
|
FLJ27354
|
NA
|
pathogenic process
|
endometrial cancer
|
Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0289447
|
ELN-AS1
|
CTB-51J22.1
|
NA
|
pathogenic process
|
endometrial cancer
|
Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0076712
|
LINC02264
|
NA
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0093666
|
LINC02201
|
NA
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0271685
|
LINC02573
|
NA
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289125
|
LINC01816
|
LOC100133985
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289355
|
LINC02381
|
LOC400043
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289366
|
MBNL1-AS1
|
LOC401093
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289513
|
MIR4697HG
|
LINC00947,LOC283174
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289073
|
LINC00968
|
NA
|
NA
|
pathogenic process
|
non-small cell lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0114453
|
NMBR-AS1
|
RP11-137J7.2
|
NA
|
pathogenic process
|
non-melanoma skin cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0289300
|
LINC01518
|
NA
|
NA
|
pathogenic process
|
non-melanoma skin cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0003783
|
LINC02574
|
RP11-288L9.1
|
transcriptional regulation
|
pathogenic process
|
UVB-irradiated KC & non-melanoma skin cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0032721
|
LINC02579
|
AC007365.1
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0030828
|
LINC02580
|
AC093609.1
|
NA
|
pathogenic process
|
UVB-irradiated KC & non-melanoma skin cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0032808
|
LINC02576
|
NA
|
NA
|
pathogenic process
|
UVB-irradiated KC & non-melanoma skin cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0127022
|
LINC02577
|
NA
|
NA
|
pathogenic process
|
UVB-irradiated KC & non-melanoma skin cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0154722
|
LINC02578
|
RP11-127L21.1
|
NA
|
pathogenic process
|
UVB-irradiated KC & non-melanoma skin cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0288962
|
FAM111A-DT
|
NA
|
NA
|
pathogenic process
|
UVB-irradiated KC & non-melanoma skin cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0289148
|
LINC02575
|
AP001065.15
|
transcriptional regulation
|
pathogenic process
|
UVB-irradiated KC & non-melanoma skin cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0025249
|
KIF26B-AS1
|
RP11-62I21.1
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0177212
|
RPS6KB2-AS1
|
AP003419.16
|
NA
|
pathogenic process
|
agingâassociated idiopathic pulmonary fibrosis
|
Physiological Phenomena
|
| HSALNT0289072
|
LINC00941
|
lncRNA-MUF
|
ceRNA
|
pathogenic process
|
hepatocellular cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289338
|
LINC00094
|
FLJ35348,bA374P20.3
|
NA
|
pathogenic process
|
lung squamous cell cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0114192
|
FILNC1
|
NA
|
translational control
|
pathogenic process
|
renal tumor
|
Neoplasms
|
| HSALNT0289199
|
PARAL1
|
NA
|
ceRNA
|
pathogenic process
|
obesity
|
Pathological Conditions, Signs and Symptoms;Nutritional and Metabolic Diseases;Physiological Phenomena
|
| HSALNT0244832
|
SOX9-AS1
|
FLJ37644
|
transcriptional regulation
|
NA
|
NA
|
NA
|
| HSALNT0289236
|
ROCR
|
LINC02095
|
transcriptional regulation
|
NA
|
NA
|
NA
|
| HSALNT0056667
|
LINC02027
|
LOC728290
|
NA
|
pathogenic process
|
hepatocellular cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289424
|
TTTY22
|
NCRNA00147
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289069
|
LINC00880
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0252974
|
LINC02582
|
CTD-2354A18.1
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289035
|
LINC00364
|
LncRNA00364
|
NA
|
pathogenic process
|
hepatocellular cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0060981
|
NCK1-DT
|
NCK1-AS1,SLC35G2-AS1
|
ceRNA
|
pathogenic process
|
cervical cancer
|
Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0288890
|
BAALC-AS1
|
lncFZD6,FZD6-DT
|
transcriptional regulation
|
pathogenic process
|
liver cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0046602
|
CPS1-IT1
|
CPS1-IT,CPS1IT,CPS1IT1,PRO0132
|
NA
|
pathogenic process
|
hepatocellular cancer;lung cancer;intrahepatic cholangiocarcinoma
|
Respiratory Tract Diseases;Neoplasms;Digestive System Diseases
|
| HSALNT0289445
|
DLX6-AS1
|
DLX6-A, DLX6A, Evf-2,NCRNA00212,NCRNA00212,FLJ34048
|
transcriptional regulation
|
pathogenic process
|
split hand/split foot malformation disorder;lung adenocarcinoma
|
Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms
|
| HSALNT0289891
|
LINC00114
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289415
|
TSIX
|
LINC00013,NCRNA00013,XIST-A, XIST-AS1,XISTAS
|
transcriptional regulation
|
pathogenic process
|
systemic sclerosis
|
Skin and Connective Tissue Diseases
|
| HSALNT0217334
|
MKRN3-AS1
|
ZNF127A, MKRN3A, MKRN3-A,FNZ127,NCRNA00009,ZNF127-AS
|
NA
|
pathogenic process
|
Prader-Willi syndrome
|
Nutritional and Metabolic Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
|
| HSALNT0290256
|
SRA
|
lnc-SRA1-1:1,SRA1,ENSG00000213523
|
transcriptional regulation
|
pathogenic process
|
nonalcoholic fatty liver disease;polycystic ovary syndrome;ovarian cancer;dilated cardiomyopathy;cardiomyopathy;breast cancer;laryngeal squamous cell cancer;uterus cancer
|
Skin and Connective Tissue Diseases;Neoplasms;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases
|
| HSALNT0289442
|
HCP5
|
6S2650E,D6S2650E,P5-1
|
NA
|
pathogenic process
|
AIDS
|
Immune System Diseases;Virus Diseases
|
| HSALNT0289284
|
WT1-AS
|
WIT1,WIT-1,WT1A, WT1-AS1
|
transcriptional regulation
|
pathogenic process
|
gastric cancer;primary myelofibrosis;hepatocellular cancer;Wilms' tumor;acute myeloid leukemia
|
Neoplasms;Hemic and Lymphatic Diseases;Digestive System Diseases
|
| HSALNT0289421
|
KCNQ1OT1
|
KCNQ1-AS2,KCNQ10T1,Kncq1,KvDMR1,KvLQT1-A, LIT1,NCRNA00012
|
transcriptional regulation
|
pathogenic process
|
prostate cancer;colorectal cancer;hepatocelluar cancer;acute myocardial infarction;kidney cancer;Beckwith-Wiedemann syndrome;breast cancer
|
Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Digestive System Diseases
|
| HSALNT0263784
|
PCNA-AS1
|
PCNAA, PCNA-AS
|
transcriptional regulation
|
pathogenic process
|
gastric cancer;hepatocelluar cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289524
|
HCG9
|
PERB11,HCGIX,HCGIX4,HCGIX-4
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289264
|
TCL6
|
TCL6e1,TNG2,TNG1
|
NA
|
pathogenic process;developmental process
|
renal cell cancer;leukemia
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0289203
|
PCA3
|
DD3,NCRNA00019,PCAT3
|
transcriptional regulation;ceRNA
|
pathogenic process
|
prostate cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0289462
|
H19
|
ASM,ASM1,BW, D11S813E,LINC00008,NCRNA00008,WT2
|
transcriptional regulation;ceRNA
|
developmental process;pathogenic process
|
prostate cancer;glioma;cancer;breast cancer;ovarian cancer;Marek's disease;gestational trophoblastic diseases;glioblastoma;non-small cell lung cancer;hyperhomocysteinemia;congenital heart defect;congenital hyperinsulinism;pancreatic cancer;Beckwith-Wiedemann syndrome;endometriosis;trophoblastic tumor;adrenocortical cancer;coronary artery disease;Wiedemann-Beckwith syndrome;bladder cancer;melanoma;myeloproliferative polycythaemia vera;hepatocelluar cancer;meningioma;breast adenocarcinoma;neuroblastoma;embryonal cancer;osteosarcoma;esophageal cancer;kidney cancer;malignant digestive cancer;chronic myeloid leukemia;mullerian aplasia;malignant hematopoiesis;gastric cardia adenocarcinoma;cervical cancer;gallbladder cancer;pheochromocytoma;germ cell tumor;colorectal cancer;hydatidiform mole;Pancreatic ductal adenocarcinoma;pre-eclampsia;atherosclerosis;esophageal squamous cell cancer;calcific aortic valve disease;gastric cancer;osteoarthritis;choriocarcinoma;chronic myeloproliferative disorders;neural tube defects;skin cancer;ulcerative colitis;type 2 diabetes;thyroid cancer;pneumoconiosis;infertility;liver cancer;heart failure;medulloblastoma;laryngeal squamous cell cancer;Silver-Russell syndrome;pituitary adenoma;hepatocellular cancer;nasopharyngeal cancer;growth restriction;Prader-Willi syndrome;diabetic cardiomyopathy;obesity;lung cancer;Parkinson's disease;renal cell cancer;Wilms' tumor
|
Nutritional and Metabolic Diseases;Cell Physiological Phenomena;Virus Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Physiological Phenomena;Neoplasms;Male Urogenital Diseases;Endocrine System Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Immune System Diseases;Hemic and Lymphatic Diseases;Musculoskeletal Diseases;Nervous System Diseases;Digestive System Diseases;Skin and Connective Tissue Diseases;Pathological Conditions, Signs and Symptoms;Respiratory Tract Diseases;Occupational Diseases;Otorhinolaryngologic Diseases;Stomatognathic Diseases
|
| HSALNT0288932
|
DLEU1
|
BCM, BCMS1,DLB1,LEU1,LEU2,LINC00021,NCRNA00021,XTP6
|
transcriptional regulation;ceRNA
|
pathogenic process
|
lymphocytic leukemia;B-cell chronic lymphocytic leukemia;myeloma;multiple myeloma;hematopoietic and solid tumors;chronic lymphocytic leukemia;inherited bone marrow failure disorder;lymphoma;breast cancer;head and neck squamous cell cancer
|
Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Immune System Diseases;Hemic and Lymphatic Diseases;Cardiovascular Diseases
|
| HSALNT0289493
|
DBH-AS1
|
NCRNA00118,BPR
|
NA
|
pathogenic process
|
hepatocellular cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0088415
|
PART1
|
DKFZP586D0823,NCRNA00206
|
NA
|
pathogenic process
|
prostate cancer;glioblastoma
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0289463
|
IGF2-AS
|
IGF2A,PEG8,IGF2-AS1
|
transcriptional regulation
|
pathogenic process
|
liver cancer;type 1 diabetes;prostate cancer;Wilms' tumor;hepatocelluar cancer
|
Neoplasms;Nutritional and Metabolic Diseases;Male Urogenital Diseases;Endocrine System Diseases;Digestive System Diseases
|
| HSALNT0269786
|
GNAS-AS1
|
GNASA, GNAS-A,SANG,NESP-A, NESPA, GNAS1A, NCRNA00075
|
transcriptional regulation
|
pathogenic process
|
non-small cell lung cancer;pseudohypoparathyroidism type Ib
|
Musculoskeletal Diseases;Respiratory Tract Diseases;Neoplasms
|
| HSALNT0289252
|
SNHG5
|
C6orf160,MGC16362,bA33E24.2,U50HG,NCRNA00044,LINC00044
|
NA
|
pathogenic process
|
gastric cancer;lymphoma;melanoma
|
Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases;Digestive System Diseases
|
| HSALNT0023827
|
DISC2
|
DISC1-AS1,DISC1O, NCRNA00015
|
transcriptional regulation
|
pathogenic process
|
bipolar disorder;affective disorder;major depressive affective disorder;schizophrenia;autism spectrum disorder;depression
|
Bacterial Infections and Mycoses;Mental Disorders;Behavior and Behavior Mechanisms
|
| HSALNT0203415
|
ATXN8OS
|
SCA8,KLHL1A,NCRNA00003
|
transcriptional regulation
|
pathogenic process
|
spinocerebellar ataxia;spinocerebellar ataxia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
|
| HSALNT0290312
|
TRAF3IP2-AS1
|
C6UA, C6orf3,NCRNA00248,TRAF3IP2-AS2
|
transcriptional regulation
|
pathogenic process
|
schizophrenia;cocaine abuse
|
Chemically-Induced Disorders;Mental Disorders
|
| HSALNT0289008
|
HYMAI
|
NCRNA00020
|
NA
|
pathogenic process
|
transient neonatal diabetes
|
Nutritional and Metabolic Diseases
|
| HSALNT0288968
|
FAM201A
|
C9orf122
|
NA
|
pathogenic process
|
leukemia
|
Neoplasms
|
| HSALNT0288969
|
FAM222A-AS1
|
NA
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0289484
|
FAM226A
|
CXorf50,NCRNA00246,NCRNA00246A,LINC00246A,MGC34827
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0289497
|
FAM215A
|
C17orf88,APR-2,LINC00530
|
NA
|
pathogenic process
|
ovarian cancer;leukemia
|
Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0289230
|
RBM5-AS1
|
LUST
|
transcriptional regulation
|
pathogenic process
|
tumor
|
Neoplasms
|
| HSALNT0002923
|
LINC00339
|
NCRNA00339,HSPC157
|
NA
|
pathogenic process;developmental process
|
Pancreatic ductal adenocarcinoma
|
Neoplasms
|
| HSALNT0144027
|
ASAP1-IT1
|
ASAP1-IT,ASAP1IT,ASAP1IT1,DDEF1IT1,HSPC054,NCRNA00050
|
NA
|
pathogenic process
|
ovarian cancer
|
Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0289212
|
PCGEM1
|
NCRNA00071,LINC00071,PCAT9
|
transcriptional regulation;ceRNA
|
pathogenic process
|
osteoarthritis;prostate cancer;glioma
|
Musculoskeletal Diseases;Male Urogenital Diseases;Neoplasms
|
| HSALNT0289016
|
KCNQ1DN
|
BWRT,HSA404617
|
NA
|
pathogenic process
|
aging;Wilms' tumor
|
Physiological Phenomena;Neoplasms
|
| HSALNT0288933
|
DLEU2
|
DLB2,BCMSUN,RFP2O,LEU2,TRIM13O, NCRNA00022,LINC00022,MIR15AHG
|
transcriptional regulation
|
pathogenic process
|
lymphocytic leukemia;B-cell chronic lymphocytic leukemia;myeloma;multiple myeloma;chronic lymphocytic leukemia;non-small cell lung cancer
|
Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Hemic and Lymphatic Diseases;Cardiovascular Diseases
|
| HSALNT0217624
|
PWAR4
|
PAR4,PAR-4
|
NA
|
pathogenic process
|
Prader-Willi syndrome and Angelman syndrome
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
|
| HSALNT0289165
|
MEG8
|
SNHG23,SNHG24,NCRNA00024,Irm,Rian,Bsr,LINC00024,AL132709.8,lnc-MGC
|
NA
|
pathogenic process
|
Prader-Willi syndrome and Angelman syndrome;temple syndrome
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
|
| HSALNT0289482
|
CECR7
|
SAHL1
|
NA
|
pathogenic process
|
hepatocellular cancer;cat eye syndrome
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Digestive System Diseases
|
| HSALNT0074223
|
PCAT4
|
GDEP,PCAN1,PCA4
|
NA
|
pathogenic process
|
prostate cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0061175
|
PISRT1
|
NCRNA00195
|
transcriptional regulation
|
developmental process;pathogenic process
|
blepharophimosis syndrome
|
Eye Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities
|
| HSALNT0190912
|
IFNG-AS1
|
Tmevpg1,LincR-Ifng-3'A, NEST
|
transcriptional regulation
|
pathogenic process
|
Hashimoto's thyroiditis;primary immune thrombocytopenia;multiple sclerosis;Sjögren syndrome
|
Immune System Diseases ;Immune System Diseases;Endocrine System Diseases;Nervous System Diseases
|
| HSALNT0038178
|
FAM138B
|
F379
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0145703
|
FAM138C
|
F379
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0288963
|
FAM138A
|
F379
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0183947
|
FAM138D
|
F379
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0226092
|
FAM138E
|
F379
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0253925
|
FAM138F
|
F379
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289326
|
LINC00312
|
LOH3CR2A,NCRNA00312,NAG7,NAG-7,ERR10,ERR-10,LMCD1DN
|
transcriptional regulation
|
pathogenic process
|
nasopharyngeal cancer;bladder cancer;non-small cell lung cancer
|
Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Otorhinolaryngologic Diseases;Stomatognathic Diseases
|
| HSALNT0288886
|
AIRN
|
AIR,NCRNA00088,IGF2RA, IGF2R-AS1
|
transcriptional regulation
|
pathogenic process
|
NA
|
NA
|
| HSALNT0254857
|
MIR7-3HG
|
C19orf30,NCRNA00306,LINC00306,PGSF1,PGSF1a,PGSF1b,Huh7,uc002mbe.2
|
NA
|
pathogenic process
|
liver cancer;hepatocelluar cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0185751
|
LOH12CR2
|
LOH2CR12
|
NA
|
pathogenic process
|
pre-B acute lymphoblastic leukaemia
|
Hemic and Lymphatic Diseases
|
| HSALNT0289479
|
DSCR8
|
C21orf65,MTAG2,CT25.1a,CT25.1b,MMA-1a,MMA-1b
|
NA
|
pathogenic process
|
Down syndrome;melanoma
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Nervous System Diseases
|
| HSALNT0289030
|
LINC00313
|
C21orf84,NCRNA00313,
|
NA
|
pathogenic process
|
lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0289029
|
LINC00310
|
C21orf82,NCRNA00310
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0272435
|
LINC00161
|
C21orf100,NCRNA00161
|
ceRNA
|
pathogenic process
|
osteosarcoma
|
Neoplasms
|
| HSALNT0289184
|
MIR99AHG
|
C21orf35,FLJ38295,C21orf34,LINC00478,MONC
|
NA
|
pathogenic process
|
myeloid leukemia
|
Hemic and Lymphatic Diseases
|
| HSALNT0289005
|
HOXA11-AS
|
HOXA11A,HOXA11-AS1,HOXA11, HOXA-AS5,NCRNA00076
|
ceRNA
|
pathogenic process
|
uterine cervix cancer;ovarian cancer;glioma;cervical cancer;gastric cancer
|
Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases
|
| HSALNT0193654
|
RMST
|
NCRM, NCRNA00054,LINC00054
|
transcriptional regulation
|
developmental process;pathogenic process
|
breast cancer;rhabdomyosarcoma
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0290079
|
ncR-PAR
|
NCRUPAR,ENSG00000225407
|
transcriptional regulation
|
developmental process;pathogenic process
|
gastric cancer;colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289167
|
MESTIT1
|
MEST-AS1,MEST-IT,MEST-IT1,NCRNA00040,PEG1-AS
|
NA
|
pathogenic process
|
Silver-Russell syndrome
|
Musculoskeletal Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities
|
| HSALNT0273791
|
DSCAM-AS1
|
M41
|
NA
|
pathogenic process
|
adolescent idiopathic scoliosis;breast cancer
|
Musculoskeletal Diseases;Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0289391
|
PWARSN
|
PAR-SN,PARSN
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0127791
|
ST7-AS1
|
ST7OT1,ST7AS1
|
NA
|
pathogenic process
|
glioma;autism
|
Mental Disorders;Neoplasms
|
| HSALNT0206298
|
DAOA-AS1
|
DAOAA, DAOA-A,G30
|
NA
|
pathogenic process
|
panic disorder;schizophrenia;bipolar disorder
|
Mental Disorders
|
| HSALNT0167060
|
OLMALINC
|
C10orf75,NCRNA00263,LINC00263,bA34D15.5,FLJ12974,HI-LNC80
|
NA
|
pathogenic process
|
type 2 diabetes
|
Nutritional and Metabolic Diseases;Endocrine System Diseases
|
| HSALNT0026878
|
LINC00299
|
C2orf46,NCRNA00299,FLJ45673
|
NA
|
pathogenic process;developmental process
|
intellectual and developmental disability;neurodevelopmental disabilities
|
Mental Disorders;Nervous System Diseases
|
| HSALNT0289081
|
LINC01020
|
NA
|
NA
|
pathogenic process
|
hereditary haemorrhagic telangiectasia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0101186
|
LINC00518
|
C6orf218,MGC40222
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0083960
|
LINC01018
|
SRHC
|
NA
|
pathogenic process
|
hepatocellular cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289361
|
LPP-AS2
|
MYCLo-5,MYCLo-6
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0143233
|
LINC00964
|
NA
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289364
|
MAPKAPK5-AS1
|
C12orf47,FLJ39616
|
NA
|
pathogenic process
|
hepatocellular cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289053
|
LINC00635
|
NA
|
NA
|
pathogenic process
|
lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0289327
|
LINC00636
|
NA
|
NA
|
pathogenic process
|
breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0262657
|
ZNF582-AS1
|
NA
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289020
|
LINC00115
|
NCRNA00115,FLJ22639
|
ceRNA
|
pathogenic process
|
lung adenocarcinoma
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0289254
|
SNHG7
|
MGC16037,NCRNA00061
|
NA
|
pathogenic process
|
lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0289162
|
MAP3K20-AS1
|
MLK7-AS1
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0145357
|
RHPN1-AS1
|
C8orf51,MGC3113
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289343
|
XIST
|
DXS399E,NCRNA00001,DXS1089,swd66,LINC00001
|
transcriptional regulation;ceRNA
|
pathogenic process
|
non-small cell lung cancer;B-cell acute lymphoblastic leukemia;bladder cancer;testicular germ cell tumor;colorectal cancer;cancer;ovarian cancer;female cancers;renal collecting duct cancer;membranous nephropathy;Trisomy 21;gastric cancer;hepatocellular cancer;nasopharyngeal cancer;Klinefelter's syndrome;glioblastoma;breast cancer;cystic fibrosis
|
Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Stomatognathic Diseases;Hemic and Lymphatic Diseases;Female Urogenital Diseases and Pregnancy Complications;Nervous System Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases
|
| HSALNT0289389
|
PRNT
|
M8
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0288942
|
EMX2OS
|
NCRNA00045,EMX2-AS1
|
transcriptional regulation
|
pathogenic process
|
NA
|
NA
|
| HSALNT0200443
|
LINC00598
|
TTL
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0289517
|
TTTY17A
|
NCRNA00140
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0027901
|
MYCNOS
|
NCYM,N-CYM,MYCN-AS1
|
transcriptional regulation
|
pathogenic process
|
neuroblastoma
|
Neoplasms
|
| HSALNT0047175
|
DIRC3
|
FLJ14199
|
NA
|
pathogenic process
|
familial renal cell cancer;breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0289363
|
MALAT1
|
PRO1073,MALAT-1,NCRNA00047,HCN,NEAT2,LINC00047,mascRNA
|
splicing regulation;;translational control;transcriptional regulation;protein localization;ceRNA
|
pathogenic process
|
prostate cancer;glioma;cancer;breast cancer;ovarian cancer;amyotrophic lateral sclerosis;proliferative vitreoretinopathy;glioblastoma;endometrial stromal sarcoma;oral squamous cell cancer;acute myocardial infarction;hemangioma;pancreatic cancer;endometrioid endometrial cancer;melanoma;tongue squamous cell cancer;HIV;hepatocelluar cancer;bladder cancer;neuroblastoma;lung cancer;nasopharyngeal cancer;osteosarcoma;esophageal cancer;kidney cancer;hepatic steatosis;urothelial cancer;diabetes;triple-negative breast cancer;liver fibrosis;cervical cancer;uterus cancer;gallbladder cancer;decreased myogenesis;esophageal squamous cell cancer;fibrosarcoma;colorectal cancer;Pancreatic ductal adenocarcinoma;pre-eclampsia;retinal neurodegeneration;small cell lung cancer;multiple myeloma;gastric cancer;lung adenocarcinoma;uveal melanoma;epithelial ovarian cancer;TDP-43-associated pathological states;thyroid cancer;congenital microtia;liver cancer;renal clear cell cancer;laryngeal squamous cell cancer;pituitary adenoma;hepatocellular cancer;non-small cell lung cancer;pulmonary arterial hypertension;diabetic cardiomyopathy;vulvar squamous cell cancer;hyperglycaemia;papillary thyroid cancer;Parkinson's disease;renal cell cancer;lung cancer brain metastasis
|
Eye Diseases;Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Nutritional and Metabolic Diseases;Male Urogenital Diseases;Cell Physiological Phenomena;Immune System Diseases;Hemic and Lymphatic Diseases;Virus Diseases;Stomatognathic Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases;Nervous System Diseases
|
| HSALNT0289744
|
DLG2-AS1
|
DLG2A, DLG2-A,PSZA11q14,SZ-1
|
NA
|
pathogenic process
|
schizophrenia;myotonic dystrophy type 1;heart failure
|
Pathological Conditions, Signs and Symptoms;Musculoskeletal Diseases;Mental Disorders;Cardiovascular Diseases;Nervous System Diseases
|
| HSALNT0289164
|
MEG3
|
FP504,GTL2,LINC00023,NCRNA00023,PRO0518,PRO2160,onco-lncRNA-83,prebp1
|
translational control;transcriptional regulation;ceRNA
|
pathogenic process
|
oral squamous cell cancer;phaeochromocytoma;prostate cancer;testicular germ cell tumor;glioma;cancer;osteosarcoma;non-functioning pituitary adenoma;heroin abuse;stroke;non-small cell lung cancer;thrombocytopenic purpura;acute myeloid leukemia;pancreatic cancer;bladder cancer;tongue squamous cell cancer;hepatocelluar cancer;meningioma;drug abuse;liver fibrosis;pancreatic neuroendocrine tumor;esophageal squamous cell cancer;myelodysplastic syndrome;retinoblastoma;chronic myeloid leukemia;type 1 diabetes;breast cancer;cervical cancer;kidney cancer;gallbladder cancer;cholestatic liver injury;colorectal cancer;neuroblastoma;multiple myeloma;gastric cancer;osteoarthritis;lung adenocarcinoma;endometrial cancer;Huntington disease;diabetes;type 2 diabetes;lung cancer;epithelial ovarian cancer;primary myelofibrosis;metabolic syndrome;pituitary adenoma;hepatocellular cancer;nasopharyngeal cancer;vulvar squamous cell cancer;papillary thyroid cancer;renal cell cancer;Wilms' tumor
|
Skin and Connective Tissue Diseases;Pathological Conditions, Signs and Symptoms;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Nutritional and Metabolic Diseases;Male Urogenital Diseases;Immune System Diseases;Stomatognathic Diseases;Hemic and Lymphatic Diseases;Chemically-Induced Disorders;Musculoskeletal Diseases;Mental Disorders;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases;Nervous System Diseases
|
| HSALNT0290298
|
TERC
|
DKCA1,PFBMFT2,SCARNA19,TR,TRC3,hTR
|
NA
|
pathogenic process
|
prostate cancer;dyskeratosis congenita;lung squamous cell cancer
|
Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases
|
| HSALNT0288907
|
CASC2
|
NA
|
ceRNA
|
pathogenic process
|
colorectal cancer;gastric cancer;endometrial cancer;lung cancer;renal cell cancer;glioma
|
Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases
|
| HSALNT0205332
|
MIR17HG
|
C13orf25,MIRHG1,FLJ14178,MIRH1,MIHG1,NCRNA00048,miR-17-92,LINC00048
|
NA
|
pathogenic process
|
diffuse large B-cell lymphoma;syndromic developmental defect;cancer
|
Neoplasms;Hemic and Lymphatic Diseases
|
| HSALNT0288716
|
TTTY6
|
TTY6,TTTY6A,LINC00127
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0288731
|
TTTY4
|
TTY4,TTTY4A,LINC00123
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0288815
|
TTTY3
|
TTY3,TTTY3A,LINC00121
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0288703
|
TTTY5
|
TTY5,LINC00126
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289255
|
SNHG8
|
NCRNA00060,LINC00060
|
NA
|
pathogenic process
|
gastric cancer;malignant pleural mesothelioma
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289486
|
BCYRN1
|
BC200,BC200a,NCRNA00004,LINC00004
|
splicing regulation;translational control
|
pathogenic process
|
aging;lung cancer;glioma;ovarian cancer;esophageal squamous cell cancer;non-small cell lung cancer;esophageal cancer;Alzheimer's disease;tongue cancer;parotid cancer;breast cancer;cervical cancer
|
Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Stomatognathic Diseases;Mental Disorders;Female Urogenital Diseases and Pregnancy Complications;Physiological Phenomena;Endocrine System Diseases;Nervous System Diseases
|
| HSALNT0144426
|
ZFAT-AS1
|
ZFATAS,ZFAT-AS,SAS-ZFAT,NCRNA00070
|
NA
|
pathogenic process
|
autoimmune disease
|
Immune System Diseases
|
| HSALNT0289285
|
ZEB1-AS1
|
NA
|
NA
|
pathogenic process
|
esophageal squamous cell cancer;autoimmune thyroid disease;hepatocelluar cancer
|
Immune System Diseases;Neoplasms;Digestive System Diseases
|
| HSALNT0289185
|
MIRLET7BHG
|
linc-Ppara
|
NA
|
developmental process
|
NA
|
NA
|
| HSALNT0289374
|
NBR2
|
NCRNA00192
|
transcriptional regulation
|
pathogenic process
|
gastric cancer;breast cancer;cancer
|
Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases
|
| HSALNT0289417
|
TUG1
|
FLJ20618,NCRNA00080,LINC00080
|
transcriptional regulation;ceRNA
|
pathogenic process
|
osteosarcoma;prostate cancer;glioma;ovarian cancer;glioblastoma;non-small cell lung cancer;B-cell neoplasms;chronic kidney disease;melanoma;bladder cancer;urothelial cancer of the bladder;esophageal squamous cell cancer;multiple sclerosis;breast cancer;hepatoblastoma;colorectal cancer;multiple myeloma;gastric cancer;Huntington disease;hepatocellular cancer;oesophageal squamous cell cancer;renal cell cancer
|
Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Hemic and Lymphatic Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Mental Disorders;Endocrine System Diseases;Digestive System Diseases;Nervous System Diseases
|
| HSALNT0288973
|
FAS-AS1
|
FASA, FAS-A,SAF
|
transcriptional regulation
|
pathogenic process
|
ataxia telangiectasia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Immune System Diseases;Nutritional and Metabolic Diseases;Cardiovascular Diseases;Nervous System Diseases
|
| HSALNT0288996
|
HAS2-AS1
|
HAS2A, HAS2-A,HASNT,NCRNA00077
|
transcriptional regulation
|
NA
|
NA
|
NA
|
| HSALNT0289390
|
PSORS1C3
|
NCRNA00196
|
NA
|
pathogenic process
|
rheumatoid arthritis;psoriasis
|
Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases
|
| HSALNT0289868
|
HLA-AS1
|
NA
|
NA
|
pathogenic process
|
psoriasis;liver injury;multiple sclerosis;AIDS
|
Skin and Connective Tissue Diseases;Immune System Diseases;Virus Diseases;Digestive System Diseases;Nervous System Diseases
|
| HSALNT0290154
|
PRINS
|
NCRNA00074
|
transcriptional regulation
|
pathogenic process
|
psoriasis;prostate cancer
|
Skin and Connective Tissue Diseases;Male Urogenital Diseases;Neoplasms
|
| HSALNT0262809
|
PEG3-AS1
|
PEG3AS,PEG3-AS,APEG3,NCRNA00155
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289533
|
7SL
|
7S RNA,SRP RNA,4.5S SRP RNA,4.5S RNA,RN7SL1 RNA,ENSG00000258486,lnc-LRR1-1:1
|
protein localization
|
pathogenic process
|
AIDS;Leishmaniasis;dermatomyositis;polymyositis
|
Skin and Connective Tissue Diseases;Immune System Diseases;Virus Diseases;Musculoskeletal Diseases;Parasitic Diseases;Nervous System Diseases
|
| HSALNT0290081
|
NDM29
|
29A,lnc-C11orf16-1:1
|
NA
|
pathogenic process
|
neuroblastoma
|
Neoplasms
|
| HSALNT0289382
|
NRON
|
NCRNA00194
|
NA
|
pathogenic process
|
AIDS;Down syndrome;HIV
|
Immune System Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases;Virus Diseases
|
| HSALNT0289253
|
SNHG6
|
U87HG,HBII-276HG,NCRNA00058
|
translational control;ceRNA
|
pathogenic process
|
hepatocellular cancer;hereditary haemorrhagic telangiectasia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases;Neoplasms;Digestive System Diseases
|
| HSALNT0289653
|
Beta-globin transcript
|
AY195961.1,NONHSAT017674,AY034469.1,NONHSAT017675,AY034470.1,NONHSAT017676
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0290398
|
Zfhx2as
|
Zfh-5AS,ENSG00000157306,ENST00000554403.1
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0011306
|
MIR137HG
|
NA
|
NA
|
pathogenic process
|
schizophrenia;lung cancer;malignant lymphoma
|
Respiratory Tract Diseases;Mental Disorders;Neoplasms
|
| HSALNT0289449
|
HOXA-AS3
|
HOXA6as
|
NA
|
pathogenic process
|
glioma
|
Neoplasms
|
| HSALNT0289451
|
CCDC26
|
MGC27434,RAM
|
transcriptional regulation
|
pathogenic process
|
hematological malignancies;glioma;acute myeloid leukemia;leukemia;pancreatic cancer;breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms;Hemic and Lymphatic Diseases;Endocrine System Diseases;Digestive System Diseases
|
| HSALNT0289893
|
LINC00271
|
C6orf217,NCRNA00271
|
NA
|
pathogenic process
|
type 2 diabetes;schizophrenia
|
Nutritional and Metabolic Diseases;Mental Disorders;Endocrine System Diseases
|
| HSALNT0288892
|
BCAR4
|
NA
|
transcriptional regulation
|
pathogenic process
|
osteosarcoma;breast cancer;colorectal cancer
|
Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases
|
| HSALNT0289890
|
LINC00032
|
C9orf14,NCRNA00032
|
NA
|
pathogenic process
|
narcolepsy;melanoma
|
Mental Disorders;Neoplasms;Nervous System Diseases
|
| HSALNT0274572
|
PICSAR
|
C21orf113,LINC00162,NCRNA00162,NLC1-C,NLC1C,PRED74
|
transcriptional regulation
|
pathogenic process
|
testicular embryonal cancer;narcolepsy;cutaneous squamous cell cancer
|
Male Urogenital Diseases;Mental Disorders;Neoplasms;Nervous System Diseases
|
| HSALNT0256354
|
UCA1
|
CUDR,LINC00178,NCRNA00178,UCAT1,onco-lncRNA-36
|
transcriptional regulation;ceRNA
|
developmental process;pathogenic process
|
oral squamous cell cancer;osteosarcoma;prostate cancer;ovarian cancer;non-small cell lung cancer;acute myocardial infarction;pancreaticobiliary maljunction;pancreatic cancer;melanoma;tongue squamous cell cancer;hepatocelluar cancer;bladder cancer;acute myeloid leukemia;esophageal squamous cell cancer;esophageal cancer;liver cancer;colorectal cancer;Pancreatic ductal adenocarcinoma;urinary bladder;gastric cancer;endometrial cancer;breast cancer;hepatocellular cancer;squamous cell cancer;lung cancer;renal cell cancer
|
Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Endocrine System Diseases;Digestive System Diseases
|
| HSALNT0003871
|
SNHG3
|
NCRNA00014,RNU17C,RNU17D,U17HG,U17HG-A,U17HG-AB
|
NA
|
pathogenic process
|
ovarian cancer;hepatocellular cancer;colorectal cancer;Alzheimer's disease
|
Neoplasms;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Mental Disorders;Endocrine System Diseases;Digestive System Diseases;Nervous System Diseases
|
| HSALNT0289475
|
HAR1A
|
HAR1F,NCRNA00064,LINC00064
|
transcriptional regulation
|
pathogenic process
|
Huntington disease;Alzheimer's disease
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Mental Disorders;Nervous System Diseases
|
| HSALNT0288995
|
HAR1B
|
HAR1R,NCRNA00065,LINC00065
|
transcriptional regulation
|
pathogenic process
|
Huntington disease;hereditary haemorrhagic telangiectasia;Alzheimer's disease
|
Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases;Nervous System Diseases
|
| HSALNT0288958
|
EPB41L4A-AS1
|
C5orf26,NCRNA00219,TIGA1
|
NA
|
pathogenic process
|
lung cancer;cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0289170
|
MIAT
|
C22orf35,FLJ25967,Rncr2,gomafu,NCRNA00066,LINC00066,lncRNA-MIAT
|
splicing regulation;ceRNA
|
pathogenic process
|
prostate cancer;chronic lymphocytic leukemia;cancer;drug abuse;diabetes-induced microvascular dysfunction;schizophrenia;acute myocardial infarction;dilated cardiomyopathy;lung adenocarcinoma;diabetic retinopathy;myocardial infarction;Alzheimer's disease
|
Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Chemically-Induced Disorders;Hemic and Lymphatic Diseases;Cardiovascular Diseases;Mental Disorders;Endocrine System Diseases;Nervous System Diseases
|
| HSALNT0289007
|
HULC
|
NCRNA00078,LINC00078,HCCAT1
|
transcriptional regulation;ceRNA
|
pathogenic process
|
prostate cancer;glioma;hepatocelluar cancer;osteosarcoma;atherosclerosis;gastric cancer;hepatocellular cancer;esophageal cancer;liver cirrhosis;diffuse large B-cell lymphoma;pancreatic cancer;papillary thyroid cancer;liver cancer;cervical cancer;colorectal cancer
|
Neoplasms;Male Urogenital Diseases;Hemic and Lymphatic Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases
|
| HSALNT0288940
|
EGOT
|
EGO,NCRNA00190
|
NA
|
pathogenic process;developmental process
|
prostate cancer;breast cancer
|
Skin and Connective Tissue Diseases;Male Urogenital Diseases;Neoplasms
|
| HSALNT0289387
|
PINK1-AS
|
PINK1-AS1,FLJ00387,PINK1A, naPINK1
|
transcriptional regulation
|
pathogenic process
|
glucose metabolism disorder;Parkinson's disease;diabetes
|
Nutritional and Metabolic Diseases;Endocrine System Diseases;Nervous System Diseases
|
| HSALNT0289225
|
PVT1
|
NCRNA00079,LINC00079,onco-lncRNA-100,MIR1204HG,PVT
|
transcriptional regulation;translational control
|
pathogenic process
|
murine plasmacytomas;prostate cancer;cancer;ovarian cancer;renal cancer;B-cell lymphoma;non-small cell lung cancer;pancreatic cancer;Hodgkin's lymphoma;asthma;hepatocelluar cancer;bladder cancer;plasmacytoma;cleft lip;acute promyelocytic leukemia;diabetic nephropathy;esophageal cancer;kidney cancer;type 1 diabetes;breast cancer;cervical cancer;diabetic kidney disease;hematological malignancies;colorectal cancer;neuroblastoma;cardiac hypertrophy;multiple myeloma;gastric cancer;lymphoma;type 2 diabetes;thyroid cancer;pleural mesothelioma;lung squamous cell cancer;Burkitt lymphoma;hepatocellular cancer;renal cell cancer
|
Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Nutritional and Metabolic Diseases;Male Urogenital Diseases;Immune System Diseases;Stomatognathic Diseases;Hemic and Lymphatic Diseases;Virus Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Endocrine System Diseases;Digestive System Diseases
|
| HSALNT0289189
|
NAMA
|
NA
|
NA
|
pathogenic process
|
papillary thyroid cancer
|
Endocrine System Diseases;Neoplasms
|
| HSALNT0246525
|
NARF-AS1
|
NA
|
NA
|
pathogenic process
|
hepatocellular cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0147433
|
CDKN2B-AS1
|
CDKN2BA,ANRIL,RP11-145E5.4,NCRNA00089,p15A, CDKN2B-A, PCAT12
|
siRNA;transcriptional regulation;ceRNA
|
pathogenic process
|
glaucoma;prostate cancer;glioma;cancer;osteosarcoma;neurofibromatosis;ischemic heart failure;stroke;non-small cell lung cancer;hypertension;intracranial aneurysm;aortic aneurysm;periodontitis;acute lymphoblastic leukemia;Alzheimer's disease;coronary artery disease;melanoma;bladder cancer;abdominal aortic aneurysm;ovarian cancer;esophageal cancer;basal cell cancer;breast cancer;cervical cancer;coronary heart disease;gallbladder cancer;acute myocardial infarction;colorectal cancer;neuroblastoma;peripheral artery disease;esophageal squamous cell cancer;atherosclerosis;leukemia;hereditary cutaneous malignant melanoma;gastric cancer;cardiovascular disease;coronary disease;frailty;diabetes;type 2 diabetes;thyroid cancer;primary open-angle glaucoma;ischemic stroke;plexiform neurofibroma;laryngeal squamous cell cancer;hepatocellular cancer;nasopharyngeal cancer;myocardial infarction;lung cancer;endometriosis;primary myelofibrosis
|
Eye Diseases;Skin and Connective Tissue Diseases;Pathological Conditions, Signs and Symptoms;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Nutritional and Metabolic Diseases;Male Urogenital Diseases;Stomatognathic Diseases;Immune System Diseases;Hemic and Lymphatic Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Mental Disorders;Nervous System Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases
|
| HSALNT0050854
|
GHRLOS
|
NCRNA00068,GHRL-AS1
|
transcriptional regulation
|
NA
|
NA
|
NA
|
| HSALNT0288959
|
ESRG
|
HESRG
|
NA
|
pathogenic process
|
embryonal cancer
|
Neoplasms
|
| HSALNT0287173
|
FMR1-AS1
|
FMR1A, FMR1-A,ASFMR1,FMR4
|
transcriptional regulation
|
pathogenic process
|
fragile X syndrome;neurological disorder
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
|
| HSALNT0289499
|
HCG4
|
HCGIV-10,HCGIV.9
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0288994
|
HAND2-AS1
|
DEIN,NBLA00301,FLJ11539
|
NA
|
pathogenic process
|
neuroblastoma
|
Neoplasms
|
| HSALNT0289286
|
ZEB2-AS1
|
ZEB2A, ZEB2-A,ZEB2NAT
|
splicing regulation
|
pathogenic process
|
bladder cancer;hepatocellular cancer
|
Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases
|
| HSALNT0017702
|
GAS5
|
SNHG2,NCRNA00030
|
transcriptional regulation;ceRNA
|
pathogenic process
|
varicose great saphenous veins;prostate cancer;glioma;cancer;ovarian cancer;non-small cell lung cancer;hypertension;pancreatic cancer;B-cell neoplasms;melanoma;head and neck cancer;hepatocelluar cancer;bladder cancer;autoimmune disease;liver fibrosis;kidney cancer;breast cancer;cervical cancer;colorectal cancer;multiple myeloma;gastric cancer;osteoarthritis;endometrial cancer;lymphoma;type 2 diabetes;pleural mesothelioma;hepatocellular cancer;lung adenocarcinoma;lung cancer;renal cell cancer
|
Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Nutritional and Metabolic Diseases;Hemic and Lymphatic Diseases;Musculoskeletal Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases
|
| HSALNT0288891
|
BACE1-AS
|
BACE1A,FJ573250,NCRNA00177,BACE1-AS1
|
translational control;transcriptional regulation
|
pathogenic process
|
ovarian cancer;colorectal cancer;Alzheimer's disease
|
Neoplasms;Female Urogenital Diseases and Pregnancy Complications;Mental Disorders;Nervous System Diseases;Endocrine System Diseases;Digestive System Diseases
|
| HSALNT0289414
|
TRPM2-AS
|
TRPM2-AS1
|
NA
|
pathogenic process
|
melanoma;prostate cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0288935
|
DNM3OS
|
DNM3-AS1,MIR199A2HG
|
NA
|
pathogenic process
|
epithelial ovarian cancer
|
Neoplasms
|
| HSALNT0288930
|
DGCR5
|
NCRNA00037,LINC00037
|
transcriptional regulation
|
pathogenic process
|
Huntington disease;DiGeorge syndrome;velocardiofacial syndrome;clear cell renal cell cancer
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Male Urogenital Diseases;Hemic and Lymphatic Diseases;Musculoskeletal Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Mental Disorders;Endocrine System Diseases;Nervous System Diseases
|
| HSALNT0288893
|
BDNF-AS
|
BDNFO,BT2A,BT2B,BT2C,BT2D,NCRNA00049,BDNF-AS1,BDNFAS
|
siRNA;transcriptional regulation
|
developmental process;pathogenic process
|
Huntington disease;schizophrenia;psychiatric disease;obesity
|
Pathological Conditions, Signs and Symptoms;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nutritional and Metabolic Diseases;Mental Disorders;Physiological Phenomena;Nervous System Diseases
|
| HSALNT0120317
|
HOTAIRM1
|
HOXA-AS1,NCRNA00179,HOXA1-AS1
|
transcriptional regulation
|
pathogenic process;developmental process
|
colorectal cancer;Pancreatic ductal adenocarcinoma;promyelocytic leukemia;acute myeloid leukemia;infiltrating ductal cancers ;acute promyelocytic leukemia;leukemia;glioma
|
Neoplasms;Hemic and Lymphatic Diseases;Digestive System Diseases
|
| HSALNT0290158
|
PTCSC1
|
PTCSC,AK023948,NCRNA00197
|
NA
|
pathogenic process
|
papillary thyroid cancer
|
Endocrine System Diseases;Neoplasms
|
| HSALNT0289004
|
HOTAIR
|
HOXC-AS4,HOXC11-AS1,NCRNA00072
|
siRNA;transcriptional regulation;ceRNA
|
pathogenic process
|
oral squamous cell cancer;prostate cancer;glioma;cancer;breast cancer;osteosarcoma;renal cancer;glioblastoma;non-small cell lung cancer;sarcoma;pancreatic cancer;large B-Cell lymphoma;bladder transitional cell cancer;B-cell neoplasms;melanoma;asthenozoospermia;hepatocelluar cancer;bladder cancer;acute myeloid leukemia;aortic valve calcification;infiltrating ductal cancers ;ovarian cancer;diffuse large B-cell lymphoma;gastrointestinal stromal tumor;atypical teratoid rhabdoid tumor;urothelial cancer;triple-negative breast cancer;gastric cardia adenocarcinoma;cervical cancer;temporomandibular joint osteoarthritis;gallbladder cancer;esophageal squamous cell cancer;colorectal cancer;Pancreatic ductal adenocarcinoma;rheumatoid arthritis;gastric cancer ;pre-eclampsia;acute leukemia;small cell lung cancer;multiple myeloma;gastric cancer;osteoarthritis;LPS-induced sepsis;endometrial cancer;head and neck squamous cell cancer;gastric adenocarcinoma;lung cancer;liver cancer;ischemic stroke;ischemic heart failure;laryngeal squamous cell cancer;pituitary adenoma;hepatocellular cancer;nasopharyngeal cancer;lung adenocarcinoma;papillary thyroid cancer;Parkinson's disease;renal cell cancer;gastrointestinal cancer
|
Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Stomatognathic Diseases;Hemic and Lymphatic Diseases;Virus Diseases;Musculoskeletal Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases;Nervous System Diseases
|
| HSALNT0289192
|
NEAT1
|
NCRNA00084,TncRNA,MENepsilon/beta,LINC00084,VINC
|
transcriptional regulation;ceRNA
|
pathogenic process
|
oral squamous cell cancer;glioma;ovarian cancer;amyotrophic lateral sclerosis;paraspeckle disintegration;nasopharyngeal cancer;AIDS;frontotemporal lobar degeneration;prostate cancer;systemic lupus erythematosus;renal syndrome;TDP-43-associated pathological states;HIV;Huntington disease;chronic lymphocytic leukemia;acute promyelocytic leukemia;esophageal squamous cell cancer;multiple sclerosis;breast cancer;intrauterine growth restriction;colorectal cancer;leukemia;gastric cancer;malignant pleural mesothelioma;endometrial cancer;gastric adenocarcinoma;papillary thyroid cancer;infertility;bladder cancer;hepatocellular cancer;non-small cell lung cancer;obesity;lung cancer;Parkinson's disease;laryngeal squamous cell cancer
|
Skin and Connective Tissue Diseases;Pathological Conditions, Signs and Symptoms;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Nutritional and Metabolic Diseases;Stomatognathic Diseases;Hemic and Lymphatic Diseases;Virus Diseases;Female Urogenital Diseases and Pregnancy Complications;Mental Disorders;Physiological Phenomena;Nervous System Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases
|
| HSALNT0095094
|
SNHG4
|
U19H,NCRNA00059
|
NA
|
pathogenic process
|
myelodysplastic syndrome
|
Hemic and Lymphatic Diseases
|
| HSALNT0245443
|
SNHG16
|
ncRAN,Nbla12061,Nbla10727
|
NA
|
pathogenic process
|
bladder cancer;bladder cancer;colorectal cancer;neuroblastoma
|
Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases
|
| HSALNT0288897
|
BOK-AS1
|
BOKA,NCRNA00151,NAToB
|
NA
|
pathogenic process
|
esophageal squamous cell cancer;testicular cancer;cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0289532
|
7SK
|
7-3 RNA,K-RNA,7SK-RNA,7SK snRNA,RN7SK,ENSG00000202198,NONHSAT113149
|
transcriptional regulation
|
developmental process;pathogenic process
|
cancer;cardiac hypertrophy;gastric cancer;AIDS;multiple sclerosis;colorectal adenocarcinoma
|
Neoplasms;Immune System Diseases;Virus Diseases;Cardiovascular Diseases;Digestive System Diseases;Nervous System Diseases
|
| HSALNT0289182
|
MIR4435-2HG
|
MIR4435-1HG,LINC00978,AGD2,AK001796,lncRNA-AWPPH,MORRBID
|
NA
|
pathogenic process
|
lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0289200
|
PARTICL
|
PARTICLE
|
transcriptional regulation
|
pathogenic process
|
low-dose irradiation
|
Disorders of Environmental Origin
|
| HSALNT0289172
|
MINCR
|
LINC01604,TCONS_00015189
|
transcriptional regulation;ceRNA
|
pathogenic process
|
gallbladder cancer;Burkitt lymphoma
|
Neoplasms;Immune System Diseases;Hemic and Lymphatic Diseases;Virus Diseases;Digestive System Diseases
|
| HSALNT0001792
|
NPPA-AS1
|
NPPAA, NPPA-AS
|
splicing regulation
|
pathogenic process
|
cardiovascular disease
|
Cardiovascular Diseases
|
| HSALNT0290230
|
RRP1B
|
NA
|
transcriptional regulation
|
pathogenic process
|
spinocerebellar ataxia;laryngeal squamous cell cancer;cancer
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Nervous System Diseases
|
| HSALNT0289467
|
CLLU1
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289173
|
MIR100HG
|
AGD1,lncRNA-N2,linc-NeD125
|
NA
|
developmental process;pathogenic process
|
myeloid leukemia;myopia;cervical cancer;neuroblastoma
|
Eye Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Hemic and Lymphatic Diseases
|
| HSALNT0059175
|
TUSC7
|
LINC00902,LSAMP-AS1,LSAMP-AS3,LSAMPAS3,NCRNA00295
|
transcriptional regulation;ceRNA
|
pathogenic process
|
glioma;Pancreatic ductal adenocarcinoma;osteosarcoma;esophageal squamous cell cancer;ischemic heart failure;gastric cancer;hepatocellular cancer;non-small cell lung cancer;acute myeloid leukemia;colorectal cancer
|
Respiratory Tract Diseases;Cardiovascular Diseases;Neoplasms;Digestive System Diseases
|
| HSALNT0289647
|
BC040587
|
NA
|
NA
|
pathogenic process
|
osteosarcoma;breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0059186
|
LINC00901
|
LSAMP-AS4,TCONS_00005428,BC040587
|
NA
|
pathogenic process
|
osteosarcoma;gastric cancer;breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases
|
| HSALNT0233366
|
HCCAT5
|
HTA,FJ222407
|
NA
|
pathogenic process
|
hepatocellular cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290040
|
LSINCT5
|
NA
|
NA
|
pathogenic process
|
chronic heart failure;colorectal cancer;ovarian cancer;gastric cancer;lung cancer;breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases
|
| HSALNT0179611
|
DISC1FP1
|
Boymaw
|
transcriptional regulation
|
pathogenic process
|
schizophrenia
|
Mental Disorders
|
| HSALNT0217643
|
SNHG14
|
115HG,IC-SNURF-SNRPN,LNCAT,NCRNA00214,U-UBE3A-AT, UBE3A-A, UBE3A-AS1,UBE3AATS
|
ceRNA
|
pathogenic process
|
Angelman syndrome;cerebral infarction;Prader-Willi syndrome
|
Nutritional and Metabolic Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases;Nervous System Diseases
|
| HSALNT0289273
|
TP73-AS1
|
KIAA0495,PDAM
|
NA
|
pathogenic process
|
esophageal squamous cell cancer;oligodendroglial tumors;non-small cell lung cancer;glioblastoma;multiple myeloma
|
Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Hemic and Lymphatic Diseases;Cardiovascular Diseases
|
| HSALNT0290311
|
TP53COR1
|
Trp53cor1
|
transcriptional regulation
|
pathogenic process
|
prostate cancer;colorectal cancer;hepatocelluar cancer;atherosclerosis;Burkitt lymphoma;chronic lymphocytic leukemia;B cell lymphoma;lung cancer;cervical cancer
|
Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Hemic and Lymphatic Diseases;Virus Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases
|
| HSALNT0289221
|
PRNCR1
|
CARLo-3,PCAT8
|
transcriptional regulation
|
pathogenic process
|
gastric cancer;prostate cancer;glioma;colorectal cancer
|
Male Urogenital Diseases;Neoplasms;Digestive System Diseases
|
| HSALNT0020131
|
PCAT6
|
KDM5B-AS1,ncRNA-a2,PCAN-R1,KDM5BAS1,onco-lncRNA-96
|
transcriptional regulation
|
pathogenic process
|
prostate cancer;triple-negative breast cancer;lung cancer
|
Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Male Urogenital Diseases;Neoplasms
|
| HSALNT0289277
|
TRERNA1
|
LINC00651,ncRNA-a7,treRNA
|
transcriptional regulation
|
NA
|
NA
|
NA
|
| HSALNT0014972
|
FALEC
|
LINC00568,ncRNA-a1,FAL1
|
transcriptional regulation
|
pathogenic process
|
ovarian cancer;thyroid cancer
|
Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Neoplasms
|
| HSALNT0290008
|
LOC100887755
|
Noncoding RNA activating7: ncRNA-a7,ENST00000431460.1,ENSG00000231265,TRERNA1
|
transcriptional regulation
|
pathogenic process
|
hepatocellular cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290248
|
snaR
|
EU035784.1,lnc-BSPH1-1:1
|
transcriptional regulation
|
NA
|
NA
|
NA
|
| HSALNT0289342
|
JPX
|
NCRNA00183,ENOX,LINC00183,DCBALD06
|
transcriptional regulation
|
pathogenic process
|
hepatocellular cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289231
|
RCAN3AS
|
TCONS_00001428
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289280
|
VLDLR-AS1
|
lincRNA-VLDLR
|
NA
|
pathogenic process
|
hepatocelluar cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0288982
|
FTX
|
NCRNA00182,MIR374AHG,LINC00182,FLJ33139
|
transcriptional regulation
|
pathogenic process
|
hepatocellular cancer;breast cancer;colorectal cancer;hepatocelluar cancer
|
Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases
|
| HSALNT0091079
|
MEF2C-AS1
|
NA
|
NA
|
pathogenic process
|
gastric cancer;Prader-Willi syndrome and Angelman syndrome
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Digestive System Diseases;Nervous System Diseases
|
| HSALNT0189341
|
PCBP2-OT1
|
TUC338
|
NA
|
pathogenic process
|
hepatocellular cancer;tongue squamous cell cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290373
|
WRAP53
|
NA
|
NA
|
pathogenic process
|
hepatocellular cancer;cancer;dyskeratosis congenita
|
Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Digestive System Diseases
|
| HSALNT0289265
|
TDRG1
|
LINC00532,lincRNA-NRNA024015
|
NA
|
pathogenic process
|
esophageal squamous cell cancer;gastric cancer;testicular cancer;aplastic anemia
|
Male Urogenital Diseases;Neoplasms;Hemic and Lymphatic Diseases;Digestive System Diseases
|
| HSALNT0289175
|
MIR155HG
|
MIRHG2,BIC,NCRNA00172
|
NA
|
pathogenic process
|
B-cell chronic lymphocytic leukemia;chronic lymphocytic leukemia;breast cancer;glioma
|
Immune System Diseases;Skin and Connective Tissue Diseases;Neoplasms;Hemic and Lymphatic Diseases
|
| HSALNT0289051
|
LINC00620
|
NA
|
NA
|
pathogenic process
|
cervical cancer
|
Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0120390
|
HOTTIP
|
NCRNA00213,HOXA-AS6,RP1-170O19.3,HOXA13-AS1
|
transcriptional regulation
|
pathogenic process
|
hirschsprung disease;colorectal cancer;prostate cancer;tongue squamous cell cancer;Pancreatic ductal adenocarcinoma;osteosarcoma;hepatocelluar cancer;gastric cancer;hepatocellular cancer;non-small cell lung cancer;pancreatic cancer;lung cancer;glioma
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Endocrine System Diseases;Digestive System Diseases
|
| HSALNT0289287
|
ZFAS1
|
C20orf199,NCRNA00275,ZNFX1-AS1,HSUP1,HSUP2
|
transcriptional regulation;ceRNA
|
pathogenic process
|
gastric cancer;hepatocellular cancer;ductal cancer;colorectal cancer;breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases
|
| HSALNT0289259
|
SPRY4-IT1
|
SPRIGHTLY
|
transcriptional regulation
|
pathogenic process
|
prostate cancer;melanoma;glioma;esophageal squamous cell cancer;pre-eclampsia;bladder cancer;renal clear cell cancer;gastric cancer;hepatocellular cancer;non-small cell lung cancer;lung cancer;breast cancer;cervical cancer;colorectal cancer
|
Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases
|
| HSALNT0105595
|
PANDAR
|
PANDA
|
transcriptional regulation
|
pathogenic process
|
colorectal cancer;cancer;bladder cancer;gastric cancer;hepatocellular cancer;non-small cell lung cancer;p53-associated pathological states;breast cancer;renal cell cancer
|
Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases
|
| HSALNT0068185
|
HTT-AS
|
HTT-AS1,HTTAS
|
NA
|
pathogenic process
|
Huntington disease
|
Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
|
| HSALNT0099036
|
HEIH
|
LINC-HEIH,lncRNA-HEIH,LINC00848,HCCAT2
|
NA
|
pathogenic process
|
hepatocelluar cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0222533
|
NPTN-IT1
|
lncRNA-LET
|
NA
|
pathogenic process
|
gallbladder cancer;colorectal cancer;hepatocelluar cancer;esophageal squamous cell cancer;lung squamous cell cancer;nasopharyngeal cancer;gastric cancer;hypoxia;squamous cell lung cancer;cervical cancer
|
Pathological Conditions, Signs and Symptoms;Neoplasms;Respiratory Tract Diseases;Stomatognathic Diseases;Female Urogenital Diseases and Pregnancy Complications;Otorhinolaryngologic Diseases;Digestive System Diseases
|
| HSALNT0289747
|
DQ786243
|
NA
|
transcriptional regulation
|
pathogenic process
|
crohn's disease;colorectal cancer;hepatocelluar cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289204
|
PCAT1
|
PCAT-1,PCA1
|
transcriptional regulation;ceRNA
|
pathogenic process
|
prostate cancer;colorectal cancer;esophageal squamous cell cancer;bladder cancer;hepatocellular cancer;lung cancer
|
Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases
|
| HSALNT0275894
|
PCAT14
|
NA
|
NA
|
pathogenic process
|
prostate cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0211999
|
HIF1A-AS2
|
3'aHIF-1A,aHIF
|
translational control
|
pathogenic process
|
bladder cancer;osteosarcoma;renal cancer;glioblastoma;gastric cancer;acute myocardial infarction;kidney cancer;breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms;Male Urogenital Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases
|
| HSALNT0288999
|
HIF1A-AS1
|
5'aHIF-1A,5'aHIF1alpha
|
NA
|
pathogenic process
|
acute myocardial infarction;non-small cell lung cancer;cardiovascular disease;aortic aneurysm;thoracoabdominal aorta aneurysm;kidney cancer
|
Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications
|
| HSALNT0289258
|
SOX2-OT
|
SOX2OT,DKFZp761J1324,NCRNA00043
|
transcriptional regulation
|
pathogenic process
|
colorectal cancer;esophageal squamous cell cancer;lung squamous cell cancer;retinal neurodegeneration;neurodevelopmental syndromes associated with the SOX2 locus;hepatocellular cancer;lung cancer;breast cancer;Alzheimer's disease
|
Eye Diseases;Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Mental Disorders;Digestive System Diseases;Nervous System Diseases
|
| HSALNT0289700
|
CDR1-AS
|
CDR1NAT,ciRS-7,CDR1as
|
ceRNA
|
NA
|
NA
|
NA
|
| HSALNT0289149
|
LINCMD1
|
MIR133BHG,LINC-MD1
|
ceRNA
|
developmental process;pathogenic process
|
Duchenne muscular dystrophy
|
Musculoskeletal Diseases
|
| HSALNT0288894
|
BGLT3
|
LINC01083,BGL3,lncRNA-BGL3
|
ceRNA
|
pathogenic process
|
chronic myeloid leukemia
|
Neoplasms;Hemic and Lymphatic Diseases
|
| HSALNT0289042
|
LINC00473
|
C6orf176,bA142J11.1
|
transcriptional regulation
|
pathogenic process
|
non-small cell lung cancer;renal cell cancer
|
Respiratory Tract Diseases;Male Urogenital Diseases;Neoplasms
|
| HSALNT0101681
|
LINC01108
|
LncRNA-ES1
|
NA
|
developmental process
|
NA
|
NA
|
| HSALNT0289418
|
TUNAR
|
LINC00617,TUNA,HI-LNC78
|
transcriptional regulation
|
developmental process;pathogenic process
|
breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0289197
|
OIP5-AS1
|
cyrano,linc-OIP5
|
NA
|
developmental process
|
NA
|
NA
|
| HSALNT0289046
|
LINC00581
|
NA
|
NA
|
pathogenic process
|
West Syndrome;West syndrome
|
Nervous System Diseases
|
| HSALNT0289656
|
BX118339
|
NA
|
NA
|
pathogenic process
|
West syndrome
|
Nervous System Diseases
|
| HSALNT0021726
|
LINC00538
|
Yiya,PROX1UT
|
NA
|
pathogenic process
|
colorectal cancer;cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0273249
|
CBR3-AS1
|
PlncRNA-1,PlncRNA1
|
ceRNA
|
pathogenic process
|
esophageal squamous cell cancer;hepatocellular cancer;prostate cancer
|
Male Urogenital Diseases;Neoplasms;Digestive System Diseases
|
| HSALNT0289179
|
MIR31HG
|
LOC554202,hsa-lnc-31,LncHIFCAR
|
ceRNA
|
pathogenic process
|
bladder cancer;gastric cancer;breast cancer;colorectal cancer;Pancreatic ductal adenocarcinoma
|
Skin and Connective Tissue Diseases;Neoplasms;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases
|
| HSALNT0288925
|
DANCR
|
KIAA0114,SNHG13,ANCR,AGU2,lncRNA-ANCR
|
transcriptional regulation
|
developmental process;pathogenic process
|
prostate cancer;colorectal cancer;osteosarcoma;bone diseases;postmenopausal osteoporosis;hepatocellular cancer;breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms;Male Urogenital Diseases;Musculoskeletal Diseases;Digestive System Diseases
|
| HSALNT0290329
|
uc.388
|
NA
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289842
|
FR0348383
|
NA
|
NA
|
pathogenic process
|
prostate cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0289279
|
TTTY15
|
DKFZP434I143,NCRNA00138
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0289718
|
CRNDE
|
LOC643911,LINC00180,CRNDEP
|
transcriptional regulation;ceRNA
|
pathogenic process
|
gallbladder cancer;colorectal cancer;ovarian cancer;medulloblastoma;chronic lymphocytic leukemia;renal cell cancer;glioma
|
Neoplasms;Immune System Diseases;Male Urogenital Diseases;Hemic and Lymphatic Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases
|
| HSALNT0289685
|
CCND1
|
NA
|
NA
|
pathogenic process
|
tumor;cervical cancer
|
Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0289935
|
lincRNA-p21
|
NA
|
transcriptional regulation
|
pathogenic process
|
lung cancer;cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0290134
|
PCNCR1
|
NA
|
NA
|
pathogenic process
|
prostate cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0289492
|
DBET
|
DBE-T,DUX4L30
|
transcriptional regulation
|
developmental process;pathogenic process
|
facioscapulohumeral muscular dystrophy
|
Musculoskeletal Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
|
| HSALNT0289455
|
BANCR
|
LINC00586
|
transcriptional regulation
|
pathogenic process
|
osteosarcoma ;lung cancer;melanoma;colorectal cancer;osteosarcoma;esophageal squamous cell cancer;bladder cancer;eosinophilic esophagitis;gastric cancer;hepatocellular cancer;non-small cell lung cancer;retinoblastoma;papillary thyroid cancer
|
Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Hemic and Lymphatic Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases
|
| HSALNT0209589
|
PTCSC3
|
NA
|
ceRNA
|
pathogenic process
|
papillary thyroid cancer;thyroid cancer
|
Endocrine System Diseases;Neoplasms
|
| HSALNT0290063
|
MVIH
|
NA
|
ceRNA
|
pathogenic process
|
hepatocellular cancer;non-small cell lung cancer;breast cancer;microvascular invasion in hepatocellular cancer;hepatocelluar cancer
|
Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Cardiovascular Diseases;Digestive System Diseases
|
| HSALNT0289103
|
LINC01268
|
LOC285758
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0289070
|
LINC00887
|
linc-ATP13A4-8,HEIRCC
|
transcriptional regulation
|
pathogenic process
|
hypoxic and inflammatory renal epithelial injury;renal clear cell cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0288931
|
DHRS4-AS1
|
C14orf167,PRO1488,AS1DHRS4
|
transcriptional regulation
|
NA
|
NA
|
NA
|
| HSALNT0288974
|
FENDRR
|
FOXF1-AS1,TCONS_00024240,lincFOXF1,onco-lncRNA-21
|
transcriptional regulation
|
developmental process;pathogenic process
|
osteosarcoma;gastric cancer;non-small cell lung cancer;lung cancer
|
Respiratory Tract Diseases;Neoplasms;Digestive System Diseases
|
| HSALNT0106473
|
LINC01512
|
LOC100132354,TCONS_00011120,HI-LNC77
|
NA
|
pathogenic process
|
lung adenocarcinoma;type 2 diabetes
|
Respiratory Tract Diseases;Nutritional and Metabolic Diseases;Endocrine System Diseases;Neoplasms
|
| HSALNT0289059
|
LINC00673
|
HI-LNC75,HILNC75,LUCAIR1,SLNCR,SLNCR1
|
transcriptional regulation
|
pathogenic process
|
pancreatic cancer;type 2 diabetes;non-small cell lung cancer;melanoma;Pancreatic ductal adenocarcinoma
|
Neoplasms;Respiratory Tract Diseases;Nutritional and Metabolic Diseases;Endocrine System Diseases;Digestive System Diseases
|
| HSALNT0289107
|
LINC01433
|
LOC728228
|
NA
|
pathogenic process
|
lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0143571
|
CCAT1
|
CARLo-5,onco-lncRNA-40
|
ceRNA
|
pathogenic process
|
gallbladder cancer;glioma;hepatocelluar cancer;ovarian cancer;acute myeloid leukemia;gastric cancer;hepatocellular cancer;non-small cell lung cancer;lung adenocarcinoma;endometrial cancer;lung cancer;breast cancer;colorectal cancer
|
Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases
|
| HSALNT0289408
|
TINCR
|
ENST00000448587.1,FLJ90734,NCRNA00036,LINC00036,onco-lncRNA-16
|
translational control
|
pathogenic process;developmental process
|
bladder cancer;colorectal cancer;esophageal squamous cell cancer;gastric cancer;skin desease;squamous cell cancer
|
Skin and Connective Tissue Diseases;Neoplasms;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases
|
| HSALNT0289152
|
LNCPRESS1
|
lncPRESS1
|
translational control
|
NA
|
NA
|
NA
|
| HSALNT0289145
|
LINC02561
|
RP11-445P17.8
|
NA
|
pathogenic process
|
cystic fibrosis
|
Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases
|
| HSALNT0289065
|
LINC00850
|
KUCG1
|
NA
|
pathogenic process
|
Duchenne muscular dystrophy
|
Musculoskeletal Diseases
|
| HSALNT0289431
|
AFAP1-AS1
|
AFAP1A, AFAP1-A,MGC10981
|
NA
|
pathogenic process
|
non-small cell lung cancer;colorectal cancer;Pancreatic ductal adenocarcinoma;esophageal squamous cell cancer;hepatocellular cancer;nasopharyngeal cancer;lung adenocarcinoma;pancreatic cancer;Barrett's Esophagus;lung cancer
|
Neoplasms;Respiratory Tract Diseases;Stomatognathic Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases
|
| HSALNT0289519
|
XACT
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0248684
|
GATA6-AS1
|
locus5689,BM742401
|
NA
|
pathogenic process
|
gastric cancer;chronic lymphocytic leukemia
|
Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases;Digestive System Diseases
|
| HSALNT0289222
|
PTCSC2
|
NA
|
transcriptional regulation
|
pathogenic process
|
papillary thyroid cancer
|
Endocrine System Diseases;Neoplasms
|
| HSALNT0289655
|
BTG3-AS1
|
ASBEL
|
translational control
|
pathogenic process
|
ovarian cancer;colorectal cancer
|
Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases
|
| HSALNT0289224
|
PTENP1
|
NONHSAT130775,PTENpg1,PTEN2,ENSG00000237984
|
transcriptional regulation;ceRNA
|
pathogenic process
|
gastric cancer;prostate cancer;renal cell cancer;cancer;hepatocelluar cancer
|
Male Urogenital Diseases;Neoplasms;Digestive System Diseases
|
| HSALNT0290129
|
PAN
|
NA
|
transcriptional regulation
|
pathogenic process
|
Kaposi's sarcoma
|
Neoplasms;Virus Diseases
|
| HSALNT0289939
|
LINC-ROR
|
lincRNA-RoR,lincRNA-ST8SIA3,ROR
|
transcriptional regulation;ceRNA
|
pathogenic process
|
gallbladder cancer;liver cancer;glioma;malignant melanoma;unveal melanoma;breast cancer;gastric cancer;hepatocellular cancer;nasopharyngeal cancer;pancreatic cancer;endometrial cancer;triple-negative breast cancer;colorectal cancer
|
Skin and Connective Tissue Diseases;Neoplasms;Stomatognathic Diseases;Female Urogenital Diseases and Pregnancy Complications;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases
|
| HSALNT0290322
|
UBE3A-ATS
|
NA
|
NA
|
pathogenic process
|
Angelman syndrome
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
|
| HSALNT0091004
|
LINC00461
|
EyeLinc1,Visc-1a,Visc-1b,Visc-2,LOC645323
|
NA
|
pathogenic process;developmental process
|
retinal and visual function
|
Eye Diseases
|
| HSALNT0289491
|
CTBP1-AS
|
PCAT10
|
transcriptional regulation
|
pathogenic process
|
chronic hepatitis C;prostate cancer;polycystic ovary syndrome
|
Neoplasms;Male Urogenital Diseases;Virus Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases
|
| HSALNT0037401
|
GACAT1
|
LINC00876,AC096655.1-002
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0120344
|
HOXA-AS2
|
HOXA3as
|
transcriptional regulation
|
pathogenic process
|
promyelocytic leukemia;gastric cancer
|
Neoplasms;Hemic and Lymphatic Diseases;Digestive System Diseases
|
| HSALNT0091313
|
LUCAT1
|
SCAL1
|
transcriptional regulation
|
pathogenic process
|
non-small cell lung cancer;lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0289425
|
BLACAT1
|
linc-UBC1,LINC00912,onco-lncRNA-30
|
transcriptional regulation
|
pathogenic process
|
bladder cancer;gastric cancer
|
Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases
|
| HSALNT0149012
|
GLIDR
|
LINC01172,MGC21881,TCONS_00015562
|
NA
|
pathogenic process
|
glioblastoma
|
Neoplasms
|
| HSALNT0217561
|
PWAR5
|
PAR5,PAR-5
|
NA
|
pathogenic process
|
glioblastoma;Prader-Willi syndrome and Angelman syndrome;Prader-Willi syndrome
|
Nutritional and Metabolic Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Nervous System Diseases
|
| HSALNT0289272
|
TP53TG1
|
TP53AP1,H_RG012D21.9,LINC00096
|
NA
|
pathogenic process
|
non-small cell lung cancer;ataxia telangiectasia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Nutritional and Metabolic Diseases;Cardiovascular Diseases;Nervous System Diseases
|
| HSALNT0289598
|
AK126698
|
NA
|
NA
|
pathogenic process
|
non-small cell lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0217598
|
IPW
|
NCRNA00002
|
transcriptional regulation
|
pathogenic process
|
Prader-Willi syndrome
|
Nutritional and Metabolic Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
|
| HSALNT0143633
|
CCAT2
|
NCCP1,LINC00873
|
transcriptional regulation
|
pathogenic process
|
non-small cell lung cancer;oral squamous cell cancer;colorectal cancer;ovarian cancer;esophageal squamous cell cancer;bladder cancer;small cell lung cancer;gastric cancer;hepatocellular cancer;prostate cancer;cervical squamous cell cancer;lung cancer;breast cancer;cervical cancer
|
Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases
|
| HSALNT0289026
|
LINC00261
|
C20orf56,NCRNA00261,bA216C10.1,HCCDR1,TCONS_00027846,ALIEN,DEANR1,onco-lncRNA-17
|
NA
|
pathogenic process
|
pancreatic cancer;non-small cell lung cancer;gastric cancer
|
Respiratory Tract Diseases;Endocrine System Diseases;Neoplasms;Digestive System Diseases
|
| HSALNT0289078
|
LINC00982
|
FLJ42875
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290082
|
NEAT1_2
|
NEAT1_2
|
protein localization
|
pathogenic process
|
amyotrophic lateral sclerosis
|
Nutritional and Metabolic Diseases;Nervous System Diseases
|
| HSALNT0288989
|
GATA3-AS1
|
NA
|
transcriptional regulation
|
pathogenic process
|
renal cell cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0289427
|
GNG12-AS1
|
NA
|
transcriptional regulation
|
NA
|
NA
|
NA
|
| HSALNT0290395
|
YAM1
|
Yam-1
|
transcriptional regulation
|
pathogenic process;developmental process
|
skeletal myogenesis
|
Musculoskeletal Diseases
|
| HSALNT0289202
|
PAX8-AS1
|
NA
|
NA
|
pathogenic process
|
malignant pleural mesothelioma;cervical cancer
|
Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0054469
|
RASSF1-AS1
|
ANRASSF1
|
transcriptional regulation
|
pathogenic process
|
breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0290261
|
SUMO1P3
|
SUMO1P3
|
NA
|
pathogenic process
|
bladder cancer;gastric cancer
|
Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases
|
| HSALNT0289002
|
HNF1A-AS1
|
C12orf27,NCRNA00262,FLJ38690,HAS1
|
ceRNA
|
pathogenic process
|
esophageal adenocarcinoma;osteosarcoma;esophageal squamous cell cancer;gastric cancer;hepatocellular cancer;nasopharyngeal cancer;adenocarcinoma;lung adenocarcinoma;pancreatic cancer
|
Neoplasms;Respiratory Tract Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases;Stomatognathic Diseases
|
| HSALNT0289377
|
NIPBL-AS1
|
NIPBL-DT,NIPBL-AS
|
NA
|
pathogenic process
|
autism spectrum disorder
|
Mental Disorders
|
| HSALNT0289249
|
SNHG15
|
C7orf40,FLJ38860,MYO1GUT,Linc-Myo1g
|
NA
|
pathogenic process
|
gastric cancer;hepatocellular cancer;hereditary haemorrhagic telangiectasia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases;Neoplasms;Digestive System Diseases
|
| HSALNT0235898
|
MIR22HG
|
C17orf91,MGC14376,DKFZp686O06159
|
NA
|
pathogenic process
|
ovarian cancer
|
Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0235898
|
MIR22HG
|
C17orf91,MGC14376,DKFZp686O06159
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0288984
|
GACAT2
|
MTCL1-AS1,HMlincRNA717
|
NA
|
pathogenic process
|
pancreatic cancer;non-small cell lung cancer;gastric cancer
|
Respiratory Tract Diseases;Endocrine System Diseases;Neoplasms;Digestive System Diseases
|
| HSALNT0289369
|
MIF-AS1
|
LOC284889,MIF-AS
|
transcriptional regulation
|
pathogenic process
|
malaria;nephrolithiasis
|
Skin and Connective Tissue Diseases;Male Urogenital Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Parasitic Diseases
|
| HSALNT0129086
|
LINC-PINT
|
MKLN1-AS1,FLJ43663,PINT,LincRNA-Pint
|
transcriptional regulation
|
pathogenic process
|
colorectal cancer;heart failure
|
Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases;Neoplasms;Digestive System Diseases
|
| HSALNT0289240
|
SCHLAP1
|
LINC00913,SChLAP1,PCAT11
|
transcriptional regulation
|
pathogenic process
|
bladder cancer;prostate cancer
|
Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0193241
|
SOCS2-AS1
|
NA
|
transcriptional regulation
|
pathogenic process
|
prostate cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0138824
|
CASC9
|
ESCCAL-1,ESSCAL1,LINC00981
|
NA
|
pathogenic process
|
esophageal squamous cell cancer;esophageal cancer
|
Neoplasms
|
| HSALNT0267627
|
HNF4A-AS1
|
uc002xlx
|
NA
|
pathogenic process
|
lung adenocarcinoma
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0289194
|
NKILA
|
NA
|
NA
|
pathogenic process
|
nasopharyngeal cancer;breast cancer;tongue squamous cell cancer
|
Skin and Connective Tissue Diseases;Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
|
| HSALNT0289304
|
LINC00942
|
NA
|
NA
|
pathogenic process
|
ovarian cancer;autism spectrum disorder
|
Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Mental Disorders;Neoplasms
|
| HSALNT0289187
|
MNX1-AS1
|
CCAT5,LOC645249
|
NA
|
pathogenic process
|
ovarian cancer;colorectal cancer
|
Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases
|
| HSALNT0289518
|
VPS9D1-AS1
|
MYU
|
NA
|
pathogenic process
|
ovarian cancer;colorectal cancer
|
Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases
|
| HSALNT0290266
|
TC0101441
|
NA
|
NA
|
pathogenic process
|
epithelial ovarian cancer
|
Neoplasms
|
| HSALNT0289426
|
ERLNC1
|
TC0101441,ElncRNA1
|
NA
|
pathogenic process
|
ovarian cancer
|
Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0290050
|
Mdgt
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0043560
|
HAGLR
|
HOXD-AS1,Mdgt
|
NA
|
pathogenic process
|
bladder cancer;neuroblastoma
|
Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0289092
|
LINC01158
|
PANTR1,linc-Brn1a,linc-POU3F3
|
transcriptional regulation
|
pathogenic process;developmental process
|
esophageal squamous cell cancer;gastric cancer;glioma
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289448
|
GHET1
|
lncRNA-GHET1
|
NA
|
pathogenic process
|
bladder cancer;gastric cancer;colorectal cancer
|
Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases
|
| HSALNT0289514
|
PEG13
|
NA
|
transcriptional regulation
|
pathogenic process
|
intellectual disabilities
|
Behavior and Behavior Mechanisms;Pathological Conditions, Signs and Symptoms;Mental Disorders;Nervous System Diseases
|
| HSALNT0289183
|
MIR503HG
|
MGC16121,H19X
|
NA
|
pathogenic process
|
choriocarcinoma
|
Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0289201
|
PAUPAR
|
NA
|
transcriptional regulation
|
pathogenic process;developmental process
|
uveal melanoma
|
Neoplasms
|
| HSALNT0288956
|
LINC01234
|
LCAL84,onco-lncRNA-32
|
ceRNA
|
pathogenic process
|
oesophageal squamous cell cancer;breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0289021
|
CYTOR
|
C2orf59,NCRNA00152,MGC4677
|
transcriptional regulation;ceRNA
|
pathogenic process
|
colorectal cancer;gastric cancer;hepatocellular cancer;pancreatic cancer;breast cancer;renal cell cancer
|
Skin and Connective Tissue Diseases;Neoplasms;Male Urogenital Diseases;Endocrine System Diseases;Digestive System Diseases
|
| HSALNT0289706
|
CHRF
|
NA
|
ceRNA
|
pathogenic process
|
cardiac hypertrophy;silicosis
|
Respiratory Tract Diseases;Occupational Diseases;Cardiovascular Diseases
|
| HSALNT0143635
|
CASC8
|
LINC00860,CARLo-1
|
NA
|
pathogenic process
|
lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0143672
|
CASC11
|
TCONS_00014535,LINC00990,CARLo-7,ENST00000518376
|
transcriptional regulation
|
pathogenic process
|
hepatocellular cancer;colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289032
|
LINC00323
|
PRED42,FLJ37173
|
NA
|
pathogenic process
|
breast cancer;hereditary haemorrhagic telangiectasia
|
Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases;Neoplasms
|
| HSALNT0024655
|
LINC01139
|
LINK-A,TCONS_00000027
|
NA
|
pathogenic process
|
hereditary haemorrhagic telangiectasia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0289018
|
LEF1-AS1
|
NA
|
NA
|
pathogenic process
|
hereditary haemorrhagic telangiectasia;colorectal cancer
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases;Neoplasms;Digestive System Diseases
|
| HSALNT0247326
|
LINC00667
|
NA
|
NA
|
pathogenic process
|
hereditary haemorrhagic telangiectasia
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
|
| HSALNT0290145
|
POU3F3
|
NA
|
transcriptional regulation
|
pathogenic process
|
esophageal squamous cell cancer;glioma
|
Neoplasms
|
| HSALNT0199349
|
LINC00426
|
NA
|
NA
|
pathogenic process
|
primary Sjögren's syndrome
|
Immune System Diseases
|
| HSALNT0155974
|
LINC00963
|
MetaLnc9
|
NA
|
pathogenic process
|
prostate cancer;renal cell cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0289211
|
PCF11-AS1
|
NA
|
NA
|
pathogenic process
|
hepatocellular cancer;adolescent idiopathic scoliosis
|
Musculoskeletal Diseases;Neoplasms;Digestive System Diseases
|
| HSALNT0289534
|
91H
|
NA
|
transcriptional regulation
|
pathogenic process
|
osteosarcoma;esophageal squamous cell cancer;breast cancer;colorectal cancer
|
Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases
|
| HSALNT0289446
|
ELFN1-AS1
|
MYCLo-2
|
transcriptional regulation
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0288883
|
ACTA2-AS1
|
uc001kfo.1,ZXF1
|
NA
|
pathogenic process
|
lung adenocarcinoma
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0289443
|
APTR
|
RSBN1L-AS1
|
transcriptional regulation
|
pathogenic process
|
liver fibrosis;glioblastoma
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289986
|
lncRNA-MVIH
|
NA
|
NA
|
pathogenic process
|
hepatocellular cancer;non-small cell lung cancer
|
Respiratory Tract Diseases;Neoplasms;Digestive System Diseases
|
| HSALNT0289977
|
lncRNA-ATB
|
NA
|
ceRNA
|
pathogenic process
|
colorectal cancer;hepatocelluar cancer;gastric cancer;pancreatic cancer;renal cell cancer;pneumoconiosis
|
Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Occupational Diseases;Endocrine System Diseases;Digestive System Diseases
|
| HSALNT0289622
|
ATB
|
NA
|
ceRNA
|
pathogenic process
|
prostate cancer;glioma;keloid;gastric cancer;hepatocellular cancer;pancreatic cancer;breast cancer;colorectal cancer
|
Pathological Conditions, Signs and Symptoms;Skin and Connective Tissue Diseases;Neoplasms;Tissues;Male Urogenital Diseases;Endocrine System Diseases;Digestive System Diseases
|
| HSALNT0289586
|
AK057054
|
NA
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0278370
|
LINC01315
|
lnc-C22orf32-1,C22orf32-1
|
NA
|
pathogenic process
|
nasopharyngeal cancer
|
Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
|
| HSALNT0055601
|
ADAMTS9-AS2
|
NA
|
NA
|
pathogenic process
|
non-small cell lung cancer;glioma
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0289383
|
PACERR
|
PACER,PTGS2-AS1
|
transcriptional regulation
|
pathogenic process
|
osteosarcoma;osteoarthritis;inflammation and cancer
|
Musculoskeletal Diseases;Neoplasms
|
| HSALNT0289268
|
TGFB2-OT1
|
FLJ11812
|
ceRNA
|
NA
|
NA
|
NA
|
| HSALNT0288938
|
DUBR
|
LINC00883
|
ceRNA
|
pathogenic process
|
asthma and chronic obstructive pulmonary disease
|
Respiratory Tract Diseases
|
| HSALNT0290147
|
POXCUT
|
TCONS_00011636
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289440
|
FOXCUT
|
LINC01379,TCONS_00011636
|
transcriptional regulation
|
pathogenic process
|
esophageal squamous cell cancer;basal-like breast cancer;oral squamous cell cancer
|
Neoplasms
|
| HSALNT0288924
|
CYP51A1-AS1
|
ENST00000453068,LRRD1-AS1
|
NA
|
pathogenic process
|
renal cell cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0289395
|
RPL34-AS1
|
FLJ37673,RP11-462C24.1
|
NA
|
pathogenic process
|
gastric cancer;colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289435
|
C5orf66-AS1
|
CTC-276P9.1,Epist
|
NA
|
pathogenic process
|
esophageal squamous cell cancer;bladder cancer
|
Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0289052
|
LINC00623
|
NA
|
NA
|
pathogenic process
|
nasopharyngeal cancer
|
Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
|
| HSALNT0289831
|
FER1L4
|
FER1L4
|
ceRNA
|
pathogenic process
|
gastric cancer;endometrial cancer;colorectal cancer
|
Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases
|
| HSALNT0288985
|
GACAT3
|
LINC01458,lncRNA-AC130710
|
NA
|
pathogenic process
|
ovarian cancer;gastric cancer
|
Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases
|
| HSALNT0288881
|
ABHD11-AS1
|
WBSCR26,LINC00035,NCRNA00035
|
NA
|
pathogenic process
|
gastric cancer;mutant huntingtin
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Digestive System Diseases
|
| HSALNT0282263
|
ZNF674-AS1
|
NA
|
NA
|
pathogenic process
|
hepatocellular cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289207
|
PCAT29
|
NA
|
NA
|
pathogenic process
|
prostate cancer;glioma;bladder cancer;renal clear cell cancer;skin melanoma;hepatocellular cancer;lung adenocarcinoma;stomach adenocarcinoma
|
Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases
|
| HSALNT0289672
|
CADM1
|
NA
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289297
|
LINC01527
|
lnc-SPRR2D-1,RP1-13P20.6
|
NA
|
pathogenic process
|
squamous cell cancer
|
Neoplasms
|
| HSALNT0289158
|
LUNAR1
|
NA
|
transcriptional regulation
|
pathogenic process
|
diffuse large B-cell lymphoma;T cell acute lymphoblastic leukemia
|
Hemic and Lymphatic Diseases
|
| HSALNT0289830
|
FAR2P1
|
NA
|
NA
|
pathogenic process
|
lung adenocarcinoma;non-small cell lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0289263
|
TARID
|
EYA4-AS1
|
transcriptional regulation
|
pathogenic process
|
kidney clear cell sarcoma
|
Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0145373
|
MAFA-AS1
|
RP11-909N17.3,TCONS_00014882
|
NA
|
pathogenic process
|
lung adenocarcinoma;non-small cell lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0290229
|
RPLP0P2
|
RPLP0P2
|
NA
|
pathogenic process
|
lung adenocarcinoma
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0289291
|
ZNF295-AS1
|
C21orf121,NCRNA00318,PRED87
|
NA
|
pathogenic process
|
lung adenocarcinoma;epithelial ovarian cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0084473
|
LINC01513
|
RP11-1C1.7,TCONS_00009352
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0289471
|
IRAIN
|
IGF1R-AS
|
transcriptional regulation
|
pathogenic process
|
pancreatic cancer;acute myeloid leukemia;non-small cell lung cancer;breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Endocrine System Diseases;Digestive System Diseases
|
| HSALNT0290402
|
ZNRD1-AS1
|
NA
|
NA
|
pathogenic process
|
hepatocellular cancer;lung cancer;cervical cancer
|
Respiratory Tract Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases
|
| HSALNT0289504
|
LCAL1
|
onco-lncRNA-27
|
NA
|
pathogenic process
|
lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0289169
|
MHRT
|
Myheart
|
transcriptional regulation
|
pathogenic process
|
heart hypertrophy;acute myocardial infarction
|
Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases
|
| HSALNT0289859
|
HA117
|
NA
|
NA
|
pathogenic process
|
hirschsprung disease
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases
|
| HSALNT0026673
|
NRIR
|
lncRNA-CMPK2
|
transcriptional regulation
|
pathogenic process
|
chronic hepatitis C;HCV
|
Digestive System Diseases;Virus Diseases
|
| HSALNT0289887
|
LET
|
NA
|
NA
|
pathogenic process
|
gallbladder cancer;esophageal squamous cell cancer;gastric cancer;nasopharyngeal cancer;renal cell cancer;cervical cancer
|
Neoplasms;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Otorhinolaryngologic Diseases;Digestive System Diseases;Stomatognathic Diseases
|
| HSALNT0007921
|
NFIA-AS1
|
RP5-833A20.1
|
transcriptional regulation
|
pathogenic process
|
atherosclerosis;glioma
|
Cardiovascular Diseases;Neoplasms
|
| HSALNT0247156
|
GAPLINC
|
LINC01540,TCONS_00026238,lncRNA-uc002kmd.1
|
siRNA
|
pathogenic process
|
gastric cancer;colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0288917
|
CERNA2
|
HOST2,lncRNA-HOST2
|
ceRNA
|
pathogenic process
|
hepatocellular cancer;epithelial ovarian cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289113
|
LINC01564
|
TCONS_00011314
|
NA
|
pathogenic process
|
prostate cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0289088
|
LINC01105
|
FLJ30594,LOC150622
|
NA
|
pathogenic process
|
gastric cancer;leukemia and neuroblastoma
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289464
|
AGAP2-AS1
|
LOC100130776,PUNISHER
|
transcriptional regulation
|
pathogenic process
|
non-small cell lung cancer;glioma;leukemia and neuroblastoma
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0288960
|
EWSAT1
|
TMEM84,NCRNA00277,LINC00277,FLJ33768
|
transcriptional regulation
|
pathogenic process
|
Ewing sarcoma
|
Neoplasms
|
| HSALNT0289242
|
SLC25A25-AS1
|
NA
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289317
|
KCNK15-AS1
|
RP11-445H22.4
|
NA
|
pathogenic process
|
osteoarthritis;breast cancer
|
Musculoskeletal Diseases;Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0289864
|
HIF2PUT
|
NA
|
NA
|
pathogenic process
|
osteosarcoma;colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289267
|
TEX41
|
DKFZp686O1327,LINC00953
|
transcriptional regulation
|
NA
|
NA
|
NA
|
| HSALNT0290361
|
UFC1
|
NA
|
transcriptional regulation;ceRNA
|
pathogenic process
|
osteoarthritis;hepatocellular cancer
|
Musculoskeletal Diseases;Neoplasms;Digestive System Diseases
|
| HSALNT0289886
|
LEIGC
|
NA
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289367
|
MDC1-AS1
|
MDC1-AS
|
NA
|
pathogenic process
|
bladder cancer;glioma
|
Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0289190
|
NBAT1
|
CASC14,NBAT-1
|
transcriptional regulation
|
pathogenic process
|
breast cancer;renal clear cell cancer;neuroblastoma
|
Skin and Connective Tissue Diseases;Male Urogenital Diseases;Neoplasms
|
| HSALNT0234826
|
LINC00917
|
NA
|
NA
|
pathogenic process
|
intervertebral disc degeneration;breast cancer
|
Musculoskeletal Diseases;Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0289419
|
LINC00173
|
NCRNA00173,FLJ42957
|
NA
|
pathogenic process
|
HIV-1-infected;hepatocelluar cancer
|
Virus Diseases;Neoplasms;Digestive System Diseases
|
| HSALNT0290138
|
PEG10
|
NA
|
NA
|
pathogenic process
|
diffuse large B-cell lymphoma;esophageal cancer
|
Neoplasms;Hemic and Lymphatic Diseases
|
| HSALNT0289136
|
LINC02224
|
BRCAT107,ENST00000505706
|
NA
|
pathogenic process
|
active tuberculosis
|
Bacterial Infections and Mycoses
|
| HSALNT0289866
|
HIT
|
NA
|
transcriptional regulation
|
pathogenic process
|
non-small cell lung cancer;breast cancer
|
Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0003927
|
SNHG12
|
ASLNC04080,C1orf79,LINC00100,NCRNA00100,PNAS-123
|
NA
|
pathogenic process
|
osteosarcoma;endometrial cancer
|
Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0289099
|
LINC01225
|
NA
|
NA
|
pathogenic process
|
hepatocelluar cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0290047
|
MALAT2
|
NA
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0176345
|
SNHG1
|
LINC00057,NCRNA00057,U22HG,UHG,lncRNA16
|
NA
|
pathogenic process
|
astrocytoma;hepatocellular cancer;non-small cell lung cancer;Parkinson's disease;neuroblastoma
|
Respiratory Tract Diseases;Neoplasms;Digestive System Diseases;Nervous System Diseases
|
| HSALNT0094592
|
WSPAR
|
TCONS_00009511-XLOC_004555,lncTCF7
|
transcriptional regulation
|
pathogenic process
|
hepatocellular cancer;liver cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289308
|
LINC00511
|
onco-lncRNA-12
|
NA
|
pathogenic process
|
lung adenocarcinoma;breast cancer
|
Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0289452
|
FAM83H-AS1
|
onco-lncRNA-3
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0289041
|
LINC00472
|
C6orf155,dJ288M22.3,FLJ13189
|
NA
|
pathogenic process
|
ovarian cancer;breast cancer
|
Skin and Connective Tissue Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Endocrine System Diseases
|
| HSALNT0289925
|
linc-ITGB1
|
NA
|
NA
|
pathogenic process
|
gallbladder cancer;breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases
|
| HSALNT0016239
|
LINC01133
|
lncRNA-PAGBC
|
transcriptional regulation
|
pathogenic process
|
non-small cell lung cancer;colorectal cancer;lung squamous cell cancer
|
Respiratory Tract Diseases;Neoplasms;Digestive System Diseases
|
| HSALNT0289489
|
CCEPR
|
CCHE1,lncRNA-CCHE1
|
transcriptional regulation
|
pathogenic process
|
hepatocellular cancer;cervical cancer
|
Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases
|
| HSALNT0289402
|
SOX21-AS1
|
NA
|
NA
|
pathogenic process
|
lung adenocarcinoma;oral squamous cell cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0288905
|
CASC15
|
LINC00340,lnc-SOX4-1
|
NA
|
pathogenic process
|
basal cell cancer;melanoma;neuroblastoma
|
Neoplasms
|
| HSALNT0289555
|
AC104699.1
|
NA
|
NA
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0096322
|
CLMAT3
|
SPARC-AS1
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289233
|
RGMB-AS1
|
NA
|
NA
|
pathogenic process
|
lung adenocarcinoma;non-small cell lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0289908
|
LINC01419
|
LVCAT7,TCONS_00014497
|
NA
|
pathogenic process
|
hepatocelluar cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289541
|
AB209630
|
NA
|
NA
|
pathogenic process
|
hypopharyngeal squamous cell cancer
|
Neoplasms
|
| HSALNT0289608
|
AOC4P
|
AOC4P
|
NA
|
pathogenic process
|
colorectal cancer;hepatocelluar cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289082
|
PURPL
|
LINC01021,LOC643401,RP11-46C20.1
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0196121
|
LINC01089
|
LIMT
|
NA
|
pathogenic process
|
breast cancer;astrocytoma
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0123080
|
EGFR-AS1
|
NA
|
NA
|
pathogenic process
|
hepatocellular cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289539
|
AB073614
|
NA
|
NA
|
pathogenic process
|
ovarian cancer;glioma
|
Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0242418
|
CACNA1G-AS1
|
NA
|
NA
|
pathogenic process
|
keloid
|
Pathological Conditions, Signs and Symptoms;Skin and Connective Tissue Diseases;Tissues
|
| HSALNT0170814
|
MIR210HG
|
NA
|
transcriptional regulation
|
pathogenic process
|
hypoxic and inflammatory stress
|
NA
|
| HSALNT0288979
|
FOXC2-AS1
|
ODRUL
|
NA
|
pathogenic process
|
osteosarcoma
|
Neoplasms
|
| HSALNT0289022
|
LINC00160
|
C21orf52,NCRNA00160
|
NA
|
pathogenic process
|
breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0105274
|
LINC01016
|
NA
|
NA
|
pathogenic process
|
breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0288904
|
CARMN
|
MIR143HG,CARMEN
|
transcriptional regulation
|
pathogenic process
|
cardiac differentiation
|
Cardiovascular Diseases
|
| HSALNT0289123
|
LINC01630
|
LOC100287225
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0288971
|
FAM30A
|
C14orf110,KIAA0125,HSPC053
|
NA
|
pathogenic process
|
gallbladder cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289506
|
LINC00346
|
C13orf29,NCRNA00346
|
NA
|
pathogenic process
|
hepatocellular cancer;breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases
|
| HSALNT0289643
|
BC032469
|
NA
|
ceRNA
|
pathogenic process
|
esophageal squamous cell cancer;gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289580
|
AK024171
|
NA
|
NA
|
pathogenic process
|
intervertebral disc degeneration;gastric cancer
|
Musculoskeletal Diseases;Neoplasms;Digestive System Diseases
|
| HSALNT0290187
|
RP11-284N8.3.1
|
NA
|
NA
|
pathogenic process
|
ovarian cancer
|
Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0289839
|
FMR6
|
NA
|
NA
|
pathogenic process
|
fragile X syndrome;fragile X-associated premature ovarian insufficiency
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Female Urogenital Diseases and Pregnancy Complications;Nervous System Diseases
|
| HSALNT0290152
|
PRAL
|
lncRNA-PRAL
|
NA
|
pathogenic process
|
hepatocellular cancer;lung cancer
|
Respiratory Tract Diseases;Neoplasms;Digestive System Diseases
|
| HSALNT0289380
|
NORAD
|
LINC00657
|
transcriptional regulation;translational control
|
pathogenic process
|
breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0086803
|
LIFR-AS1
|
NA
|
NA
|
pathogenic process
|
preterm
|
Female Urogenital Diseases and Pregnancy Complications
|
| HSALNT0076183
|
PANCR
|
NA
|
NA
|
pathogenic process
|
atrial fibrillation
|
Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases
|
| HSALNT0288975
|
FEZF1-AS1
|
NA
|
transcriptional regulation
|
pathogenic process
|
gastric cancer;colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0238475
|
CCDC144NL-AS1
|
NA
|
ceRNA
|
pathogenic process
|
ovarian cancer;cardiac hypertrophy
|
Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Cardiovascular Diseases;Neoplasms
|
| HSALNT0290102
|
NR_026689
|
NA
|
NA
|
pathogenic process
|
ovarian cancer;lung cancer
|
Respiratory Tract Diseases;Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0289522
|
ADARB2-AS1
|
C10orf109,NCRNA00168,bA466B20.1
|
NA
|
pathogenic process
|
breast cancer;pancreatic ductal adenocarcinoma
|
Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0288936
|
DPP10-AS1
|
BC032913
|
NA
|
pathogenic process
|
breast cancer;colorectal cancer
|
Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases
|
| HSALNT0289474
|
GAS8-AS1
|
C16orf3
|
NA
|
pathogenic process
|
papillary thyroid cancer;breast cancer
|
Skin and Connective Tissue Diseases;Endocrine System Diseases;Neoplasms
|
| HSALNT0289063
|
MANCR
|
LINC00704
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0289238
|
SAMMSON
|
LINC01212
|
NA
|
pathogenic process
|
melanoma
|
Neoplasms
|
| HSALNT0289027
|
LINC00302
|
C1orf46,NCRNA00302,XP33
|
NA
|
developmental process
|
NA
|
NA
|
| HSALNT0245543
|
SNHG20
|
C17orf86,NCRNA00338,LINC00338,PRO0872,FLJ25582,DKFZp686L05235,SCARNA16HG
|
transcriptional regulation
|
pathogenic process
|
hepatocellular cancer;colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0015631
|
DCST1-AS1
|
RP11-307C12.11
|
NA
|
pathogenic process
|
ovarian cancer
|
Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0149810
|
PGM5-AS1
|
FAM233A,LOC572558
|
NA
|
pathogenic process
|
bladder cancer
|
Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0290236
|
SBF2-AS1
|
NA
|
transcriptional regulation
|
pathogenic process
|
non-small cell lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0290325
|
uc.338
|
NA
|
transcriptional regulation
|
pathogenic process
|
hepatocellular cancer;lung cancer
|
Respiratory Tract Diseases;Neoplasms;Digestive System Diseases
|
| HSALNT0289973
|
LNCRI
|
lnc-RI
|
ceRNA
|
NA
|
NA
|
NA
|
| HSALNT0290002
|
LOC100130476
|
NA
|
NA
|
pathogenic process
|
esophageal squamous cell cancer;gastric cardia adenocarcinoma
|
Neoplasms
|
| HSALNT0289049
|
LINC00599
|
Rncr3
|
NA
|
pathogenic process
|
diabetes
|
Endocrine System Diseases
|
| HSALNT0020406
|
LINC00628
|
NA
|
transcriptional regulation
|
pathogenic process
|
gastric cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0289478
|
DSCR4
|
DCRB
|
NA
|
pathogenic process
|
Down syndrome
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
|
| HSALNT0017675
|
GAS5-AS1
|
NA
|
NA
|
pathogenic process
|
oral submucous fibrosis;non-small cell lung cancer
|
Respiratory Tract Diseases;Neoplasms;Stomatognathic Diseases
|
| HSALNT0289523
|
HCG11
|
bK14H9.3,FLJ14049,FLJ30357
|
NA
|
pathogenic process
|
prostate cancer
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0134828
|
LINC02099
|
AC145110.1
|
NA
|
pathogenic process
|
rheumatoid arthritis;breast cancer
|
Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases;Neoplasms
|
| HSALNT0209098
|
G2E3-AS1
|
CAT1647
|
NA
|
pathogenic process
|
bladder cancer
|
Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0289139
|
LINC02245
|
lnc-SERTAD2-3,AC007386.2
|
NA
|
pathogenic process
|
ovarian cancer
|
Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
|
| HSALNT0008167
|
FOXD3-AS1
|
pasFOXD3
|
transcriptional regulation
|
pathogenic process
|
glioma
|
Neoplasms
|
| HSALNT0289335
|
LINC00998
|
NA
|
NA
|
pathogenic process
|
major depression disorder
|
Behavior and Behavior Mechanisms
|
| HSALNT0289379
|
NNT-AS1
|
NA
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0055497
|
PSMD6-AS1
|
ENST00000462717,lnc00462717
|
NA
|
pathogenic process
|
papillary thyroid cancer;glioma
|
Endocrine System Diseases;Neoplasms
|
| HSALNT0289130
|
LINC02081
|
CTD-2357A8.3,XLOC_012582
|
NA
|
pathogenic process
|
esophageal cancer
|
Neoplasms
|
| HSALNT0289306
|
LINC00052
|
TMEM83,NCRNA00052,FLJ31461
|
ceRNA
|
pathogenic process
|
hepatocellular cancer;breast cancer
|
Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases
|
| HSALNT0199070
|
PLUT
|
PDX1-AS1,PLUTO,HI-LNC71
|
transcriptional regulation
|
pathogenic process
|
type 2 diabetes
|
Nutritional and Metabolic Diseases;Endocrine System Diseases
|
| HSALNT0289341
|
LINC01505
|
RP11-308N19.1
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0289315
|
LINC01116
|
TALNEC2
|
transcriptional regulation
|
pathogenic process
|
prostate cancer;glioblastoma
|
Male Urogenital Diseases;Neoplasms
|
| HSALNT0006439
|
FOXD2-AS1
|
MGC12982
|
NA
|
pathogenic process
|
lung cancer
|
Respiratory Tract Diseases;Neoplasms
|
| HSALNT0252387
|
LINC00305
|
C18orf20,NCRNA00305,MGC39571,HsT1235
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289473
|
FBXL19-AS1
|
NCRNA00095,MGC125469,MGC125470,MGC125472
|
NA
|
pathogenic process
|
colorectal cancer
|
Neoplasms;Digestive System Diseases
|
| HSALNT0187807
|
LINC02555
|
AC079630.2
|
NA
|
pathogenic process
|
papillary thyroid cancer
|
Endocrine System Diseases;Neoplasms
|
| HSALNT0251493
|
LINC01929
|
CTD-2171N6.1
|
NA
|
pathogenic process
|
papillary thyroid cancer
|
Endocrine System Diseases;Neoplasms
|
| HSALNT0244776
|
LINC01152
|
TCONS_00025128,CMPD
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0284591
|
DIAPH2-AS1
|
NA
|
NA
|
pathogenic process
|
Hodgkin's disease
|
Neoplasms
|
| HSALNT0289226
|
PWAR1
|
PAR1,PAR-1
|
NA
|
pathogenic process
|
Prader-Willi syndrome and Angelman syndrome
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
|
| HSALNT0289339
|
LINC00950
|
FP588
|
NA
|
NA
|
NA
|
NA
|
| HSALNT0289740
|
DGCR12
|
DGS-E
|
NA
|
pathogenic process;developmental process
|
DiGeorge syndrome
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Hemic and Lymphatic Diseases;Musculoskeletal Diseases;Cardiovascular Diseases;Endocrine System Diseases
|
| HSALNT0275220
|
DGCR9
|
DGS-A,POM121L5P
|
NA
|
pathogenic process
|
DiGeorge syndrome
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Hemic and Lymphatic Diseases;Musculoskeletal Diseases;Cardiovascular Diseases;Endocrine System Diseases
|
| HSALNT0288929
|
DGCR10
|
DGS-B
|
NA
|
pathogenic process
|
NA
|
NA
|
| HSALNT0289494
|
DGCR11
|
DGS-D
|
NA
|
pathogenic process
|
NA
|
NA
|
